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ABSTRACT
Adsorbent solid phases having suitable designs applicable to the generic recovery of 
nanoparticulate products have been demonstrated. Practical recovery of nanoparticulate 
mimics, of products such as plasmid DNA and viruses, as putative gene therapy vectors from 
both single component model systems and complex feedstocks has been studied.
The adsorbents employed in the study had one of four discrete designs (Type I-IV), 
including (I) microporous (pore size 0.02um- 0.2um), (II) macroporous (pore size > 0.6um), 
(III) solid (non-porous) and (IV) pellicular (pore size 0.2nm-0.4um). Commercially available 
adsorbents (STREAMLINE, Amersham Biosciences; Toyopearl HW-40, Tosohaas; POROS 
SOD, Applied Biosystems) and custom designed adsorbents (PVA composites supplied by 
Igor Galaev, Lund University; Celbead adsorbents supplied by Arvind Lali, Mumbai 
University; 2% ZsA and perfluorocarbon emulsions developed at the University of 
Birmingham) were included in the study.
The adsorbents were evaluated exploiting ligands appropriate for both anion exchange 
and pseudo-affinity chromatography employing both soluble and particulate forms of bovine 
and human serum albumin. Soluble protein was included in the study to represent cellular 
components of complex feedstocks and the separation of assemblies from components, whilst 
particulate protein, fabricated by coacervation and crosslinking procedures, served as 
surrogate size and charge mimics of less easily sourced viral and plasmid gene therapy 
vectors. Insect cell culture lysate was employed as an industrially relevant feedstock and 
experiments were completed exploiting representative nanoparticulate production systems.
Candidate adsorbents were physically characterised to assess their suitability for 
fluidised bed operation and biochemically characterised exploiting batch binding 
experimentation and laser scanning confocal microscopy. The adsorptive capacity and 
desorption efficiency of both nanoparticulate products and cellular component were strongly 
influenced by the physical design and geometry of the adsorbent solid phases together with 
the concentrations of interacting chemical ligands available for adsorption.
Microporous adsorbents (as defined above) developed for the purification of 
macromolecular products appeared to be less suited for the recovery of nanoparticulate 
products from complex feedstocks than macroporous or pellicular adsorbents.
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CHAPTER 1 
INTRODUCTION
1.1 Downstream Processing in the Bioprocessing Industry
There has been much interest generated in the recovery of (i) nanoparticulate products 
such as plasmid DNA and viruses as putative gene therapy vectors, (ii) macromolecular 
assemblies as drug delivery vehicles and (iii) virus like particles as vaccine components 
(Prazeres et al, 1998; Andreadis et al, 1999). These nanoparticulate products have been 
recovered from complex feedstocks such as cell culture supernatants, fermentation broths and 
cell disruptates using techniques collectively described as downstream processing (DSP; 
Wheelwright, 1987). The objective of DSP is to determine a sequence of steps that will result 
in the generation of a desired product from the initial starting material. The individual steps 
tend to be designed based upon the biochemical and molecular behaviour of the desired 
product and the impurities within the system. This enables the establishment of an efficient 
and economic process that achieves the purity and specification of the end product required.
As a consequence of the sensitivity of nanoparticulate and protein products to 
temperature, pH, chemical reagents or processes that compromise the 3-dimensional structure 
and conformation of the product, a general approach to the downstream processing of such 
products has evolved (see Figure 1.1). However, individual steps during a purification 
process are product specific. Typical nanoparticulate products that require purification for 
gene therapy applications include viruses, such as adenoviruses, retroviruses and adeno- 
associated viruses and plasmid DNA (Lorens et al, 2001). For such products there are several 
criteria for the selection of appropriate techniques. The protocols selected must be capable of 
processing large volumes of viral/plasmid preparations having high yields and it is essential 
that the stability and activity of the product be preserved. As for any downstream processing 
procedure the operation must be easily scalable and have a relatively low cost. Finally the
Figure 1.1 Conventional downstream processing for nanoparticulate products
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Figure 1.1 represents the conventional downstream processing steps required for the 
purification of nanoparticulate products such as plasmid DNA and viruses.
processing of the end product must meet the Food and Drug Administration (PDA) standards 
for biological therapeutics (Andreadis et al, 1999; Levy et al, 2000).
In the literature the downstream processing procedures employed for the purification 
of nanoparticulate products follow the same general procedures that have been developed for 
the purification of protein products. The initial DSP step is concerned with harvesting the 
product. In the case of viruses such as retrovirus, this involves the recovery from clarified 
cell culture supernatant, whilst plasmid DNA is harvested by alkaline cell lysis to release the 
DNA from within the host cell (Andreadis et al, 1999; Prazeres et al, 1999). As a 
consequence of the complex feedstocks associated with cell culture supernatants and cell 
lysates prior to purification there is the need for clarification and concentration of the 
product. Clarification is generally achieved using centrifugation methods that have been 
shown to be robust and operable procedures at process scale (Phillips et al, 1985), whilst 
concentration is achieved using precipitation, ultrafiltration/diafiltration or density gradient 
centrifugation techniques (Shabram et al, 1997; Andreadis et al, 1999; Ferreira et al, 2000). 
Subsequent purification is commonly achieved by chromatographic adsorption. Affinity, ion 
exchange and hydrophobic interaction chromatography have been described as effective tools 
for the primary purification of nanoparticulate products (Ferreira et al, 2000).
Fixed bed chromatography is generally exploited for the purification procedures, and 
consequently the preliminary clarification and concentration of the feedstock is an essential 
requirement. If this is not undertaken the particulate material within the feedstock will 
become trapped within the voids of the bed which leads to the formation of a plug that 
distorts or obstructs the flow of the liquid through the bed compromising the efficiency of the 
separation (Bierau et al, 2001).
1.2 General Problems Associated with Downstream Processing of Nanoparticulate 
Products
The number of downstream processing steps required to achieve the desired purity of 
a product considerably influences the cost of DSP. Datar et al (1993) and Lyddiatt and 
O'Sullivan (1998) have suggested that DSP can account for 70-80% of the total production 
costs due to the capital investment and amount of consumables required for each step and the 
time required for each individual operation. With each additional step there are also inherent 
handling losses affecting the recovery of the final product and the product activity.
The traditional techniques employed for the purification of nanoparticulates are not 
necessarily the ideal DSP operations for such products. The initial clarification step is often 
carried out using centrifugation or cross-flow filtration (Kahn et al, 2000). Their relative 
success in terms of the resolution of fractionation is dependent upon the differences in size 
and density between the product, product components and the cell debris and impurities. Also 
the potential for batch to batch variation of nucleic acid content influences the viscosity of 
the feedstock (Braas et al, 1996). If centrifugation is chosen as the desired operation for the 
clarification of the feedstock the hydrodynamic shear effects upon the nanoparticulates 
(viruses, plasmid DNA etc.) must be considered when using an industrial centrifuge (Brunner 
and Hemfort, 1988). Cross-flow filtration has also demonstrated process advantages, 
although Aimar et al (1989) and Walker (1998) highlighted that the pore size distribution of a 
clean membrane is constantly modified due to fouling. Consequently the resolution of the 
nanoparticle fraction will be compromised. This is also a factor influencing the use of 
ultra/diafiltration for the product concentration operational step. Other DSP operations 
employed for product concentration have also demonstrated practical limitations (Andreadis 
et al, 1999; Levy et al, 2000). Precipitation using reagents such as polyethylene glycol (PEG) 
or ammonium sulphate and density gradient centrifugation methods employing sucrose or
caesium chloride co-concentrate impurities such as inhibitors resulting in a loss of product 
activity and integrity.
1.3 Approaches to Optimising Downstream Processing Techniques for Nanoparticulate 
Products
The major problem associated with the downstream processing of nanoparticulate 
products is the loss of product integrity due to the number of operational steps required to 
clarify and concentrate the desired product. The ideal process is that whereby preliminary 
capture of the target product from the bulk feedstock is achieved by a process that combines 
clarification, concentration and product capture in a single unit operation.
There are four general approaches described in the literature that match the criteria 
required for the processing of biologically sensitive products. Aqueous two phase systems 
(ATPS) are liquid-liquid extraction systems formed by the mixing of aqueous solutions of 
polymers (e.g. poly-ethylene glycol, poly-vinyl alcohol) and second polymers or salt 
(dextran, modified starch, phosphate). Above critical concentrations there is a formation of 
two water rich phases (Huddleston et al, 1991). Complex feedstocks containing high 
biomass loads can be successfully processed in such systems (Huddleston et al, 1992) where 
the mechanical separation of the particulate material by centrifugation is circumvented by the 
thermodynamically controlled separation of the particulate materials and the desired product 
into two separate phases (Kula, 1990). In addition, nanoparticles such as inclusion bodies 
have been successfully recovered using this technique (Walker and Lyddiatt, 1996; 1999) as 
well as HIV-1 and HIV-2 viruses (Gilljam et al, 1994).
Another approach to simplify downstream processing operations is the inclusion of 
protein binding ligands to cross-flow filtration membranes thereby combining concentration, 
clarification and adsorption procedures. This technique has been exploited for the recovery of
proteins in solution (Tennikov et al, 1998), for the isolation of protein receptors from 
Streptococci G (Kasper et al, 1998) and for the recovery of lysozyme (Kacar and Arica, 
2001). However, as indicated previously (see Section 1.2) fouling of the membrane will 
affect the integrity of the selected pore size and consequently yield of the recovered product.
Recent reports in the literature have suggested that affinity precipitation is a valuable 
technique for direct product capture from particulate containing feedstocks. Polymers such as 
N,N diethylacrylamide and poly-N-isopropylacrylamide can be affinity tagged with ligands 
such as iminobiotin, N-acetylglucosamine and w-aminophenyl boric acid. These are used to 
initially bind and co-precipitate the target product (Eggert et al, 1998). This is achieved by 
changing critical solution parameters such as temperature, pH or salt concentration resulting 
in the polymer-product complex precipitating out of the particulate containing feedstock. 
Affinity precipitation has been shown to successfully purify monoclonal antibodies from 
hybridoma cell culture supernatant (Taipa et al, 2000), separate lysozyme from hen egg white 
(Vaidya et al, 2001), and separate avidin from cell culture supernatant (Garret-Flaudy and 
Freitag,2001).
The fourth approach to reducing the number of downstream processing steps is based 
upon the adsorption of the desired product to adsorbent particles in the presence of biomass. 
This can be achieved from different modes of operation including batch adsorption, 
suspended bed and fluidised bed adsorption operations (Lyddiatt, 2002). Batch adsorption is 
one of the simplest methods for separating a desired product from particulate containing 
feedstocks where the adsorbent particles are contacted with the feedstock in a stirred tank 
configuration (Robbins and Wang, 1986). After product capture the adsorbent particles are 
separated from the feedstock by decantation washing after which the product is eluted. Batch 
adsorption lacks high resolution in comparison to conventional frontal chromatography as the 
process is characterised by a single equilibrium stage. In addition, there are still problems
associated with recovery of the product loaded adsorbent from the feedstock. However, 
Hubbuch et al (2001) demonstrated the use of superparamagnetic supports for the rapid 
separation of product loaded adsorbent particles from fermentation broth after batch 
adsorption.
A recently reported approach has seen the development of a hybrid operation 
encompassing both stirred tank batch adsorption coupled with elution in an enclosed column 
system. This technique has been termed suspended bed chromatography (Levison et al, 2000; 
Quinones-Garcia et al, 2001). The mode of operation has been compared to both batch 
adsorption and column chromatography methods (Quinones-Garcia et al, 2001) and it was 
demonstrated that suspended bed chromatography performed well in comparison to batch 
adsorption, although column chromatography was highlighted as the most efficient 
separation technique. Whilst suspended bed chromatography is a viable process technique it 
is not necessarily suitable for the recovery of nanoparticulate products. The most common 
method of whole broth processing is the use of stable liquid fluidised beds whose 
fundamentals and characteristics are described in Section 1.4.
The washing and cleaning procedures are very important in fluidised bed operations 
as contacting the adsorbent particles with complex biological feedstocks significantly 
increases the physical challenge of the adsorbent. The removal of this material can require 
large washing volumes which increases both process times and cost. Hjorth et al (1995) 
demonstrated that to reduce the cell load by 105 when STREAMLINE particles were 
fluidised with an Eschericia coli homogenate containing 109 colony forming units per ml, 20 
settled column volumes of washing buffer were required. Similar results were obtained by 
Hansson et al (1994) with whole E.coli cells. The presence of particulate containing 
feedstocks also influences other performance parameters in a fluidised bed adsorption 
operation. It has been demonstrated that the presence of cells and cell debris negatively
influences the achievable adsorption capacities of a desired product. Chase and Draeger 
(1992) showed that the presence of 3% dry mass of Saccharomyces cerevisiae cells reduced 
the equilibrium adsorption of BSA to Q Sepharose by 49%. In addition, Gilchrist et al (1994) 
were able to show that the presence of 2% dry mass of S. cerevisiae reduced the BSA 
capacity during adsorption in a single stage fluidised bed (serviced by recirculating 
feedstocks) by 20% for a titanium dioxide/ cellulose composite and 86% for the silica based 
DEAE Sepherosil LS. Therefore the physical design of adsorbent solid phases developed for 
fluidised bed adsorption demands consideration with respect to reducing the processing times 
by limiting the number of washing steps required after product adsorption whilst maximising 
the potential product capacities.
1.4 Fluidised Bed Adsorption Chromatography
Fluidised bed adsorption chromatography (FBAC) and the similar process of 
Expanded Bed Adsorption Chromatography (EBAC), has emerged as an efficient method for 
the recovery of products from complex feedstocks demonstrating advantages over the 
traditional methods of recovery, e.g. circumventing the need for clarification of feedstocks 
before application to a fixed bed chromatography column (Bierau, 2001).
The conventional chemical engineering view of a fluidised bed is one that is 
characterised by a significant degree of mixing as is exhibited by gas-fluidisation systems 
(Levenspiel, 1972) and it has been commonly assumed that a fluidised bed contactor 
generates a highly mixed system for the feedstock and adsorbent (Anspach et al, 1999), but 
this has been shown to not necessarily be the case (Lan et al, 1999). It has been demonstrated 
that the physical properties of the adsorbent particles can generate an inherently stable 
fluidised bed. If the adsorbent particles have an appropriate distribution of both size and 
density a classification occurs within the bed with large, dense particles located at the base of
the bed and light, less dense particles at the top of the bed. This segregation behaviour 
restricts the local mobility of the particles when fluidised (Chase, 1994; Thommes et al, 
1995; Barnfield Frej et al, 1997; Thommes, 1997). In order to account for the difference in 
the mixing characteristics of the classified, stable fluidised bed and the conventional well 
mixed fluidised bed, the term Expanded Bed Adsorption has been adopted by several authors 
and a leading supplier of chromatography media and equipment (Amershani Biosciences; 
Chase, 1994; Hjorth, 1997). The work presented herein uses the term Fluidised Bed 
Adsorption Chromatography to refer to adsorbents fluidised under conditions seeking to 
minimize particle mixing.
Adsorbent particles within a bed are fluidised by the application of an upward liquid 
flow through the adsorbent particles that are not constrained by an upper flow adapter. 
Consequently the bed can expand upward resulting in spaces opening up between the 
adsorbent particles. Therefore, particulate containing feedstocks do not require clarification 
or concentration prior to the application of the material to the column. The spaces between 
the adsorbent particles allow the feedstock to pass freely through the bed without entrapment 
(refer to Figure 1.2). At the end of the adsorption phase the unbound or loosely bound 
material can be removed by washing the adsorbent particles whilst still in a fluidised mode. 
Subsequently, the adsorbed product can be eluted from the bed whilst the adsorbent particles 
are in a fluidised or fixed bed configuration. As a consequence of this mode of operation 
clarification, concentration and primary capture is achieved in a single unit operation, thus 
enabling the simplification of downstream processes alongside economic savings in both 
capital and operating costs.
Fluidised bed adsorption chromatography has previously been used for industrial 
applications including the industrial scale recovery of antibiotics such as novobiocin (Belter 
et al, 1973) and streptomycin (Barthels et al, 1958). In addition, at laboratory scale many
Figure 1.2 Diagrammatic representation of adsorbent particles in fixed and fluidised 
bed contactors
FIXED BED
Upper 
Adapter
Lower 
Adapter
FLOW
FLUIDISED BED
FLOW
Figure 1.2 represents the configuration of a fixed bed and fluidised bed contactor. The 
adsorbent particles in a fixed bed are constrained by an upper and lower adapter. The 
intraparticle space (i.e. voidage) is minimal, therefore feedstock clarification is essential to 
avoid clogging of the bed. In afluidised bed the adsorbent isfluidised by an upward liquid 
flow, not constrained by an upper flow adapter. The bed voidage is increased therefore 
particulate containing feedstocks can pass unhindered through the bed.
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proteins have been purified using fluidised bed adsorption chromatography including proteins 
from Eschericia coli homogenates (Barnfield Frej et al, 1994; Zhang et al, 1999). 
Recombinant protein from animal cell culture supernatant (Erickson et al, 1994) and L- 
asparaginase from Envinia chrysanthemi (Bierau et al, 1999) have also been purified. 
However, more recently interest has been shown in the fluidised bed recovery of larger 
products such as nanoparticulate mimics (Zhang et al, 2001), plasmid DNA (Varley et al, 
1999) and whole cells (Ujam et al, 2000).
1.4.1 Principles of Fluidised Bed Adsorption Chromatography
Fluidisation is achieved by pumping liquid upwards through a settled bed of 
adsorbent particles. At low linear flow velocities the liquid passes through the voids in the 
bed. As the flow rate increases the adsorbent particles begin to move apart until they are 
suspended in the liquid phase. This is achieved when the velocity of the liquid phase exceeds 
a minimum value, termed the minimum fluidisation velocity (Umf; see Figure 1.3). As the 
liquid flow increases the adsorbent particles move further apart resulting in a progressive bed 
expansion referred to as a steady state fluidisation (Kunii and Levenspiel, 1991). This steady 
state remains so long as the flow velocity does not exceed the terminal settling velocity (or 
the maximum fluidisation velocity) of the fluidised adsorbent particle (Ut). This is defined as 
the point when the adsorbent particles are elutriated from the column. The maximum 
fluidisation velocity depends upon the properties of the fluidising adsorbent particles and can 
be described by Stoke's law (see Equation 1.1). This indicates that Ut is dependent upon the 
particle diameter (dp), particle density (pp), the density of the liquid (pi) and the viscosity of 
the liquid phase (r|).
U, = (pp - pi) dp2g /18ri Equation 1.1
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Figure 1.3 Operational window of fluidisation velocities
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Figure 1.3 (reproduced from Bierau, 2001) represents the operational window of a 
fluidised bed process. This is defined by the minimum fluidisation velocity (Umf>, the 
velocity at which the adsorbent particles begin tofluidise and the terminal settling velocity 
the velocity at which the particles are elutriated from the bed.
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1.5 Design of Adsorbent Solid Phases Suitable for the Recovery of Nanoparticulate 
Products
As a consequence of the limitations associated with downstream processing of 
nanoparticulate products as outlined above, fluidised bed adsorption chromatography has 
been classified as a suitable DSP operation having the potential to circumvent current process 
bottlenecks. Therefore the next logical step is the establishment of design criteria for 'ideal' 
adsorbent solid phases suitable for the recovery of nanoparticulate products. These include (i) 
an enhanced density to make the adsorbent suitable for fluidised operation (see Equation 1.1), 
(ii) rapid adsorption/desorption rates to minimise the processing times to protect the integrity 
and activity of the desired product and to reduce costs associated with long processing times, 
(iii) Rapid washing procedures are required to minimise operational costs and (iv) adequate 
capacities and recoveries are required to optimise the purification of a desired product in a 
single step primary capture operation.
Conventional adsorbent solid phases designed for fixed bed adsorption processes are 
not suitable adsorbent solid phases for fluidised bed adsorption due to their limited density 
and size. For example, Sepharose FastFlow (Amersham Biosciences, Uppsala, Sweden) is a 
well characterised adsorbent for fixed bed chromatography (refer to Table 1.1). However, 
this adsorbent has been demonstrated to have a maximum fluidisation velocity of 3.7cm/min 
in water. Consequently, even in water the adsorbent particles are elutriated from the column 
at linear flow velocities greater then 3.8cm/min. In addition, if complex feedstocks such as 
fermentation broths or cell homogenates are considered (having viscosities of 0.003kg/m.s, 
for a 3% wet weight yeast homogenate; Thommes, 1997) Umf is reduced further. It is clear 
that enhanced densities and particle diameters are required for adsorbents suitable for 
fluidised bed adsorption chromatography (Chase and Draeger, 1992) to increase the fluid 
flow throughput, hence reduce processing times.
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Table 1.1 Physical characteristics of Sepharose FastFlow
PHYSICAL PROPERTIES
Particle diameter (fim)
Particle density (g/ml)
Ut (cm/min)
Umf (cm/min)
DATA
90
1.13
3.7
0.34
Table 1.1 represents the physical characteristics of Sepharose FastFlow (Affinity 
Chromatography: Principles and Practice; Amersham Biosciences, Uppsala, Sweden).
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Denser adsorbent particles, such as silica were considered to be more appropriate 
materials for fluidised bed adsorption applications (Dasari et al, 1993; Finette et al, 1996). 
However, silica containing materials have limited stability at high pH values which makes 
them less suitable for pharmaceutical products where alkaline conditions are often used for 
sanitisation and clean in place procedures. There has been much work published concerned 
with the development of denser adsorbent solid phases employing higher flow rates for faster 
processing times and improvements in fluidised bed stability. Custom designed adsorbents 
were produced using hydrophilic natural polymers such as agarose, cellulose and trisacrylate 
base materials. These adsorbents were density enhanced by the addition of inert filler 
materials during the manufacturing process. Composite adsorbents have included cellulose- 
titanium dioxide (Gibson and Lyddiatt, 1990; 1993; Gilchrist et al, 1994) ceramic-hydrogel 
(Coffman et al, 1999) and dextran silica (Morton and Lyddiatt, 1992). In addition, other 
materials such as glass and zirconium have been modified to fabricate dense adsorbent solid 
phases suitable for fluidised bed operations. In 1995 Thommes et al exploited controlled pore 
glass particles for the recovery of monoclonal antibodies. Fluoride modified zirconium 
(Mullick et al, 1999) has been used to successfully purify bovine serum albumin in a 
fluidised bed configuration.
More recently, pellicular adsorbents have been shown to be suitable adsorbents for 
the fluidised bed recovery of biological products (Zhang et al, 2001; Thwaites et al, 2002). 
These adsorbents are characterised by a dense core such as glass (Lihme et al, 1998), 
stainless steel (Palsson et al, 2000) or zirconium silicate (Sun et al, 2001) surrounded by a 
layer of porous material such as agarose. Commercial pellicular adsorbents such as Upfront 
Chromatography adsorbents are also available (Lihme et al, 1999). These adsorbents not only 
fulfil the fluidisable qualities desired but also the short diffusion distances of the thin porous 
layer promise rapid adsorption/desorption kinetics.
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Conventional adsorption processes such as affinity, ion exchange and hydrophobic 
interaction chromatography have been employed as the purification operation for the 
recovery of nanoparticulate products such as viruses and plasmid DNA. However, current 
chromatographic technology has been developed primarily for the purification of 
macromolecular products such as proteins (l-5nm in diameter; Miyabe and Guiochon, 2000) 
and is not well suited to the recovery of nanoparticles that have a size range of 20-3 OOnm in 
diameter and have complex surface characteristics (Zhang et al, 2001). Currently available 
adsorbent solid phases used for nanoparticulate recovery have characteristically small pore 
sizes that have been optimised for the purification of protein rather than nanoparticulate 
products (see Table 1.2). Small pore sizes (5-400nm in diameter) limits the diffusion of the 
nanoparticulates (20-300nm in diameter) into the adsorbent solid phase, thus only the 
external surface area is available for adsorption. In addition, low molecular weight 
contaminants (such as proteins, DNA and endotoxins) will enter the pores resulting in a 
process requirement for excessive washing steps to purge the internal volume of the 
adsorbent solid phases (Zhang et al, 2001; Thwaites et al, 2002). Therefore the adsorbent 
geometry should also be considered in addition to the density enhancement for the fluidised 
bed recovery of nanoparticulate products. Alternative adsorbent designs suitable, or custom 
designed for improved nanoparticulate recovery have been suggested (Lyddiatt and 
O'Sullivan, 1998; Braas et al, 2000; Zhang et al, 2001).
Adsorbent solid phases characterised by large pores (termed macropores in the 
present study; Type II) would facilitate an enhanced adsorption/desorption performance. The 
macropores would facilitate free diffusive or convective transport of nanoparticles into the 
internal volume of the adsorbent solid phase. In addition to commercial macroporous 
adsorbents such as POROS 50D (refer to Section 2.1.1) there are descriptions in the literature
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Table 1.2 Adsorbent solid phases used for the purification of nanoparticulate products
ADSORBENT
Sepharose 
FastFlow
Cellufine 
Sulphate
Q Sepharose XL
Resource Q
Heparin- 
sepharose
Cellufine- 
heparin
Toyopearl HW-
75F
Q Sepharose
MANUFACTURER
Amersham 
Biosciences
Amicon
Amersham 
Biosciences
Amersham 
Biosciences
Amersham 
Biosciences
Amicon
Tosohaas
Amersham 
Biosciences
NANOPARTICULATE 
PRODUCT
Plasmid DNA
Feline herpes virus
AV3 RSV GDNF 
adenovirus
ACN 53 adenovirus
Herpes simplex virus
Herpes simplex virus
ACN 53 adenovirus
Plasmid DNA
REFERENCE
Levy et al, 2000
O'Neil and 
Balkovic, 1993
Blanche et al, 
2000
Shabram et al, 
1997
O'Keeffe et al, 
1999
O'Keeffe et al, 
1999
Huyghe et al, 
1995
Prazeres et al, 
1998
Table 1.2 lists some of the commercially available adsorbent solid phases currently exploited 
for the recovery of nanoparticulate products such as viruses andplasmid DNA.
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of adsorbent solid phases custom fabricated with large macropores. Gustavsson et al (1998) 
described a superporous agarose bead prepared having an average pore diameter of 30um by 
the emulsification of 6% agarose with the surfactant Span 85 in cyclohexane. This 
macroporous adsorbent was tested for comparison to Sepharose FastFlow in a fixed bed 
configuration (Palsson et al, 1999). Macroporous adsorbents suitable for operation in a 
fluidised bed have also been described in subsequently demonstrated to have a superior 
recovery of recombinant factor VIII SQ in the literature. Pai et al (1999; 2000) described 
macroporous cellulose adsorbent particles having a pore diameter of 3um. The preparation 
method is currently under patent application. It was demonstrated that high flow rates could 
be used to fluidise the adsorbent particles shortening the contact time required for adsorbent 
saturation. However, as with all macroporous adsorbents the major process disadvantage is 
the loss of capacity due to the limited surface area available for adsorption.
As briefly mentioned earlier there are perceived process advantages to using 
pellicular adsorbent solid phases, which are comprised of a dense solid core surrounded by a 
porous layer, such as agarose. The enhanced densities achievable due to the dense core 
enables high flow rates to be employed to shorten processing times. In addition, the diffusion 
distances are reduced in proportion to the depth of the pellicle. In another approach solid 
adsorbents have been considered for their suitability as fluidised bed adsorbents. McCreath 
and colleagues developed perfluoropolymer particles consisting of either dense liquid or solid 
perfluorocarbons coated in a hydrophilic polymeric surfactant (McCreath et al, 1992; 1994; 
1995). The advantage associated with solid adsorbents is rapid adsorption/desorption rates as 
there is exclusive surface binding. The washing procedures required to clean the adsorbent 
after contact with complex biological feedstocks are also perceived to be simpler since there 
is no internal volume that needs to be purged. However, as with macroporous adsorbents
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there is a limited surface area available for binding resulting in lower bulk adsorption 
capacities.
1.6 Aim of the Study
The aim of the study presented here was to investigate adsorbent solid phases having 
different internal and external topographical designs for their suitability for the potential 
recovery of nanoparticulate products in fluidised bed adsorption operations, exploiting batch 
adsorption studies. It was envisaged that the study would highlight suitable adsorbent designs 
that demonstrated adequate capacities and recoveries of nanoparticulate products in addition 
to limiting the co-purification of impurities such as cells, cell debris and DNA.
1.6.1 Batch Adsorption Studies
It was highlighted in Section 1.4 that fluidised bed adsorption is the preferred method 
for the recovery of industrially relevant nanoparticulates from complex feedstocks; however 
this study was concerned with the screening of adsorbents suitable for the application to 
fluidised bed recovery. Consequently, batch adsorption studies were solely employed to 
investigate the adsorption of soluble and particulate protein to candidate adsorbent solid 
phases. As previously stated in Section 1.3, batch adsorption is a simple method where 
adsorbent particles are contacted with the desired product in a well mixed system and is a 
process characterised by a single equilibrium stage (Robbins and Wang, 1986). For the 
purpose of this study batch contacting processes were adopted as scouting procedures to 
identify adsorbent designs suited to larger scale fluidised bed adsorption of nanoparticulate 
products (see Section 1.4; Ferreira et al, 2000; Zhang et al, 2001).
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1.6.2 The Relevance of the Need to Purify Nanoparticulate Products
The term nanoparticulate products encompasses all desirable products in the 
nanometer size range such as viruses, plasmid DNA and drug delivery vehicles for gene 
therapy that is a therapeutic modality with the potential of treating inherited and acquired 
diseases (Andreadis et al, 1999). There are two methods generally employed for introducing 
genes into cells; (i) physiochemical methods including DNA-liposome electroporation, poly 
(L) lysine-DNA aggregates and gene guns and (ii) biological methods utilising recombinant 
viruses, retroviruses, adenoviruses and adeno-associated viruses. Table 1.3 summarises the 
present number of ongoing gene therapy clinical trials.
As a consequence of the current gene therapy trials, it is becoming evident that large 
volumes of biologically active recombinant viruses are required for gene therapy. Typically 
in vivo gene transfer requires significantly large volumes of concentrated and pure viruses in 
the region of 10-1000ml per patient. Hence, large quantities of vector containing cell culture 
supernatant/lysate need to be processed. Cheaper and more efficient downstream processing 
steps need to be developed to meet the pharmaceutical demand for high quality, high yield 
virus and plasmid DNA products.
1.7 Thesis Outline
The study presented in Chapter 2 investigated the physical characterisation of 
adsorbent solid phases having different geometrical configurations and topographies. The 
aim was to establish if the adsorbents included in the study were potentially suitable for 
fluidised bed operations. Generally, nanoparticulate products, such as retroviruses or plasmid 
DNA are commonly recovered from complex feedstocks such as cell culture supernatants and 
cell lysates (Lorens et al, 2001; Thwaites et al, 2002). Consequently, fluidised bed adsorption 
chromatography was considered to be a suitable downstream processing application for 
nanoparticulate recovery, circumventing the requirement for prior clarification and
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Table 1.3 The number of gene therapy trials currently in operation
GENE THERAPY VECTOR
Retrovirus
Adenovirus
Lipofection
Plasmid DNA
Pox virus
Adeno-associated virus
RNA transfer
Gene gun
Herpes simplex virus
Others
PERCENTAGE OF CURRENT 
TRIALS (%)
35.8
27.7
13
9.3
6.2
2.2
0.8
0.8
0.5
3.9
September 2001
Table 1.3 represents the present number of gene therapy trials currently running in addition 
to the vectors that are being used in the trials. This data was reproduced with permission 
from the Wiley Journal of Gene Medicine website, http://www.wiley.co.uk/genmed.
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concentration of the feedstock (see Section 1.4). The adsorbents used were variously sourced 
from commercial suppliers (Amersham Biosciences; Applied Biosystems, Tosohaas) and 
custom fabricated prototype adsorbents produced in Birmingham, Mumbai University, India 
and Lund University, Sweden. The adsorbents studied herein were categorised with respect to 
the internal and external geometries. Microporous adsorbents having a pore size of less than 
0.2um were designated as Type I and macroporous adsorbents characterised by pores greater 
than 0.6um were designated as Type II. Type III adsorbents were solid, or relatively solid 
assemblies and pellicular adsorbents were designated as Type IV. The quoted pore sizes of 
the adsorbent solid phases included in the study were based upon information supplied by the 
manufacturers. The pore sizes were not measured in the present study as the facilities 
required to determine pore size were not available within the group, hence it was too 
expensive to send samples to be sized elsewhere. The custom fabricated adsorbents were 
supplied with a minimal amount of information therefore physical characterisation studies 
were completed to assess the suitability of the adsorbent types for fluidised bed recovery of 
desirable products, in addition the adsorbent solid phases were derivatised with anion 
exchange chemistry.
Chapter 3 summarises the critical evaluation of adsorptive studies with 
nanoparticulate and protein products in batch binding experimentation. Adsorption and 
desorption studies with soluble and particulate BSA were compared for candidate adsorbents 
exploiting anion exchange chemistry. The aim of this study was to investigate the suitability 
of the selected adsorbent solid phases for fluidised bed recovery of nanoparticulate products 
such as viruses, plasmid DNA and drug delivery vehicles. For commercially realistic studies 
of virus or plasmid recovery, large quantities of product are required. Therefore to 
circumvent the practical problem of material supply synthetic protein nanoparticulates were 
exploited for the binding studies. In addition soluble protein components were included in the
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study as a mimic for small molecular impurities that are expected to characterise cell culture 
supernatant, fermentation broths and cell disruptates and to illustrate problems associated 
with the separation of cellular assemblies from components. Suitable adsorbents were chosen 
for further experimentation as a consequence of the preliminary binding studies and the 
uptake kinetics of BSA nanoparticles were compared in batch binding studies.
Chapter 4 summarises the use of laser scanning confocal microscopy to provide a 
realistic picture of product distribution during the adsorption process within selected phases, 
and to validate the assumptions made as a consequence of the preliminary batch binding 
experiments. Both fluorescently labelled soluble and particulate BSA were used in the study 
to further investigate the impact of the pore structure of the adsorbent upon adsorption and 
desorption performance. As a consequence of the results of this study, adsorbent solid phases 
demonstrated as suitable for nanoparticulate recovery were chosen for further 
experimentation.
Chapter 5 summarises experiments that sought to demonstrate the affinity capture and 
recovery of nanoparticulate products exploiting a readily available model affinity system. 
Cibacron Blue 3GA and human serum albumin (HSA) have a reported affinity attributed to 
the specific interaction of the dye to the billirubin binding site on HSA due to the structural 
similarities of the dye and billirubin (refer forward to Section 5.1.2). The adsorbents that 
exhibited the best performance in the preliminary studies (Chapters 2-4) were further 
investigated herein exploiting HSAp manufactured in an equivalent manner to BSAp (refer to 
Section 3.2.3).
The aim of this study was to benchmark the affinity capture and recovery of 
nanoparticulate products exploiting realistic systems of equivalent viral particle loads in 
complex biological feedstocks. The capture and recovery of both the feedstock components 
and HSAp was determined using the Bradford assay and fluorescence assay respectively.
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CHAPTER 2
PHYSICAL CHARACTERISATION OF ADSORBENT SOLID
PHASES
2.1 General Introduction
Developments in the field of fluidised bed recovery of nanoparticulate products have 
been limited due to the lack of solid phases that have both suitable biochemical and physical 
characteristics. Adsorbents have been specifically designed for fluidised bed adsorptive 
recovery operations (McCormick, 1993), but current chromatographic technology has been 
developed primarily for the recovery of macromolecular products (l-5nm particle diameter). 
They are not necessarily suitable for the recovery of nanoparticulates that have a size range 
of 20-300nm, coupled with complex surface characteristics. As a consequence, 
nanoparticulate products tend to be recovered using a combination of ultracentrifugation and 
ultrafiltration protocols that are commonly scale limited (Kahn et al, 2000; see Figure 1.1). In 
addition, complex feedstocks such as cell lysates from animal and microbial cell cultures 
limit the efficiency of such processes.
Fluidised bed adsorption technology is an alternative process that can be employed 
for the direct recovery of nanoparticulates from complex particulate feedstocks (see Section 
1.4). Fluidised bed adsorption chromatography is a single pass operation in which desired 
proteins are purified without the need for separate clarification, concentration and initial 
purification procedures. The adsorbent particles within the settled bed are fluidised by the 
application of an upward liquid flow from the base of the column contactor. The fluidisation 
of the adsorbent bed creates a distance between the adsorbent particles that allows for 
unhindered passage of cells, cell debris and other particulates during the application of a 
crude feedstock to the column (see Figures 1.2 and 1.3).
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Work has been undertaken herein to investigate the 'ideal' adsorbent design for the 
recovery of nanoparticulate products in fluidised bed adsorption operations. The ideal particle 
for nanoparticulate recovery is defined in this study as an adsorbent that enables fluidised bed 
adsorptive recovery of nanoparticles with adequate separation of the product and the cellular 
impurities within the feedstock.
This chapter details the physical characterisation of adsorbent solid phases that were 
selected for study as candidate adsorbent particles. Currently available chromatographic 
adsorbents (designated Type I and depicted in Figure 2.1) are expected to reveal practical 
disadvantages. These include (i) the limited product accessibility to the internal surfaces 
within the adsorbent particle, due to restrictive pore dimensions (Type I adsorbents are 
characterised in this study as having a pore size of less than 200nm; refer to Figure 2.1), (ii) 
excessive washing times may be required to purge the internal particle volumes of feedstock 
contaminants and (iii) validating the adsorbent cleaning may be difficult as a consequence. 
Alternative adsorbent designs suitable or custom designed for improved nanoparticle 
recovery have been suggested (Lyddiatt and O'Sullivan, 1998; Braas et al, 2000; Zhang et al, 
2001) and the adsorbent designs selected for this study are depicted in Figure 2.1. These 
adsorbents were variously sourced from commercial suppliers (Amersham Biosciences, 
Tosohaas, Applied Biosystems) and custom fabricated prototype adsorbents produced in 
Birmingham and other laboratories (Mumbai University, India; Lund University, Sweden; 
refer to Table 2.1).
2.1.1 Description of the Selected Adsorbent Solid Phases
For this study several adsorbents having different internal and external geometries 
were investigated to assess their suitability for the recovery of nanoparticulates exploiting 
fluidised bed adsorption chromatography (FBAC). The adsorbent designs used were (i) 
microporous Type I, Figure 2.1), (ii) macroporous (Type II, Figure 2.1), (iii) solid adsorbents
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Figure 2.1 Internal and external configurations of the selected adsorbent solid phases
Type I Type II
Type III Type IV
Figure 2.1 is a diagrammatic representation of the adsorbent configurations included in the 
present study. Microporous adsorbents are designated as Type I adsorbents and are 
characterised in this study by a pore size of less than 0.2pm. In addition, Type II adsorbents 
are classified as macroporous having a pore size of greater than 0.6 urn in diameter and Type 
HI adsorbents are designated as solid or relative solid adsorbents having either no pores or 
having a molecular size exclusion of10,000 Daltons (refer to Table 2.1). Type IV adsorbents 
in this study are pellicular in nature, consisting of a dense, solid core surrounded by a layer 
of porous agarose material.
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Table 2.1 Summary of the adsorbent solid phases included in the present study
ADSORBENT 
TYPE
I
II
III
IV
ADSORBENT
STREAMLINE
(6%)
Celbead (II)
Celbead Amino
POROS
PVA
PVAMo
PVA TiO2
PVAZr
Perfluorocarbon 
Emulsion
Toyopearl
2% ZsA
PORE 
SIZE
<0.2um
3um
3(iim
0.6- 
O.Sum
lum
lum
lum
lum
Oum
1000- 
10,000 
MW
<0.4um
ADSORBENT 
GEOMETRY
Microporous
Macroporous
Macroporous
Macroporous
Macroporous
Macroporous
Macroporous
Macroporous
Assumed Solid
Virtual Solid
Macroporous 
Pellicular
MANUFACTURER
Amersham 
Biosciences
Indian 
Construct
Indian 
Construct
Applied 
Biosystems
Swedish 
Construct
Swedish 
Construct
Swedish 
Construct
Swedish 
Construct
Birmingham 
construct
Tosohaas
Birmingham 
Construct
REFERENCE
McCormick 
(1993)
Paie/o/(1999)
P&i et al (2000)
Rodrigues et al 
(1996)
Personal 
Communication
Personal 
Communication
Personal 
Communication
Personal 
Communication
McCreath et al 
(1996)
Tosohaas 
Product 
Information
Sun etcd (2001)
Table 2.1 summarises the commercial and custom fabricated adsorbent solid phases that 
were included in the present study having different adsorbent configurations designated as 
Types I to IV. The aim of this study was to investigate candidate adsorbent solid phases 
suitable for fluidised bed recovery of nanoparticulate products. The respective manufacturers 
supplied the data for pore size of the PVA and Celbead composites and the commercial 
adsorbents.
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(Type III, Figure 2.1) and (iv) pellicular adsorbents (Type IV, Figure 2.1, Zhang et al, 2001).
2.1.2 STREAMLINE
STREAMLINE is a commercial solid phase included in the study as the benchmark 
adsorbent classified as a Type I adsorbent (see Section 2.1; Figure 2.1). STREAMLINE was 
introduced in 1993 by Amersham Biosciences (Carlsson et al, 1993; McCormick, 1993), and 
was specifically designed for FBAC. The base material of the adsorbent was 6% crosslinked 
agarose (refer to Section 2.1.2.1) modified by the addition of inert crystalline quartz particles. 
This enhanced density composite adsorbent demonstrated superior fluidisation properties in 
comparison to the conventional fixed bed adsorbents available at that time. STREAMLINE is 
an established commercial adsorbent solid phase that has demonstrated a consistent 
hydrodynamic performance (Hjorth et al, 1995) and adsorption characteristics that are similar 
to standard fixed bed chromatography media. (Hjorth et al, 1995, Chang and Chase, 1996).
STREAMLINE has been proven to be a versatile adsorbent for fluidised bed recovery 
of a variety of biological materials. These include the recovery of recombinant proteins from 
Eschericia coli homogenates (Barnfield Frej et al, 1994; 1997; Lan et al, 1999), the recovery 
of proteins from unclarified yeast homogenates (Chang and Chase, 1996, Zurek et al, 1996) 
and fluidised bed adsorption of monoclonal antibodies from crude mammalian cell culture 
broths (Thommes et al, 1995). STREAMLINE has been termed a microporous (Type I) 
adsorbent due to the limited size exclusion for globular proteins of 4 x 106 Daltons, that 
enabled only relatively small products (proteins, endotoxins such as lipopolysaccharides and 
molecules less than 0.2um in diameter) to enter the porous structure.
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2.1.2.1 Agarose
Agarose is a polysaccharide extracted from the natural polymer agar which is found 
in the cell wall of marine algae from the agarophyte group of genera including Gelidium, 
Pterocladia, Acanthopeltis and Gracillaria that are distributed world wide (Haug, 1975). One 
of the recognised structures of agar is neutral agarose that is comprised of two residues, 
1,3,substituted p-D-galactopyranosyl and 1,4,substitued 3,6,anhydro-a-L-galactopyranosyl 
(Ergorov et al, 1970).
Agarose has been successfully exploited as the base material for several types of 
adsorbent solid phases because of its endogenous secondary and tertiary structure (see 
Section 2.1.2). The single fibres of agarose (assembled naturally from the primary linear 
structure), produce bundles of fibres that in turn become a fabric network containing 'large 
pores' (Amersham Biosciences, 1997). Figure 2.2 represents the open pore structure of 
agarose (Amersham Biosciences, 1997). In addition agarose contains primary and secondary 
hydroxyl groups, which allows for easy chemical derivatisation. In 1964, Hjerten proposed a 
method of adsorbent production using agarose that has been adapted and commonly used as 
the basis for adsorbent fabrication. Hjerten showed that due to the insolubility of agarose in 
water, it can be prepared by melting in an autoclave at 121°C under the pressure of one 
atmosphere. The beads are fabricated using an emulsification method with hot oil (85°C) 
under constant agitation whilst gelation of the agarose to form stable beads is achieved by 
controlled cooling. A distinctive feature of commercially available agarose is the low content 
of pyruvate and sulphate groups. This limits the non-specific binding of impurities to the 
agarose matrix during selective adsorption processes. For example a typical commercially 
available agarose such as Agarose VII from Sigma-Aldrich Ltd. (Poole, UK) has less than 
1% sulphate and pyruvate groups compared to crude agar which can contain up to 10% 
sulphate groups and 2.5% pyruvate groups (Duckworth and Yaphe, 1971). There are
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Figure 2.2 Secondary and tertiary structure of agarose
Bundles of 
single fibres 
that in turn 
become a 
network
The fabric 
network 
produced by 
the bundles of 
fibres contains 
large pore 
structures
Figure 2.2 represents the secondary and tertiary structure of agarose formed due to 
hydrogen bonds reproduced from 'Affinity Chromatography: Principles and Methods' 
(Amersham Biosciences, Sweden).
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commercially available adsorbent solid phases using agarose as the base material in addition 
to STREAMLINE, such as the Sepharose adsorbents (Amersham Biosciences, Uppsala, 
Sweden).
2.1.3 POROS SOD
POROS is a commercial macroporous adsorbent manufactured by Applied 
Biosystems and designated a Type II adsorbent in this study (see Figure 2.1). The POROS 
adsorbent used for this study was POROS SOD perfusion chromatography media, an 
adsorbent that has been specifically designed for perfusion chromatography (Afeyan et al, 
1996; Rodrigues et al, 1996). In contrast to conventional chromatography materials, POROS 
adsorbents are engineered to contain two discrete pore types, (i) large 'throughpores' (or 
convective pores) and (ii) smaller diffusive pores. The convective pores (0.6um-0.8um in 
diameter) allow for convective flow to occur within the particles that carries the biological 
materials rapidly through the particle to the smaller diffusive pores (0.08um-0.15um in 
diameter; refer to Figure 2.3). This results in shorter distances over which diffusion must 
occur, thus reducing the time for the saturation capacity to be reached, which is economically 
desirable as the overall process time is reduced. POROS SOD consists of a crosslinked 
polymer, poly(styrene-divinylbenzene) (refer to Section 2.1.3.1) which is surface coated with 
a polyhydroxylated polymer functionalised with dimethylaminoalkyl groups. (Applied 
Biosystems Product Information).
2.1.3.1 Poly(styrene-divinylbenzene)
Poly(styrene-divinylbenzene) (PS-DVB) is formulated from a hydrocarbon compound 
comprised solely of carbon and hydrogen in the presence of benzene and is commonly 
termed an aromatic hydrocarbon. PS-DVB is generally recognised as having excellent
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Figure 2.3 Internal structure of POROS SOD
Convective transport in 
large pores
Diffusive transport in 
small pores
Figure 2.3 represents the flow through a macroporous particle of POROS. The large 
convective pores allows for liquid flow through the particle to the diffusive pores resulting in 
shorter diffusion distances for adsorption, thereby reducing the time taken to reach 
saturation capacity.
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chemical and mechanical strength (the material does not compress under high pressures) in 
comparison to commonly used adsorbent materials such as agarose (Nash et a/,1996). The 
chemical robustness of PS-DVB was investigated by Afeyan and Fulton (1991) who 
demonstrated that the material was stable in the presence of several types of harsh chemicals. 
However, due to the nature of hydrocarbons the surface of PS-DVB adsorbents is 
extremely hydrophobic which promotes protein denaturation upon adsorption. Hence 
methods of surface modification of PS-DVB have been developed to exploit the chemical 
and mechanical strength of the material. These include (i) the adsorption of polyoxyethylene 
monomers onto the surface followed by polymerisation (Fulton et al, 1991) and (ii) the 
adsorption of polymers onto the surface followed by crosslinking, using polymers such as 
polyvinyl alcohol (PVA; Tuncel and Adil, 1993, Leonard et al, 1995).
2.1.4 Celbead Adsorbents
Celbeads were macroporous cellulose beads supplied by Dr Arvind Lali (Mumbai 
University, India) and prepared following a method for which a patent application has been 
filed. The adsorbents were classified Type II macroporous adsorbents in this study since they 
were claimed to have an average pore size of 3urn (Pai et al, 2000). No further information 
about the Celbead adsorbents was available prior to the initiation of the present study.
2.1.4.1 Cellulose
The only information made available to our laboratory concerning the Celbead 
adsorbents was that they were fabricated from cellulose. Cellulose is a linear polymer of 
glucose and is the most abundant polymer on earth. The repeating glucose units are linked in 
the P configuration allowing for the chains to crystallise. Cellulose is found in wood and 
natural fibres such as flax and cotton and tends to have a highly crystalline structure (90-
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95%) which produces a high tensile strength material comprising plant cell walls. Cellulose is 
most commonly found to have polymer lengths equal to 1000 to 15000 glucose units and its 
crystalline form has been the subject of much study (Marchessault and Sarko, 1967; Krassig, 
1984). X-ray crystallography studies have shown that there are at least four different 
crystalline forms of cellulose. Cellulose I is the naturally occurring form of cellulose showing 
a parallel arrangement of polymer chains. In comparison Cellulose II exhibits an antiparallel 
arrangement and is formed by the regeneration of Cellulose I from solution. Cellulose II is 
judged to be the more stable structure as the reaction to form Cellulose II from Cellulose I is 
irreversible (Gilchrist, 1996). Cellulose III and Cellulose IV are formed from Cellulose I and 
II by the addition of ammonia and hot glycerol respectively. These structures are less stable 
than Cellulose II as the original structure can be returned by simple treatment procedures 
with distilled water (Blackwell and Marchessault, 1971).
Cellulose has been successfully exploited as the base material for chromatography 
adsorbents (Peterson and Sober, 1956), although limitations were shown to be a lack in 
porosity and poor geometrical shape (Gibson, 1992).
2.1.5 PVA Adsorbents
The PVA adsorbents were supplied by Dr Igor Galaev (Lund University, Sweden) 
and prepared following an unreported and proprietary method. The limited information 
supplied indicated that the adsorbents were prepared using polyvinyl alcohol (PVA) as the 
base material together with various fillers added for density enhancement. The adsorbents 
were composites of PVA and (i) titanium oxide, (ii) molybdenum, (iii) zirconium silicate 
together with (iv) an adsorbent comprised solely of PVA. The adsorbents were described as 
crosslinked and macroporous, and designated herein as Type II adsorbents since they were 
claimed to have a pore size of 1 jam (see Figure 2.1).
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2.1.5.1 Polyvinyl Alcohol
Polyvinyl alcohol (PVA) is fabricated from polyvinyl esters, and is a synthetic colloid 
(Herrmann and Hoehnel, 1964). The polymer is now commercially available varying in 
degrees of polymerisation and states of hydrolysis. The starting material for the production of 
polyvinyl alcohol is a polymerised ester, vinyl acetate. PVA is produced from either acid or 
alkaline hydrolysis of this polymerised ester and the molecular weight of the final product 
depends on the degree of polymerisation and the molecular weight of the original polyvinyl 
acetate. The degree of polymerisation and hydrolysis affects the properties of PVA including 
solubility and viscosity.
PVA is not a commonly used base material for chromatographic adsorbents where 
conventional biocompatible assemblies include agarose (Davies et al, 1994), chitosan (Gallo 
and Hassan, 1988) and cellulose (Peterson and Sober, 1956). In recent years, PVA has been 
used as a polymeric surfactant for coating hydrophobic perfluorocarbon materials to fabricate 
dense solid adsorbents (McCreath et al, 1992; 1994, Zhang et al, 2001). The hydroxyls 
present on PVA allow for easy derivatisation making the material suitable for adsorption 
chromatography
2.1.6 Perfluorocarbon Emulsion Adsorbent Particles
Perfluorocarbon emulsion particles were included in this study as a representative 
solid, designated herein as a Type III adsorbent (see Figure 2.1). Perfluorocarbons are 
synthetic molecules comprised solely of carbon and fluorine atoms. They are characterised as 
being chemically and biologically inert and exhibit the properties of high density materials 
(1.6-2.1g/ml). Perfluorocarbons are insoluble in both aqueous and common organic solvents 
and demonstrate thermal stability (Fluorochem Product Information). There have been many 
applications for both solid and liquid perfluorocarbons including, (i) packings for reversed
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phase chromatography (Williams et al, 1986), (ii) oxygen transport fluids (Lowe, 1987), (iii) 
liquid carriers for cell culture (Keese and Giaever, 1983), (iv) adsorbents for the extraction of 
organic pollutants (Josefson et al, 1984), (v) stationary phases in gas-liquid chromatography 
(Kirkland, 1963) and (vi) oxygen transport for bioreactors and microorganisms in culture 
(Aldercreutz and Mattiasson, 1982). They have also recently been used in both solid and 
liquid form as supports for chromatographic applications (Chang et al, 1993; Zhang et al, 
2001).
The inherent hydrophobic nature of perfluorocarbons makes them unsuitable in the 
native state for chromatographic applications where hydrophilicity and ease of derivatisation 
are desirable features. Therefore a polymeric surfactant is added to the perfluorocarbon 
material to produce a hydrophilic layer around the hydrophobic core of perfluorocarbon. 
Perfluorocarbon materials have been used to produce perfluorocarbon emulsions, designed 
for chromatographic separation of biological materials including applications such as cell 
separations (McCreath and Chase, 1996a; McCreath and Chase, 1996b), immobilised 
enzymes in bioreactors (Yang and Chase, 1998) the recovery of nanoparticulate products 
(Zhang et al, 2001) and the recovery of proteins and enzymes from complex feedstocks 
(McCreath et al, 1994; 1995; Owen et al, 1997). The perfluorocarbon base material used in 
this study was perfluorodecalin as used by McCreath and Chase (1996b). Perfluorodecalin is 
a fully fluorinated, odourless, colourless oil that is chemically and thermally stable, non-toxic 
and non-flammable. The physical properties of perfluorodecalin are illustrated in Table 2.2a
2.1.7 Toyopearl HW-40
Toyopearl HW-40 is a commercial adsorbent solid phase 40um in diameter classified 
as a Type III solid adsorbent in this study due to a molecular exclusion of 100-10,000 
Daltons.
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Table 2.2a Physical properties of perfluorodecalin
PROPERTY
Boiling Point (°C)
Molecular Weight
Density (g/ml)
Viscosity (mPas)
DATA
142
462
1.917
5.1
Table 2.2 represents the physical characteristics of perfluorodecalin, the base material of the 
solid perfluorocarbon emulsions (see Section 2.1.5). Perfluorodecalin is characterised as 
having a high density making the adsorbent suitable for fluidised bed adsorption recovery 
operation.
Table 2.2b A selection of commonly used ion exchangers.
ANION EXCHANGERS
Diethylaminoethyl (DEAE)
Quaternary aminoethyl (QAE)
Quaternary ammonium (Q)
CATION EXCHANGERS
Carboxymethyl (CM)
Sulphopropyl (SP)
Methyl Sulphonate (S)
FUNCTIONAL GROUP
-O-CH2-CH2-N+H(CH2CH3)2
-O-CH2-CH2-N+(C2H5)-CH2-CHOH-CH3
(-O-CH2-CHOH-CH2-)2N+(CH3)3
FUNCTIONAL GROUP
-o-CH2-co<y
-O-CH2-CHOH-CH2-O-CH2-CH2-CH2SO3"
(-O-CH2-CHOH-CH2)2SO3'
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Toyopearl is a semi rigid spherical resin produced from a hydrophilic vinyl 
copolymer composed exclusively of C, H and O atoms. Due to the presence of numerous free 
hydroxyl groups the total surface including the internal pore area is hydrophilic. This 
chemistry minimises non-specific adsorption and thus Toyopearl is an excellent resin for the 
separation of biomolecules. The material used in the present study was Toyopearl HW-40, 
which was mechanically stable (working pressures of 3 to 5 bar) and chemically stable at a 
working pH of pH 2-12.
2.1.8 2% Agarose Zirconium (2% ZsA)
2% agarose zirconium (2% ZsA) was an 'in house' fabricated prototype adsorbent 
produced by Professor Yan Sun, seconded to the Biochemical Recovery Group in 1999/2000 
from Tianjin University, PR China (Sun et al, 2001). The adsorbent was a dense pellicular 
adsorbent (designated herein as a Type IV adsorbent, see to Figure 2.1) that consisted of a 
dense solid core of zirconium silicate (sourced from Glen Creston) surrounded by a 20um 
pellicle of 2% agarose (see Section 2.1.2.1). This was an adsorbent specifically designed for 
fluidised bed adsorption chromatography with an enhanced density and an adsorption layer.
2.1.9 Ion Exchange Chromatography
Ion exchange chromatography (IEC) is one of the most frequently used 
chromatographic techniques (Bonnerjea et al, 1986). The technique is used for the separation 
and purification of many biological materials including proteins (Erickson et al, 1994; 
Hansson et al, 1994; Hjorth et al, 1995), plasmid DNA (Prazeres et al, 1998; Ferreria et al, 
2000; Zhang et al, 2001) and viruses (Huyghe et al, 1995; Shabram et al, 1997; Blanche et 
al, 2000). Therefore it was selected as a suitable adsorption method in the present study.
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IEC is a separation method that depends upon the principle of reversible adsorption of 
charged molecules to oppositely charged immobilised ion exchange groups. There are two 
types of ion exchangers, positively charged anion exchangers and negatively charged cation 
exchangers (see Table 2.2b). Separation is achieved due to the differences in charge between 
the molecules to be separated and the ion exchanger. This interaction can be controlled and 
influenced by varying conditions such as pH and ionic strength which alter the charge on the 
desired molecules but not the charge on the adsorbent solid phase.
Early types of ion exchanger were fabricated from synthetic resins, such as PS-DVB 
(Tooper and Wirth, 1956; refer to Section 2.1.3.1) and designed for procedures such as 
demineralisation, water treatment and the recovery of ions from waste products (Adams and 
Holmes, 1935). The hydrophobic nature of these materials made them unsuitable for use with 
biological molecules. In 1956, Peterson and Sober developed ion exchangers that exploited 
cellulose as the base material for use in biological separations. Subsequently there have been 
a variety of materials used for adsorbents employed for ion exchange chromatography. 
Including dextran (Molday and Mackenzie, 1982), chitosan (Gallo and Hassan, 1988) and 
agarose (Davies et al, 1994). As previously noted the interaction between an ion exchanger 
and a biological material is dependent on their relative charges. For anion exchangers the pH 
of the system must generally be above the isoelectric point (pi) of the biological molecule to 
make it negatively charged in order to adsorb to the positively charged adsorbent solid phases 
(see Figure 2.4). The type of ions present in the liquid phase determines whether the 
molecules are positively or negatively charged and the net charge changes from positive to 
negative as the concentration of OH" ions increases. The isoelectric point is the pH at which 
the change occurs and the molecules carry no charge (see Figure 2.4). Therefore with cation 
exchangers the pH of the system must be below the pi to ensure that the molecule is 
positively
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Figure 2.4 Diagrammatic representation of the modification of protein charge with 
changing pH
Positively charged 
for anion exchange
+ve
Charge
-ve Negatively charged 
for cation exchange
pH
Isoelectric Point
Figure 2.4 represents the change in the charge of a protein molecule as the pH increases. 
The isoelectric point (pi) indicated represents the pH at which the net charge of the protein 
molecule changes from positive to negative, where the molecule carries no net charge. When 
the pH of the protein molecule is below the pi, the protein is positively charged and can be 
recovered using anion exchange chromatography whilst when the pH is greater than the pi 
the protein can be recovered by cation exchange chromatography.
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charged overall (see Figure 2.4). For example bovine serum albumin (BSA) has a pi of pH 
5.1 (Righetti and Caravaggio, 1976) and thus at pH 7.5, BSA can be recovered using anion 
exchange chromatography and at pH 4.0 BSA can be recovered using cation exchange 
chromatography (Williams and Lyddiatt, unpublished data). Additionally, due to the 
dependence of the interaction on charge, the product adsorbed to the ion exchanger can be 
eluted using mild conditions such as changes in pH or by increases in the salt concentration 
of the system.
The ion exchange chemistry used in this study was the anion exchange 
diethylaminoethyl (DEAE) ligand selected as a commonly used chemistry with established 
preparative protocols (Peterson and Sober, 1956; Gilchrist, 1996). Furthermore, there are 
widely used commercial adsorbents exploiting DEAE chemistry, such as STREAMLINE 
DEAE, which were exploited as benchmark adsorbents in this study.
2.2 Materials and Methods
2.2.1 Chemicals
Agarose was supplied by Sigma-Aldrich (Poole, Dorset, UK) and zirconium silicate 
was sourced from Glen Creston (Middlesex, UK). All other chemicals used were reagent 
grade unless otherwise stated and supplied by Sigma-Aldrich (Poole, UK) or BDH (Poole, 
Dorset, UK).
2.2.2 Equipment
• Rotary mixing unit consisting of a speed adjustable rotary unit (Watson-Marlow 
Company Ltd, Cornwall, UK) and in house designed support fittings.
• pH meter, Hanna Instruments, H19321, Microprocessor Bench pH meter.
• Olympus BH-2 light microscope, Olympus Optical Company Ltd, London, UK.
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• Peristaltic pump, model 101U (maximum output 15W), Watson-Marlow Company Ltd, 
Cornwall, UK.
• Malvern Mastersizer, version 2.18, Malvern Instruments Ltd, Malvern, UK.
• Polytron PT3000 Homogeniser, Philip Harris Scientific, (Formerly of Kinematica, 
Germany).
• Pharmacia LKB Ultrospec III spectrophotometer, Amersham Biosciences, Uppsala, 
Sweden.
• Magnetic stirrer/ hotplate, Stuart Scientific Company Ltd, UK.
• Fluid FL200L Power Unit, Labortechnik, Germany
• General laboratory glassware
2.2.3 Fabrication of Perfluorocarbon Emulsion Particles
A method established by McCreath and Chase (1996a) was adopted for the 
fabrication of perfluorocarbon emulsion particles. The principle of perfluorocarbon emulsion 
production was based on the interaction between the hydrophilic polymeric surfactant, 
polyvinyl alcohol (PVA) and the hydrophobic perfluorodecalin oil.
A solution of PVA (9,000-10,OOOMW, 80% hydrolysed) was prepared in 200ml of 
distilled water at a concentration of lOmg/ml. The PVA solution was added to a baffled glass 
vessel that contained 50ml of perfluorodecalin oil. The contents were then homogenised 
using a Polytron PT3000 homogeniser (Philip Harris Scientific, UK) at 17500rpm for 45 
seconds. The emulsion was allowed to settle and then 100ml of the supernatant was removed 
to eliminate a proportion of the excess uncoupled PVA from the system. This was replaced 
with 50ml of distilled water. The suspension was mixed using a magnetic stirrer/ hotplate and 
heated to 40°C in a water bath for 30 minutes. Glutaraldehyde (200ul of 25% w/v) was added 
to the suspension as the crosslinking reagent. Mixing was continued for 10 minutes after
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which crosslinking was catalysed by the addition of hydrochloric acid to the suspension to a 
final concentration of 0.25M. This suspension was mixed for 1 hour before 4g of NaOH (in 
20ml of distilled water) was added to stop the crosslinking reaction. The mixture was stirred 
for a further 10 minutes. The emulsion was repeatedly washed in distilled water until all the 
unbound PVA had been removed (refer to Section 2.2.3.1) then the emulsion was stored at 
4°C in distilled water containing 0.02% sodium azide. Before experimental use, the emulsion 
was degassed thoroughly.
2.2.3.1 lodometric Assay
This was the method used to determine the amount of PVA bound to the 
perfluorodecalin oil to form the perfluorocarbon emulsion. The method was adapted from a 
protocol reported by Garvey et al (1974) based upon difference analysis. The PVA 
concentration was measured spectrophotometrically using an iodine reagent to visualise the 
PVA in solution, which contained 0.45% (w/v) potassium iodide, 0.225% (w/v) iodine and 
3.6% (w/v) boric acid in deionised water. PVA solutions were analysed by diluting the 
sample to an appropriate amount in a 2ml volume followed by the addition of 1ml of iodine 
reagent. This produced a green coloured complex that was measured at 670nm using a 
spectrophotometer against a blank sample. The PVA-iodine complex is thought to form due 
to the random coil structure of PVA in solution. In the presence of iodine atoms, a helical 
structure is induced followed by intramolecular helix association. Iodine complexes with 
groups of 12 PVA residues that when supported by one boric acid molecule, form a single 
helical turn that entwines one iodine atom. This complex resulted in a colour change that was 
measured spectrophotometrically between 580 and 700nm. In order to determine the PVA 
concentration of the samples a calibration curve was determined using known concentrations 
of PVA measured at 670nm (refer to Appendix I).
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2.2.4 Fabrication of 2% Agarose Zirconium
The 2% ZsA adsorbent solid phase was a dense, pellicular Type IV adsorbent 
fabricated by Professor Yan Sun (Tianjin University, PR China) using an oil in water 
emulsification method (Sun et al, 2001) first reported by Hjerten (1964). The vessel used was 
a 2 litre-glass tank with an internal diameter of 12cm and a removable baffle frame (4 
baffles). The impeller was 83mm in diameter and the vessel was water jacketed to ensure 
temperature control. Sunflower oil (1.5 litres) containing 12.8g/litre Span 80 was added to the 
vessel and heated to 80°C using the temperature controlled water jacket. Mixing was 
employed by the use of an impeller driven by a power unit (Fluid FL200L, Labortechnik, 
Germany) at 1160rpm. In a separate glass vessel agarose was dissolved in distilled water at 
4% (w/v) under heating with magnetic stirring. Washed zirconium silicate particles (sourced 
from Glen Creston) were added to this agarose in a volume ratio of 1:7. After the temperature 
of the slurry was increased to 85-90°C it was pumped into the oil phase at a flow rate of 
20ml/min. After mixing the oil emulsion slurry for 30 minutes, cold water was added to the 
water jacket to cool the suspension to 20-24°C and the agitation was stopped. The agarose 
coated zirconium particles were allowed to settle for 30 minutes. The particles were then 
separated from the oil phase and washed in acetone in order to remove all the oil phase whilst 
the final polishing was done with excess volumes of distilled water.
2.2.4.1 Composite Crosslinking
Crosslinking of the polymer content of the adsorbent enhances the structural and 
mechanical strength. The method of Crosslinking used with the agarose composites was 
chemically based using epichlorohydrin, which using a three-carbon propane 2-ol spacer arm 
reacts with a primary amine group to form a secondary amine linkage that is very stable. The 
protocol was adapted from a method proposed by Porath et al (1971). The adsorbent particles
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were suspended in an equal volume of 0.1M NaOH containing 5g/litre of sodium 
borohydride that effectively removes the sulphate groups present in native agarose (see 
Section 2.1.2.1). After mixing for 30 minutes epichlorohydrin was added to a final 
concentration of 2% (v/v) and the reaction was allowed to continue for 4 hours at 25°C. Once 
the reaction was assumed to be completed the adsorbent solid phase was washed in excess 
volumes of distilled water.
2.2.5 Fabrication of PVA Adsorbents
The PVA adsorbents were manufactured by a proprietary method and supplied by Dr 
Igor Galaev, (Lund University, Sweden), no method of fabrication was provided. Four 
different PVA adsorbents were supplied having different fillers of molybdenum, zirconium 
silicate (sourced from Glen Creston), titanium oxide and an adsorbent composed solely of 
PVA. All of the adsorbents were supplied crosslinked using an undisclosed method.
2.2.6 Fabrication of Celbead Adsorbents
The Celbead adsorbents were manufactured using a proprietary method and supplied 
by Dr Arvind Lali (Mumbai University, India). The fabrication method is under patent 
application. Three different Celbead adsorbents were supplied, and two were employed in 
this study and referred to as Celbead (II) and Celbead Amino. The Celbead Amino adsorbent 
was claimed to be crosslinked cellulose beads with surface amino and hydroxyl groups. The 
adsorbent had a density of 1.67g/ml (Pai et al, 2000) that was considered to be high in 
comparison to the density of STREAMLINE (1.2g/ml; see Section 2.1.2). The adsorbent was 
claimed to be 60% pore volume, therefore it was assumed that a high density filler was added 
to the cellulose base material to achieve the enhanced density that was experimentally 
measured.
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2.2.7 Physical Characteristics
2.2.7.1 Adsorbent Shape
The appearance and shape of the adsorbents was recorded using a light microscope 
Olympus BH-2 (with the support of photography) with a magnification of x40, x 100 or x200. 
As a comparison, the shape of the commercial benchmark, STREAMLINE was recorded.
2.2.7.2 Size Distribution Determination
The size distribution of the adsorbent solid phases was determined using a Malvern 
Mastersizer (version 2.18, Malvern Instruments Ltd, UK). The principle of the Mastersizer is 
based upon light scattering, which delivers a fast, non-intrusive method of particle sizing. 
The optical configuration employed for the measurement of adsorbent size was conventional 
Fourier optics. Fourier optics is based on the principle of Fraunhofer diffraction. This is the 
diffraction of a parallel beam observed at a distance from the diffracting aperture. A lens 
produces the parallel beam prior to diffraction whilst the adsorbent particle within the beam 
causes the laser to diffract and a subsequent lens focuses the generated pattern (Figure 2.5; 
Malvern Instruments Manual). The analyser laser beam used in the device was a Helium- 
Neon laser that formed the parallel, monochromatic beam of light. The adsorbent particles 
were introduced to the system via the flow cell (Figure 2.5). The light scattered by the 
adsorbent particles was reflected through a focusing lens that focuses the diffraction pattern 
of the scattered light onto a custom designed detector. The unscattered light was brought to a 
focus on the detector and passed out of the system. The results generated by the Malvern 
Mastersizer were expressed in terms of equivalent spheres and are volume based. Thus, 
within a specific size range, x% of the distribution means that the total volume of all 
adsorbent particles of the diameter within this range, represent x% of the total volume of the
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Figure 2.5 Particle sizer system
Laser Collimating lens
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dispersion unit
Focusing lens
Flow
Cell
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Figure 2.5 represents the particle sizer system used in the Malvern Master sizer (Malvern 
Instruments, UK). The sample to be analysed was added to the sample dispersion unit which 
moved the adsorbent through the flow cell. The parallel laser beam passing through the flow 
cell was diffracted by the presence of the adsorbent particles. This diffracted beam was 
focused onto a detector which sends the information to a computer where the particle size is 
analysed based upon the relationship between the laser diffraction and the particle size 
assuming that the particles are spherical (see Section 2.2.7.2).
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adsorbent particles (Mastersizer Reference Manual). Using the Malvern Mastersizer the 
particle size range and average particle size was determined for all the adsorbents used in this 
study.
2.2.7.3 Density Determination
The density of the adsorbents was determined using a simple method of water 
displacement to yield a value for the wet weight density. A volumetric flask (50ml) was filled 
with distilled water to the calibrated mark. This weight was taken as weight Xg. An amount 
of vacuum filtered adsorbent (filtered using a Buchner filter until liquid flow ceased) was 
added to the flask and the new weight recorded as Yg. The excess water above the calibrated 
mark was removed and the weight noted as Zg. It was assumed that at ambient temperature 
the density of the distilled water was l.Og/ml hence the adsorbent density was determined 
using the following equation
Density (g/ml) = Y-X / Y-Z
Equation 2.1 
2.2.8 Measurement of Bed Expansion Characteristics
A volume of pre-equilibrated adsorbent (equilibrated in lOmM Tris-HCl, pH 7.5, 
0.02% sodium azide with 0.01% Tween 20, Buffer A) was added to a 1cm (i.d) Omnifit 
column to a settled bed height (H0) of 15cm. The settled bed was fluidised by applying an 
upward liquid flow to the base of the column contactor using a peristaltic pump (refer to 
Figure 2.6). The bed was expanded in stepwise increases by increasing the linear flow
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Figure 2.6 Diagrammatic representation of the mode of bed expansion
Settled bed 
height (H0)
Expanded 
bed height 
(H)
Flow distributor
Direction of liquid 
flow
Figure 2.6 represents the expansion of adsorbent within a column contactor when liquid is passed 
through the column in an upward flow from the base of the column through a flow distributor. The 
flow is increased and decreased stepwise and the bed height measured with respect to the flow rate 
entering the column. The bed expansion was determined as H/Ho.
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velocity. Between each step the bed was allowed to stabilise for approximately 15 minutes, 
then the bed height and flow rate was measured up to a maximum expansion. The flow 
velocity applied to the bed was then decreased stepwise and the bed expansion measured 
after stable bed expansion was achieved. The settled bed height was recorded as H0 and the 
stabilised bed expansion was recorded as H, whilst the degree of expansion was expressed as 
follows:
% Bed Expansion = H-HO/HO x 100
Equation 2.2
2.2.9 Ion Exchange Derivatisation
The method used for anion exchange derivatisation was first proposed by Peterson 
and Sober (1956) and further developed by Gilchrist (1996) and Zhang et al (2001). NaOH 
(16ml at 5.88M) was added to 20g of vacuum filtered adsorbent in small aliquots. The 
volume of liquid added to the adsorbent was limited to increase the efficiency of the reaction. 
In order to ensure a thorough coating of all the adsorbent particles only small aliquots of 
alkali were added and were mixed thoroughly between each addition. The mixture was then 
allowed to stand in an ice bath for 30 minutes with occasional stirring, which ensured the full 
penetration of the alkali into the adsorbent particles. Diethylaminoethyl chloride 
hydrochloride (2.4g in 16ml of distilled water) was added to the mixture in small aliquots to 
ensure that the system was well mixed. The reactants were then transferred to a round- 
bottomed flask and attached to a rotary mixing unit that was submerged into a water bath at 
80-85°C and the flask rotated for 2 hours. The reaction products were cooled on ice until the 
mixture was at ambient temperature, whereupon 84ml of 2M NaCl was added in several 
aliquots. The strong alkaline conditions used in the procedure promoted the production of
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reaction side products that are difficult to remove. The presence of salt facilitated the 
filtration of the impurities from the adsorbent solid phase in addition to controlling the 
swelling of the adsorbent. The adsorbent was vacuum washed with 1M NaOH using a glass 
sinter, until the filtrate was clear. The adsorbent cake was subsequently washed with 200ml 
of 1M HC1 and 200ml of 1M NaOH. The adsorbent was suspended in 150ml of 1M NaOH 
diluted to 1 litre with distilled water and left to stand overnight at room temperature. The 
adsorbent slurry was finally washed with deionised water and stored in 0.02% sodium azide 
at 4°C.
2.2.9.1 Small Ion Capacity Determination
Small ion capacity estimation was undertaken following a method described by 
Helfferich (1962) and based upon the establishment of a pH titration curve. Ion exchange 
capacity was defined as the number of ionic groups per specified amount of ion exchanger 
and measured in milliequivalents of chloride ions per gram of adsorbent. Vacuum filtered 
adsorbent was washed in 1M NaOH to completely convert the DEAE anion exchanger to the 
OH" form, and then washed with deionised water to remove the excess base. Anion 
exchangers in their hydroxyl form are insoluble bases that can be considered to act like 
soluble bases, and hence be titrated with acid. Recording the pH to form a pH titration curve 
can monitor the neutralisation of the insoluble base. Vacuum filtered adsorbent (Ig) was 
suspended in 50ml of 0.5M NaCl and titrated with 0.01M HC1. Aliquots of 20ul of 0.01M 
HC1 were added and the equilibrium pH of the adsorbent slurry was recorded. A considerable 
time period (greater than 30 minutes) was required between additions of acid in order to 
ensure that equilibrium conditions had been established. The titration end point was taken as 
the point of greatest change of pH per fixed aliquot of acid.
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For correct interpretation of the pH titration curve, the mechanism of the titration 
must be fully explained. Once the adsorbent was completely converted to the OH" form the 
solid phase was placed in a salt solution followed by the addition of the titrant. Upon the 
addition of the HC1 the ion exchange took place. The OH" ions that were released from the 
solid phases immediately combined with the added H+ ions:
H+ + OH" ———»> H2O
According to the Le Chatelier principle the neutralisation of the OH" ion in solution drives 
the ion exchange to completion. Cl" ions are almost completely taken up as long as there are 
OH" ions still present on the adsorbent. Therefore the amount of OH" ions released from the 
adsorbent was stoichometrically equivalent to the amount of HC1 added. Theoretically the pH 
of the supernatant remains unchanged. Once all the OH" ions had been replaced by Cl" ions 
further additions of the HC1 caused a sharp decrease in pH. As seen in Figure 2.7 there was a 
noticeable pH drop in the initial stages of the titration that was due to the weak nature of 
DEAE. The hydroxyl groups on the anion exchanger are weakly dissociated which resulted in 
the adsorbent being reluctant to exchange OH" groups for the Cl" ions. Due to this the ion 
exchange was incomplete after HC1 addition resulting in a pH drop. As more HC1 was added 
to the system the ion exchange was driven further to completion, shown by a small plateau in 
the central region of the titration, and a sharp decrease in pH at the titration end point.
2.3 Results and Discussion
2.3.1 Physical Characteristics of Adsorbent Solid Phases
The main characteristics of the adsorbent solid phases investigated herein include size 
distribution, shape, density and bed expansion characteristics. All of these properties were 
recognised to have an influence upon the physical and biochemical performance of the 
adsorbents for product recovery (refer to Equation 2.3; Section 2.3.2).
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Figure 2.7 Small Ion Capacity Determination of STREAMLINE DEAE
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Figure 2.7 represents the pH titration of STREAMLINE DEAE, showing the drop in pH 
with the addition ofaliquots ofO.OlMHCL Adsorbent (Ig) was added to 50ml ofO.SM 
Nad Between each addition of acid the pH was allowed to equilibrate for at least 30 minutes. 
The titration end point was determined as the point at which there was the greatest drop in 
pH per fixed aliquot of acid.
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2.3.1.1 Adsorbent Shape
The commercial adsorbent solid phases STREAMLINE (Type I; Figure 2.1), POROS 
(Type II; Figure 2.1) and Toyopearl (Type III; Figure 2.1) were characterised by microscopic 
analysis to reveal apparently spherical shapes (Figures 2.8-2.10). The custom fabricated 
perfluorocarbon emulsion particles (Type III, Figure 2.1; Figure 2.11) were also characterised 
by a spherical adsorbent shape for the droplet particles, in contrast to the irregularly shaped 
2% ZsA adsorbent (Type IV, Figure 2.1). The light micrograph enabled the zirconium filler 
material to be visualised showing that the agarose pellicle surrounding the zirconium filler is 
irregular, as is the number of zirconium particles per adsorbent particle (Figure 2.12). This is 
also seen with the PVA Zr adsorbent particles (Type II, Figure 2.1; Figure 2.16). The shape 
of the PVA adsorbents (Type II, Figure 2.1) is generally near spherical and the fillers can 
clearly be seen in PVA (Figure 2.13), PVA TiO2 (Figure 2.14), PVA Mo (Figure 2.15) and 
PVA Zr (Figure 2.16). Both Celbead materials (Type II, Figure 2.1) appeared to be the least 
spherical of the experimental adsorbents and exhibited a very irregular shape (Figures 2.17 
and 2.18).
2.3.1.2 Size Distribution of Adsorbent Solid Phases
The adsorbent solid phases sourced for this study exhibited a wide distribution of 
sizes. The adsorbents were sized using a Malvern Mastersizer (see in Section 2.2.7.2) which 
generated data recording the apparent size distribution of the adsorbent populations. Figure 
2.19a represents the narrow size distribution of the commercial benchmark adsorbent, 
STREAMLINE, in comparison to Figure 2.19b that illustrates the wide size distribution of 
PVA Mo. Such a characteristic is representative of all the custom fabricated prototype 
adsorbents. STREAMLINE had a more discrete size range as a specific range of adsorbent
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Figure 2.8 Optical light micrograph of STREAMLINE
The optical light micrograph represents the commercial adsorbent STREAMLINE which has 
an average size of 200jum (refer to Table 2.3). The image was recovered at times 100 
magnification (1cm = lOOjum).
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Figure 2.9 Optical light micrograph of POROS SOD
|___| = 25um 
Figure 2.10 Optical light micrograph of Toyopearl
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Both of these adsorbents are commercial adsorbents that had an average size of50jum and 
40jum respectively (refer to Table 2.3). The image of POROS was recovered at 400 times 
magnification (1cm = 25f*m) and Toyopearl at 200 times magnification (1cm = 50pm).
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Figure 2.11 Optical light micrograph of perfluorocarbon emulsion
Figure 2.12 Optical light micrograph of 2% ZsA
«* Jfe •
These are both adsorbents that were assembled in the Biochemical Recovery Group at 
Birmingham University. Perfluorocarbon emulsions were fabricated using a method 
proposed by McCreath and Chase (1996a) and the 2% ZsA was assembled by Professor Yan 
Sun (Sun et al, 2001; Tianjin University, PR China). The image of perfluorocarbon emulsion 
was recovered at 400 times magnification (1cm = 25 um) and 2% ZsA image was recovered 
at 40 times magnification (1cm = 250um).
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Figure 2.13 Optical light micrograph of PVA
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Figure 2.14 Optical light micrograph of PVA TiO2
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The optical light micrographs above represent PVA and PVA 7702 adsorbents that were 
manufactured and supplied by Igor Galaev (Lund University, Sweden). The image of PVA 
was recovered at 100 times magnification (1cm = lOOum) and PVA TiO2 at 40 times 
magnification (1cm = 250um).
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Figure 2.15 Optical light micrograph of PVA Mo
—-I = 250|am 
Figure 2.16 Optical light micrograph of PVA Zr
TTze optical light micrographs represent PVA Mo and PVA Zr adsorbents that were 
manufactured and supplied by Igor Galaev (Lund University, Sweden. The image of PVA Mo 
was recovered at 40 times magnification (1cm = 250um) and PVA Zr was recovered at 100 
times magnification (1cm = lOOjum).
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Figure 2.17 Optical micrograph of Celbead (II)
Figure 2.18 Optical light micrograph of Celbead Amino
The optical light micrographs above represent the Celbead adsorbents fabricated by Arvind 
Lali (Mumbai University, India). The Celbead (II) and Celbead Amino images were 
recovered at 40 times magnification (1cm = 250jum).
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Figure 2.19 Size distribution graphs a) STREAMLINE and b) PVA Mo
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These graphs represent the size distribution profiles of the commercial adsorbent STREAMLINE 
(Figure 2.19a) in comparison to the 'in house 'fabricated adsorbent PVA Mo (Figure 2.19b). 
The traces were generated from the Malvern Mastersizer (Malvern Instruments, Malvern, UK). 
The adsorbent particles were suspended in water.
61
size is selected for the commercial market. The size distribution analysis enabled the average 
particle size of each adsorbent to be determined. This illustrated a marked difference in 
particle size of the selected adsorbents from the perfluorocarbon emulsions at lOum in 
diameter (Type III, see Figure 2.1) to PVA Zr with a diameter of 515um (Type II, see Figure 
2.1; refer to Table 2.3). Adsorbent particle size is an important factor to be considered in 
terms of the bed expansion performance of the adsorbents (refer to Equation 2.3, Section 
2.3.2).
2.3.1.3 Density Determination
The measurement of density for each of the adsorbent solid phases was carried out 
since density is recognised to be an influencing factor upon the bed expansion properties of 
adsorbents (refer to Equation 2.3; Section 2.3.2). The density of the adsorbents under study 
varied depending on both the base material and also the filler that was contained within the 
adsorbent structure. The highest density adsorbent used in this study was the perfluorocarbon 
emulsion (Table 2.3) where the density was due to the perfluorodecalin base material (density 
= 1.917g/ml; see Table 2.2a). All of the custom designed adsorbents showed higher densities 
than the Type I benchmark adsorbent, STREAMLINE (see Figure 2.1), except the adsorbent 
that consisted solely of PVA (see Table 2.3). Since STREAMLINE was a commercial 
adsorbent specifically designed for fluidised bed adsorption chromatography and the selected 
adsorbents had superior densities the data suggested that these adsorbents would also show a 
superior bed expansion performance.
2.3.2 Bed Expansion Characterisation
It was important to characterise the bed expansion properties of the adsorbent solid 
phases in order to assess the suitability of the adsorbents for fluidised bed recovery of
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Table 2.3 Average adsorbent particle sizes and density
ADSORBENT 
TYPE
I
II
III
IV
ADSORBENT
STREAMLINE
Celbead (II)
Celbead Amino
POROS
PVA
PVAMo
PVA TiO2
PVAZr
Perfluorocarbon emulsion
Toyopearl
2% ZsA
DENSITY 
(g/ml)
1.2
1.38
1.45
1.01
1.01
1.39
1.13
1.37
2.1
1.46
1.67
SIZE (fun)
209
395
398
50
390
423
428
515
10
30
209
Particle sizes of both the commercial and custom fabricated prototype adsorbents were 
determined using a Malvern Mastersizer (Malvern Instruments Ltd, UK). This technique is 
based upon the principle of light scattering therefore it is a fast and non-intrusive technique 
for particle sizing. The pattern of light scattering is converted into equivalent spheres which 
is then expressed as a volume percentage (see Section 2.2.7.2). In addition, the densities were 
based on wet weight adsorbent densities and were determined using a simple method of 
water displacement (see Section 2.2.7.3). Both the size and density of the adsorbent solid 
phases are important characteristics since both affect the sedimentation of adsorbent 
particles according to Stokes law (refer to Section 3.2.3). Each figure represents an average 
determined from triplicate measurements.
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biological materials. For experimental characterisation a single buffer system was applied to 
determine the degree of bed expansion of the selected adsorbent solid phases. Figure 2.20 
illustrates the bed expansion characteristics of the adsorbents in lOmM Tris-HCl, pH 7.5 with 
0.02% sodium azide and 0.01% Tween 20 (Buffer A). The bed expansion at a specific linear 
flow velocity increased with the decreasing density of the adsorbent solid phases, with the 
exception of the perfluorocarbon emulsion (Type III, see Figure 2.1). This adsorbent had a 
density of 2.1g/ml (refer to Table 2.3), the highest density overall, but the expansion was 
poor which was attributed to the small size (lOum) of the adsorbent (see Figure 2.3). 
According to Stake's Law (see Equation 2.3) the particle diameter (p) has a greater effect on 
sedimentation velocity than the particle density (p).
Ut = (pp.pi)dp2g/l 8r| Equation 2.3
Two adsorbents (POROS, Type II; see Figure 2.1 and Toyopearl, Type III; see Figure 
2.1) were not subjected to the bed expansion tests, since the limited size and density of both 
materials compromised controlled bed expansion (see Table 2.3).
There are numerous theories and correlations describing the liquid fluidisation of 
particles (Di Felice, 1995) including bed expansion characterisation. One of the most 
commonly used methods is the simple correlation of Richardson and Zaki (1954) where the 
expansion of particles in liquid is characterised by the following equation
U = Ut x s" Equation 2.4
which correlates the voidage of the bed (s) with the linear velocity (U) using the terminal 
settling velocity of a single particle (Ut) and the expansion index (n). The terminal settling 
velocity and bed expansion index is determined from measurements of the bed void volume
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Figure 2.20 Bed expansion profiles of adsorbent solid phases
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The liquid phase used for the bed expansion was lOmM Tris-HCl, pH 7.5, 0.02% sodium azide 
and 0.01% Tween 20. The settled bed height used was 15cm in a 1cm (i. d) Omnifit column. 
The flow was applied to the base of the column using a peristaltic pump. The bed was allowed 
to settle for 15 minutes until stable and the bed height was measured against the flow rate 
entering the column. Triple determinations were completed for each bed expansion test.
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at different linear velocities. A double -log plot of g vs U enables n and Ut to be determined 
from the slope and intercept respectively using linear regression analysis.
The Richardson and Zaki analysis was not the method chosen for bed expansion 
characterisation in this study because this equation assumes that the particles are 
monodisperse, spherical particles. As a consequence of the physical characterisation studies 
some of the selected adsorbent solid phases were shown to be non-spherical (see Figures 2.17 
and 2.18) and all the adsorbent solid phases were characterised with a wide particle size 
distribution (see Figure 2.19).
2.3.3 Anion Exchange Derivatisation
The adsorbents used were derivatised with diethylaminoethyl (DEAE) chemistry that 
is defined as a weak anion exchanger in the face of the limited degree of ionisation of the 
group over a wide pH range. The DEAE chemistry was introduced using a method from 
Peterson and Sober (1956) adapted by Gilchrist (1996). The protocol adopted herein followed 
the original method except for the use of an 'in house' built rotary mixing unit to 
accommodate batch reactions of 50ml which limited any mechanical destruction of the 
adsorbents during the mixing process. The success of the reaction was indicated by a minimal 
generation of fines and was quantified in terms of the small ion capacity using the method 
reported in Sections 2.2.9.1 and 2.3.3.1.
2.3.3.1 Small Ion Capacity Determination
The amount of DEAE groups immobilised covalently upon the adsorbent solid phase 
was quantified using pH titration following the method reported by Helfferich (1962) and 
developed by Griessbach (1939). An anion exchanger in the hydroxyl (OH") form was 
considered to be an insoluble base, which could be neutralised by the addition of acid. This
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neutralisation was measured by monitoring the pH of the system and a pH titration curve 
could be produced relating the molarity of acid added to the changing pH. Figure 2.7 
illustrates a representative pH titration curve determined for the commercial adsorbent, 
STREAMLINE DEAE. The titration end point of the neutralisation was determined as the 
greatest change of pH per fixed aliquot of acid added (see Section 2.2.9.1). Small ion 
capacity was measured in terms of milliequivalents of Cl" ions per milliliter of adsorbent. The 
shape of the pH titration curve was typical of that for a 'weak' DEAE anion exchanger 
(Peterson and Sober, 1956; see Section 2.2.9.1).
Table 2.4 represents the small ion capacities for all the adsorbent solid phases used 
(Types I-IV) which demonstrates there was a variation in capacity for the different adsorbent 
types. The PVA adsorbents (Type II, see Figure 2.1) and the perfluorocarbon emulsion (Type 
III, see Figure 2.1) exhibited the lowest small ion capacities. This was attributed to the 
hydroxyls on the PVA being less reactive than those found on agarose and cellulose thus 
diminishing the coupling reaction. The Celbead materials also demonstrated low capacities in 
comparison to the other adsorbent solid phases investigated in the study. However the pore 
volume of this adsorbent was reported to be 60% of the total adsorbent volume (Pai et al, 
2000), which indicated that there was a limited surface area available for ligand attachment. 
In addition, it was unknown whether the Celbead materials were crosslinked, which would 
have had further impact upon adsorbent derivatisation (Gilchrist, 1996). The data expressed 
in Table 2.4 may be over estimations due to the extended times required for equilibration and 
it could not be guaranteed that equilibrium had been reached. However the small ion capacity 
determined for STREAMLINE DEAE by pH titration (ITOumol) compared favourably with 
the data supplied by the manufacturers (120-180umol).
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Table 2.4 A summary of the small ion capacities determined for the selected adsorbent 
solid phases.
ADSORBENT 
TYPE
I
II
III
IV
ADSORBENT
STREAMLINE
Celbead (II)
Celbead Amino
POROS SOD
PVA
PVAMo
PVA TiO2
PVAZr
Perfluorocarbon emulsion
Toyopearl
2% ZsA
SMALL ION CAPACITY 
(jumol Q /ml adsorbent)
170
41
300*
100
1.6
2.78
3.3
54.4
8
490
89
*For Celbead Amino the small ion capacity equivalent is umol amine groups/ml adsorbent as 
determined at Mumbai University, India.
The small ion capacities of the adsorbent solid phases were determined by the generation of 
a pH titration curve (see Figure 2.7). The titration end point was determined as the point at 
which there was the largest drop in pH per fixed aliquot of HCl added and the small ion 
capacity was determined as the Cl- molar equivalent added at the titration end point (see 
Section 2.3.3.1)
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2.3.4 General Conclusions
The aim of this chapter was to investigate the physical characteristics of a variety of 
adsorbent solid phases having different internal and external geometries. The adsorbent used 
were either commercial or custom fabricated prototype adsorbents produced in Birmingham, 
or in other laboratories (Mumbai University, India; Lund University, Sweden; see Table 2.1). 
The physical characteristics investigated were size, shape, density and bed expansion. The 
adsorbents exhibited a variety of sizes from lOum (perfluorocarbon emulsion) to 515um 
(PVA Zr; see Table 2.3). The density of these adsorbents also varied from 1.12g/ml to 
2.1g/ml, however the increase in density did not necessarily correspond to a decrease in bed 
expansion (see Figure 2.20). This was attributed to the relative sizes of the adsorbent, as the 
adsorbent that had the highest density (perfluorocarbon emulsion) had the smallest adsorbent 
size (see Table 2.3). All of the fluidisable adsorbents demonstrated superior expansion 
characteristics in comparison to the commercial benchmark, STREAMLINE. Toyopearl 
(Type III, see Figure 2.1) and POROS (Type II, see Figure 2.1) were not included in the bed 
expansion tests due to their limited density (see Table 2.3). During bed expansion the top of 
the bed was indiscernible due to the adsorbent particles being entrained out of the column 
contactor as a result of the upward liquid flow velocity applied to the bed to fluidise the 
adsorbent particles.
The commercial adsorbents all exhibited a spherical geometry (see Figures 2.8-2.10) 
and the custom fabricated adsorbents were generally spherical (see Figures 2.11-2.16), except 
for the Celbead materials (Type II, see Figure 2.1; Mumbai University, India) which were 
very irregular in shape, particularly Celbead Amino (see Figure 2.17-2.18). The difference in 
shape between the Celbead materials suggested that the adsorbents were fabricated using 
different unknown manufacturing methods. However, due to the enhanced densities they 
demonstrated adequate bed expansion behaviour in comparison to STREAMLINE (Type I,
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see Figure 2.1; see Figure 2.20). The selected adsorbent solid phases were derivatised with 
DEAE or amino anion exchange chemistries and showed a variety of small ion capacities 
(see Table 2.4), as a consequence of both the surface area available for ligand attachment and 
the reactivity of the hydroxyls on the adsorbent base material. The measurement of small ion 
capacity represents the number of anion exchange groups immobilised to the adsorbent solid 
phase. However, all of these groups will not be available for adsorption due to the groups 
being inaccessible to both soluble and particulate products. A realistic measurement of the 
number of groups available for adsorption can be determined from batch binding experiments 
with soluble and particulate protein.
As stated (see Section 2.1) the aim of this study was to investigate candidate 
adsorbent solid phases as ideal adsorbents for fluidised bed adsorptive recovery of 
economically desirable nanoparticulate products such as viruses, plasmid DNA and drug 
delivery vehicles. Chapter 2 investigated the physical characterisation of the selected 
adsorbent solid phases. The results demonstrated that the adsorbent solid phases (Types I-IV) 
exhibited a variety of sizes, densities, shapes and small ion capacities. The physical 
characterisation studies suggested that Celbead Amino (Type II, see Figure 2.1) exhibited 
superior bed expansion characteristics in comparison to the adsorbent solid phases included 
in the study.
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CHAPTER 3
BIOCHEMICAL CHARACTERISATION OF ADSORBENT SOLID
PHASES
3.1 General Introduction
There has been a growing interest in the manufacture of nanoparticulate products (see 
Section 2.1) that has not been matched by the development of chromatographic adsorbents 
suitable for the fluidised bed recovery of such products. Currently available chromatographic 
adsorbents are expected to show process disadvantages as noted in Section 2.1, and thus 
alternative adsorbent configurations have been investigated as candidate adsorbents for 
nanoparticulate recovery (designated Type I to IV, see Figure 2.1). Chapter 2 detailed the 
physical performance of the adsorbents selected for this study (see Table 2.1) and the data 
generated suggested that Celbead Amino (Type II, see Figure 2.1) demonstrated the best 
performance in terms of the fluidisable quality of the adsorbent (see Figure 2.20).
Chapter 3 describes the study of commercial and custom designed adsorbent solid 
phases, classified as Types I to IV (see Figure 2.1), that have been critically evaluated in 
adsorptive studies with nanoparticulate and protein products in batch binding 
experimentation. This is justified as follows. A major problem associated with commercially 
realistic studies of virus or plasmid recovery, is the quantity of nanoparticulates required for 
representative binding studies. Effective working capacities of ion exchangers and other 
adsorbents are not widely reported in the literature, however they appear to be between 109 
and 10 12 particles per milliliter of settled adsorbent (O'Neil and Balkovic, 1993; Hughye et 
al, 1995). Lyddiatt and O'Sullivan (1998) described naive calculations with respect to the 
number of 50nm spheres (i.e. an average virus particle) that could be packed as a single layer 
upon the surface of a lOOum spherical, solid adsorbent particle. The yielded values
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approximated to 10 12 particles per milliliter of settled adsorbent. Typical virus harvest litres 
have been claimed to be in the range of 106 to 10 11 virus particles per milliliter of cell culture 
supernatant. Therefore for one milliliter of settled adsorbent 1-1000 litres of supernatant will 
be required for saturation to be achieved.
The practical problem of material supply for the primary scouting experiments was 
circumvented by exploiting synthetic nanoparticulates, such as particulate BSA formed by 
coacervation and crosslinking to form protein nanoparticles (see Section 3.1.1). Preliminary 
batch binding experiments were completed using both soluble bovine serum albumin (BSA, 
refer to Section 3.1.3) and particulate BSA. The separation of soluble BSA from particulate 
BSA is a model for all nanoparticulate recovery with respect to the separation of product 
assemblies from product components. In addition, the recovery of soluble BSA can be 
representative of the separation of products from components of complex feedstocks.
3.1.1 Fabrication of Synthetic Protein Nanoparticulates
Protein nanoparticles were employed as representative nanoparticulate products in the 
present study and were fabricated as size and charge mimics. The nanoparticles can be 
fabricated having different sizes representative of a variety of nanoparticular products such as 
plasmid DNA, viruses and drug delivery vehicles (see below). Protein nanoparticles are an 
example of macromolecular assemblies that have been produced as putative drug delivery 
vehicles for the delivery of intravenous drugs to specific organs or target sites within the 
body (Lin et al, 1994). Such protein nanoparticles have been modified for both drug delivery 
functions and gene therapy applications (Coester et al, 2000; Langer et al, 2000).
The protein nanoparticles used in this study were fabricated following a method 
proposed by Lin et al (1993) based upon the principle of coacervation which is the reversible 
aggregation of particles of an emulsion into liquid droplets preceding flocculation. The
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protein used for this study was bovine serum albumin (refer to Section 3.1.3) which is 
characterised as having a high content of charged amino acids such that the protein is 
insoluble in organic solvents (refer to Section 3.1.3). BSA nanoparticles (BSAp) can be 
prepared by adding water miscible organic solvents, such as ethanol or acetone to the BSA 
solution, to encourage the protein to aggregate into small particles which can be subsequently 
stabilised by the addition of crosslinking reagents. The nanoparticle size is dependent on 
several factors including the amount of coacervation agent added, the mixing conditions, 
temperature and the viscosity of the solution (Lin et al, 1994).
3.1.2 Nanoparticle Sizing using Photon Correlation Spectroscopy
The size distribution of the fabricated BSAp was analysed by photon correlation 
spectroscopy (PCS) using a Malvern Zetasizer 1000HS/IHPL (Malvern Instruments, UK) 
made available by Dr L. Seymour, (Cancer Research Centre, University of Birmingham).
PCS is the industrially preferred method of sub-micron particle size analysis. The 
PCS equipment comprises a 5mW helium neon laser and 90° scattering optics linked to a 
computer for real time analysis of the results. The samples analysed in the PCS device should 
consist of well dispersed particles in a liquid medium. In such conditions the particles are in 
constant random motion, referred to as Brownian motion and PCS measures the speed of this 
motion by passing a laser (at a wavelength of 532nm) through the sample at 90°. PCS relates 
the diffusion speed of the particles to the speed of Brownian motion using the Einstein- 
diffusion equation.
D = 52/2T = RT/67tr|rNA Equation 3.1
As a result of Brownian motion, particles migrate an average distance (8) in each small time 
interval (T). The diameter of the particles can be determined from the Einstein-diffusion 
equation where D is the diffusion coefficient, NA is Avogadro's number, and R is the gas
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constant and T absolute temperature. The measurements determined by PCS include the 
average particle size and the Polydispersity Index (PI) which is a measure of the range of 
particle sizes within the measured sample. The measurement must be below 0.7 (70%) for the 
average particle size to be determined accurately, a higher PI indicates that the particle size 
range is too large for the device to accurately measure the speed of the Brownian motion. The 
data generated expresses the particle size as a percentage of the total number of particles in 
any one size range.
3.1.3 Bovine Serum Albumin
Bovine serum albumin (Fraction V powder, 96% purity) was the protein chosen for 
this study on the basis of its availability and relatively low cost. Serum albumin is a 
nonglycoprotein, i.e. the protein does not contain covalently linked sugar residues (Cohn et 
al, 1947) and has been shown to have a molecular weight of 66.7kD with an isoelectric point 
of pH 5.1 (see Section 2.2.9). Albumins are characterised by a low content of tryptophan and 
methionine residues together with a high content of cysteine residues and charged amino 
acids. These include aspartate, glutamate, lysine and arginine (Peters, 1985) with glycine and 
isoleucine also present in lower numbers than in an average protein (see Table 3.1). Aspartate 
and glutamate residues are negatively charged amino acids and are the residues that will 
primarily interact with the positively charged DEAE anion exchange chemistry immobilised 
to the adsorbent solid phases (see Section 2.2.9; 2.2.9.1). Serum albumin is a soluble protein 
that exhibits a good stability due to the high total charge of the protein in addition to the 
many disulphide bonds present in the protein.
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Table 3.1 Amino acid composition of bovine and human serum albumin
AMINO ACID RESIDUE
Aspartate (-ve)
Glutamate (-ve)
Lysine (+ve)
Histidine (+ve)
Arginine (+ve)
NUMBER OF AMINO ACIDS
BSA
41
59
59
17
23
HSA
36
62
59
16
24
Table 3.1 summarises the number of charged amino acids present in both bovine and human 
serum albumin (Peters, 1995).
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3.1.4 Estimation of the Maximum Binding Capacity for the Selected Adsorbent Solid 
Phases
Subsequent to the adsorption/desorption batch binding experiments, the maximum 
binding capacity of the selected adsorbent solid phases was estimated using Langmuir 
assumptions. The Langmuir isotherm permits an estimate of how much product an adsorbent 
is capable of adsorbing (qm) and how tightly the product binds to the immobilised ligand (kd). 
Consequently the estimates made from the Langmuir isotherm can be applied to the scale up 
of a chromatographic separation and the approximation of the desorption behaviour of the 
product for a particular immobilised ligand.
The principle of separation by ion exchange chromatography is dependent upon the 
reversible adsorption of charged molecules to oppositely charged immobilised ion exchange 
groups (see Section 2.1.9). This interaction can be described by an equilibrium relationship
k, 
A + B^I^ AB Equation 3.2
k2
The rate constants, ki and k2 govern the forward and backward direction of the reaction 
whilst the equilibrium relationship is described by the dissociation constant (Kd) which is 
equal to the ratio of ki/kj. Several isotherm models have been proposed for determining both 
the dissociation constant (Kd) and maximum binding capacity (qm) including linear, 
Freundlich, bi-Langmuir, Langmuir and Freundlich-Langmuir isotherm models. In 1984 
Chase proposed the Langmuir isotherm model to describe affinity chromatography and it is 
recognised as the most popular model due to its simplicity and good agreement with 
experimental data (Lan et al, 2001). The Langmuir model is based on the following equation
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q* = qm C*/(Kd + C*) Equation 3.3 
(Chase, 1984)
The constants q* and C* represent the equilibrium concentration of the biomolecules for the 
adsorbent solid phase and liquid phase respectively. The maximum binding capacity is 
represented by qm whilst Kd is the dissociation constant of the solute-adsorbent complex, that 
represents a measure of the affinity between the biomolecules and the adsorbent solid phase.
The Langmuir isotherm (Langmuir, 1916) was proposed to describe the adsorption of 
gases onto surfaces and several assumptions are made when applying the model to protein 
adsorption,
i) the biomolecule can bind to the ligand via independent binding sites,
ii) the kinetics of the interaction follows first order approximations (i.e. the rate 
of reaction is proportional to the concentration of a single reactant),
iii) the stoichiometry of the protein-ligand interaction remains 1:1 throughout the 
isotherm range,
iv) all binding sites are of equal energy,
v) a molecule adsorbed onto one binding site does not influence the adsorption of
another molecule on a neighbouring binding site (Chase, 1984),
The Langmuir isotherm has been widely accepted as a method for describing protein 
adsorption to ion exchange and affinity adsorbents. However, Langmuir assumptions may be 
unrealistic due to a number of effects, such as the heterogeneity of the protein and adsorbent 
surface and the tendency of the protein molecules or adsorbent particles to aggregate. As a 
result this model is considered to be more an empirical model rather than a theoretical model 
(Lanet al, 2001).
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3.2 Materials and Methods
3.2.1 Chemicals
The Bradford Assay reagent was supplied by PERBIO (formerly Pierce Warriner Ltd, 
Cheshire, UK) and Bovine Serum Albumin (Fraction V powder, 96% purity) was supplied by 
Sigma-Aldrich (Poole, Dorset, UK). All other chemicals used were reagent grade unless 
otherwise stated and supplied by Sigma-Aldrich (Poole, Dorset, UK) or BDH (Poole, Dorset, 
UK).
3.2.2 Equipment
• Malvern Zetasizer 1000HS/IHPL, Malvern instruments Ltd, Malvern, UK.
• Rotary blood mixer, Stuart Scientific Company Ltd, UK.
• Pharmacia LKB Ultrospec III spectrophotometer, Amersham Biosciences, Uppsala, 
Sweden.
• pH meter, Hanna Instruments, H19321, Microprocessor Bench pH meter.
• Millipore ultrafiltration unit, Millipore, Bedford MA, USA
• Beckman Centrifuge, Model J2-21, Beckman Coulter Research
• Peristaltic pump, model 101U (maximum output 15W), Watson-Marlow Company Ltd, 
Cornwall, UK.
• General laboratory glassware
3.2.3 Preparation of BSA Nanoparticles
BSA nanoparticles were prepared following a method proposed by Lin et al (1993) 
adapted by Zhang et al (2001). A BSA solution (300ml) at a concentration of 5mg/ml was 
prepared in lOmM Tris-HCl buffer, pH 7.5 containing 0.02% sodium azide and 0.01% 
Tween 20 (Buffer A). A volume of absolute ethanol was added to the BSA solution, under
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constant magnetic agitation, using a peristaltic pump until the solution became turbid 
indicating the formation of protein nanoparticles. Glutaraldehyde (150ul of 50% w/v) was 
subsequently added to crosslink the protein nanoparticles formed by coacervation. The 
reaction was continued for 1 hour at room temperature under magnetic agitation. To block 
any unreacted aldehyde groups 75 ul of 1M ethanolamine was added and the reaction 
continued for one hour. To stabilise the so-formed nanoparticles, Tween 20 was added to a 
final concentration of 0.01% (v/v). Larger particles (greater than 200nm in diameter) were 
sedimented from the mixture by centrifuging for 30 minutes at 48,400g at a temperature of 
10°C. Ethanol was removed from the mixture by dialysis with distilled water overnight 
(100ml of supernatant to 500ml of distilled water). Soluble BSA was separated from the BSA 
nanoparticles by ultra/diafiltration using a polyacrylonitrile/polyvinylchloride copolymer 
membrane with a molecular weight exclusion of 300,000 Daltons (supplied by Millipore, 
Bedford, MA, USA). In accordance with the manufacturers guidelines, before use the 
membrane was washed in distilled water whilst in between uses the membrane was washed in 
a 0.5% solution of Tergazyme for 30 minutes followed by washing in distilled water to 
remove any debris from the membrane surface. Soluble BSA was determined to be fully 
removed when the BSA concentration of the permeate was less than 1% of the concentration 
of the nanoparticle solution. The protein concentration was determined using the Bradford 
assay (see Section 3.2.6) and finally to remove any remaining large nanoparticles the 
supernatant was filtered through a 0.2um cellulose nitrate membrane (Millipore, Bedford, 
MA, USA). The final nanoparticle yield, after dia/ultrafiltration, was approximately 220ug of 
nanoparticles (soluble BSA equivalents) per milliliter of supernatant in a final volume of 
200ml (equivalent to a yield of approximately 2.5%). The final nanoparticle yield was very 
low, and could be attributed in part to the degree of aggregation observed on the addition of 
the coacervation agent (ethanol) and the centrifugation (at 48,400g) selected for a narrow
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range of particle sizes (100-500nm, see Section 3.3.3). The nanoparticle size was determined 
using photon correlation spectroscopy (see Section 3.1.2).
3.2.4 Nanoparticle Sizing by Photon Correlation Spectroscopy
The BSA nanoparticles were sized using the Malvern Zetasizer HS1000, whilst 
suspended in Buffer A (lOmM Tris-HCl, pH 7.5, 0.02% sodium azide with 0.01% Tween 20) 
at a protein concentration of 220ug/ml. A sample of nanoparticles (0.6ml) was added to a 
1.5ml disposable cuvette and placed into the device. The nanoparticle size was determined by 
computer analysis using the Einstein-diffusion equation (see Section 3.1.2).
3.2.5 Primary Scouting Experiments with the selected Adsorbent Solid Phases and 
Soluble and Particulate BSA
The selected adsorbent solid phases were assessed in primary scouting experiments 
with both BSAs and BSAp exploiting batch binding experimentation. Before use the 
adsorbents were exhaustively washed in Buffer A to equilibrate the system. Adsorbent 
(O.lml) was added to 1.5ml of protein solution (either soluble or nanoparticulate) and 
rigorously mixed at room temperature using a rotary mixer. Samples of the supernatant 
(O.lml) were taken at regular time intervals over 2 hours resulting in the removal of 
approximately 40% of the supernatant. The soluble BSA solution had an initial concentration 
of 5mg/ml whilst the initial BSA nanoparticle concentration was 220ug/ml. The binding 
profiles were plotted as C/Co values (equilibrium concentration divided by the initial 
concentration) against time. After 2 hours the remaining protein solution was removed and 
the adsorbent washed in Buffer A (5 x 1ml) to remove any unbound or loosely bound protein. 
The elution solution was Buffer A containing I.OM NaCl. Protein loaded adsorbent (O.lml) 
was added to 1.5ml of elution buffer and rigorously mixed for 2 hours at room temperature
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using a rotary mixer and samples of the supernatant (O.lml) were taken at regular time 
intervals and the protein concentration determined using the Bradford assay (refer to Section 
3.2.6). The protein capacity was determined by difference analysis of the initial and 
intermediate protein concentrations, whilst the percentage recovery was determined as the 
concentration of protein eluted as a percentage of the total protein bound.
3.2.6 Total Protein Determination - The Bradford Assay
The total protein concentration was determined using a commercially available assay 
reagent supplied by PERBIO (formerly Pierce and Warriner Ltd, Cheshire, UK). The assay is 
based upon a method proposed by Bradford (1976) where the assay reagent is comprised of 
the dye Coomassie G-250 suspended in phosphoric acid and solubilising agents (Coomassie 
Protein Assay Reagent Kit Instructions). Coomassie G-250 primarily binds to arginine 
residues in proteins and to other aromatic and basic residues. In an acidic environment, when 
Coomassie G-250 binds to the protein, an absorbance shift occurs from 465nm to 595nm 
with a simultaneous colour change from brown/red to blue. This reaction can detect protein 
concentrations as low as lug/ml. The Bradford assay reagent has been shown to be 
compatible with commonly used buffers and reagents.
As previously stated the assay depends on the binding of Coomassie G-250 to 
arginine, basic and aromatic amino acid residues, consequently the efficacy will vary 
depending on the amino acid composition of the protein. As a result the protein concentration 
determined using the Bradford assay is expressed as an equivalent to the standard protein 
used. For this study the standard was generated using BSA at concentrations between 0- 
30ug/ml in Buffer A. The standards were incubated in an equal volume of assay reagent for 5 
minutes at room temperature (e.g. 0.5ml of sample + 0.5ml of assay reagent). The absorbance 
of the standards was determined at 595nm against a buffer blank and assay reagent (see
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Appendix II). Experimental samples diluted to a suitable concentration were prepared using 
the same method as the standards and the total protein determined from the standard curve. 
All the samples were analysed in duplicate.
3.2.7 Determination of Maximum Binding Capacity
Subsequent to the adsorption/desorption batch binding experiments the maximum 
binding capacity of the adsorbent solid phases was estimated in addition to estimates of how 
tightly the BSAp were bound. Information on the binding kinetics of the system is an 
important factor to be considered when scaling up chromatographic adsorption processes. 
Before use the adsorbents were washed exhaustively with Buffer A to ensure that the system 
was equilibrated. Adsorbent (50ul) was added to 1.5ml of BSA nanoparticle solutions of 
increasing concentration from Oug/ml to 220ug/ml, and mixed for five hours at room 
temperature using a rotary mixer. The protein concentration was determined using the 
Bradford assay (refer to Section 3.2.6). The equilibrium binding concentrations were used to 
estimate the maximum binding capacity (qm) and the dissociation constant (K<j) for BSA 
nanoparticles binding based upon Langmuir assumptions.
A Langmuir isotherm was produced by plotting the concentration of protein per unit 
volume of adsorbent (q*) against the equilibrium protein concentration (C*) where q* was 
determined from the following equation
q* = volume of supernatant x (Co-C*/volume of adsorbent) Equation 3.4
where Co was the initial protein concentration and C* represented the protein concentration 
at equilibrium. The values of K^ and qm were determined from straight line plots of C*/q*
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against C*. The x-axis (C*) intercept was -Kd and the gradient was equal to l/qm (see Figure 
3.1).
3.2.8 The Effect of Small Ion Capacity on the Adsorptive/Desorptive Behaviour of BSAp
Subsequent to BSAp batch binding experiments the impact of the ion exchange ligand 
concentration (referred to as small ion capacity; see Section 2.2.9.1) upon BSAp recovery 
was investigated as an important process parameter to be considered when designing 
adsorbent solid phases suitable for fluidised bed recovery of nanoparticulate products. The 
adsorbent particles within the perfluorocarbon emulsion were judged to be inherently solid in 
nature, and consequently all the ion exchange chemistries immobilised onto the adsorbent 
were expected to reside at the surface and be available for protein adsorption. It was therefore 
expected that if modifying the immobilisation procedure reduced the small ion capacity, the 
number of ion exchange groups directly involved in protein binding would also be reduced. 
Five perfluorocarbon emulsion solid phases were produced having different small ion 
capacities by modifying the proposed derivatisation method (see Section 2.2.9).
Perfluorocarbon 1 was produced using the method stated in Section 2.2.9 whereas 
perfluorocarbon 2 and 3 were produced by reducing the initial concentration of 
diethylaminoethyl chloride hydrochloride by 1/5 0th and 17100th respectively with a reaction 
time of 120 minutes at 85°C. Perfluorocarbons 4 and 5 were produced using 
diethylaminoethyl chloride hydrochloride at the same concentration as perfluorocarbon 3, but 
the DEAE was immobilised at room temperature for 120 minutes and 10 minutes 
respectively. The small ion capacity of these adsorbents was determined using the pH 
titration method proposed by Helfferich (1962; see Section 2.2.9.1).
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Figure 3.1 Example Langmuir and linear isotherm plots
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Figure 3.1 represents example plots for the Langmuir isotherm and linear isotherm from 
which the dissociation constant and the maximum binding capacity can be determined 
and described in Section 3.2.7. Using the Linear Isotherm -Kd is equal to the X-axis 
intercept whilst the gradient is equal to 1/qm.
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3.3 Results and Discussion
The performance of four configurations of adsorbent solid phases (designated Types I 
to IV, Figure 2.1) has been critically evaluated in the anion exchange recovery of BSAs and 
BSAp.
3.3.1 Preliminary Study of Adsorptive Capture of Soluble BSA
BSAs was included in the present study as a mimic for the adsorptive behaviour of 
small molecular impurities that are present in complex feedstocks such as virus containing 
cell culture supernatants. In addition, the separation of soluble and paniculate BSA is a 
model system representative of the problems associated with the separation of products from 
product components. It is interesting to note that during the preparation of the synthetic BSA 
nanoparticles the soluble and particulate BSA was sepaated exploiting dia/ultrafiltration, a 
conventional technique employed for the purification of nanoparticulates such as viruses 
(Lyddiatt and O'Sullivan, 1998). The adsorptive capture of BSAs is summarised in Figure 
3.2, which indicates that all the adsorbent solid phases designated Type II to IV (see Figure 
2.1) reached an adsorption equilibrium within 30 minutes, with the exception of 
STREAMLINE DEAE (Type I, see Figure 2.1). This was attributed to the internal and 
external geometry of the adsorbent solid phases in the study. Type I adsorbents are 
characterised by pore dimensions of less than 0.2um in this study, established for 
macromolecular, rather than nanoparticulate products (see Table 2.1). The tortuous, porous 
network thought to characterise STREAMLINE DEAE, is expected to result in diffusion 
limited BSAs adsorption hence, longer times will be required for equilibrium to be reached. 
Solid phases characterised by large macropores (Type II, see Figure 2.1) are thought to 
facilitate transport of the protein into the internal volume of the adsorbent reducing the 
diffusion distances for adsorption. This would result in a rapid adsorptive performance that
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Figure 3.2 Adsorption of soluble BSA to the selected adsorbent solid phases
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Figure 3.2 represents the adsorption ojBS'As for adsorbents derivatised with 
anion exchange chemistry. Adsorbent (0.1ml settled volume) was added to 1.5ml 
ofBSAs (5mg/ml dissolved in Buffer A) and mixed for 2 hours at room temperature 
using a rotary mixer. Samples -were taken at regular time intervals and analysed 
using the Bradford assay (see Section 3.2.6). C/Co represents the protein concentration 
•with respect to the initial protein concentration. 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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was characteristic of all the Type II adsorbents included in the study (POROS SOD, Celbead 
(II), Celbead Amino, PVA, PVA Ti02, PVA Mo and PVA Zr). Perfluorocarbon emulsion 
DEAE and Toyopearl DEAE (Type III, see Figure 2.1) and the Type IV adsorbent, 2% ZsA, 
were also characterised by a rapid adsorptive performance in comparison to STREAMLINE 
DEAE. Type III adsorbents were expected to demonstrate rapid adsorption characteristics, as 
BSAs should adsorb exclusively to the surface of the adsorbent solid phase. A pellicular 
adsorbent was included in this study having the potential to reduce adsorption processing 
times. The adsorbent was comprised of a solid, dense core of zirconium silicate surrounded 
by a 20um pellicle of porous agarose (see Figure 2.1 and 2.12) that results in shorter 
diffusion distances over which adsorption occurs in comparison to STREAMLINE DEAE 
that is characterised by an agarose continuum. This was illustrated in the preliminary batch 
binding experiments (see Figure 3.2).
Table 3.2 represents a summary of BSAs capacities for the selected adsorbent solid 
phases determined from the batch binding studies (see Section 3.2.5). It was observed that 
POROS SOD exhibited the highest BSAs capacity whilst Celbead (II) DEAE exhibited the 
lowest binding capacity under the same experimental conditions. Both were Type II, 
macroporous adsorbents, however the adsorbent designs were claimed to be different. 
POROS SOD was comprised of both convective pores (0.6-0.Sum in diameter) and diffusive 
pores (0.08-0.1 Sum in diameter) that resulted in a large surface area over which protein 
adsorption could occur. In contrast, Celbead (II) DEAE was claimed to have a pore volume 
of 60% of the total adsorbent volume (Pai et al, 2000) which would dramatically reduce the 
surface area available for adsorption.
3.3.2 The Recovery of Soluble BSA from the Selected Adsorbent Solid Phases
The impact of the external and internal adsorbent geometry upon the recovery of
BSAs from the selected adsorbent solid phases was investigated to predict the recovery
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Table 3.2 Summary of soluble BSA binding capacities and recoveries from the 
preliminary binding studies
ADSORBENT
TYPE
I
II
III
IV
ADSORBENT
STREAMLINE
DEAE
Celbead (II)
DEAE
Celbead Amino
POROS SOD
PVA DEAE
PVA Mo DEAE
PVA TiO2 DEAE
PVA Zr DEAE
Perfluorocarbon
emulsion DEAE
Toyopearl DEAE
2% ZsA
SMALL ION
CAPACITY
(umol Cl-/ml
adsorbent)
170
41
300*
100
1.6
2.78
3.3
54.4
20
490
89
BSA
CAPACITY
(mg/ml
adsorbent)
60.0
0.4
0.45
74.25
0.9
9.6
10.2
5.44
5.4
11.25
39.0
% BSA
RECOVERY
77.2
113.1
30.0
77.0
100.0
65.6
102.9
57.9
93.3
36.8
80.1
Table 3.2 summarises the adsorptive capacities and percentage recovery of BSAs for the 
selected adsorbent solid phases having four different configurations (designated Types I to 
IV, see Figure 2.1). The adsorption capacities were determined from 120 minute batch 
binding experiments (see Section 3.2.5 and Figure 3.2) with an initial common BSAs 
concentration of5mg/ml. BSAs was recovered in IMNaCl after 5 x 1ml washes with Buffer 
A, and the recovery is expressed as a percentage of the estimated adsorption capacity. 
(Buffer A = 1 OmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide).
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behaviour of macromolecular impurities expected to be contained in nanoparticulate 
containing feedstocks (e.g. cell debris and product components). The desorptive recovery of 
BSAs in 1M NaCl is summarised in Figure 3.3 and indicates that BSAs was desorbed from 
the majority of the selected adsorbent solid phases to reach a constant recovery within 30 
minutes. In contrast, a slower release of BSAs was observed for Toyopearl DEAE (Type III, 
see Figure 2.1) which suggested that there was BSAs penetration into this assumed solid 
adsorbent. Toyopearl DEAE is characterised by the manufacturers (Tosohaas) as having a 
molecular weight exclusion of 100-10,000 Daltons (see Table 2.1); hence any penetration of 
BSAs, having a molecular weight of 67,000 Daltons (see Section 3.1.3), was unexpected. 
Consequently, two conclusions were possible; (i) the initial classification of the adsorbent as 
a Type III solid adsorbent (see Figure 2.1) was incorrect, or (ii) the high concentration of 
anion exchange groups at the surface of the adsorbent (refer to Table 3.2) inhibited the rapid 
release of BSAs (refer forward to Figure 3.7). In contrast, perfluorocarbon emulsion DEAE 
had a constant level of desorption within 10 minutes that confirmed the classification of the 
adsorbent as a Type III, solid particle. Near quantitative recovery of BSAs (93.3%; refer to 
Table 3.2) was an encouraging observation for the Type III adsorbent. The desorption 
profiles of the remaining adsorbent configurations (Type I, II and IV, see Figure 2.1) 
suggested that BSAs recovery was diffusion limited, indicating there was BSAs penetration 
during adsorptive capture, as was concluded in Section 3.3.1.
Table 3.2 also represents a summary of the BSAs recoveries for the selected 
adsorbent solid phases determined from batch recovery experimentation (see Figures 3.2 and 
3.3). It was observed that 2% ZsA (Type IV), Celbead (II) DEAE (Type II), PVA DEAE 
(Type II) and perfluorocarbon emulsion DEAE (Type III) exhibited good recoveries in 
comparison to STREAMLINE DEAE (Type I, see Figure 2.1) whilst Celbead Amino (Type
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Figure 3.3 Recovery of soluble BSA from the selected adsorbent solid phases
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Figure 3.3 represents the recovery ofBSAsfrom adsorbents derivatised with anion 
exchange chemistry. After BSAs was adsorbed to the adsorbent (see Figure 3.2) was 
washed in Buffer A to remove unbound protein from the system (5 x 1ml). Adsorbent (O.lml) 
was added to 1.5ml of l.OMNaCl (in Buffer A) and mixed at room temperature for 2 hours 
using a rotary mixer. Samples were taken at regular time intervals and analysed using the
Bradford assay (refer to Section 3.2.6).
The percentage recovery of BSAs was expressed as a percentage of the BSAs adsorbed.
(Buffer A = WmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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II) and Toyopearl DEAE (Type III) exhibited the poorest recoveries that was attributed to 
both the small ion capacity and adsorbent design.
3.3.3 BSA Nanoparticle Sizing
Figure 3.4 represents the size distribution profile of the fabricated BSA nanoparticles. 
The nanoparticles have a size distribution between 100 and 500nm, with an average 
nanoparticle diameter of 154nm. 82% of the nanoparticles were 100-200nm in diameter.
3.3.4 The Adsorptive Capture of BSA Nanoparticles to Selected Adsorbent Solid Phases
BSA nanoparticles (BSAp) were employed as representatives of less easily sourced 
nanoparticulate products, such as viruses, having a particle size of approximately ISOnm (see 
Section 3.3.3; see Figure 3.4). The adsorptive capture of BSAp to the selected adsorbent solid 
phases (Types I to IV) is summarised in Figure 3.5 that indicates two distinct adsorption 
profiles. The adsorbents having pore dimensions that were expected to exclude nanoparticles, 
Type III (solid, see Figure 2.1) reached an adsorption equilibrium within 20 minutes, an 
observation explained by assuming that there was dedicated external surface binding of 
BSAp. In contrast, the adsorbents believed to possess larger pores (Type II macroporous 
adsorbents, see Figure 2.1) reached an equilibrium after an experimental time of 60 minutes, 
which suggested nanoparticle penetration. This was not however characteristic of all the 
Type II adsorbents. POROS SOD, PVA DEAE and Celbead Amino demonstrated rapid 
adsorptive capture of BSAp to reach adsorption equilibrium within 20 minutes. It was 
concluded that the adsorptive behaviour of POROS SOD was a consequence of the challenge 
sample being totally depleted, suggesting that the adsorption capacity could be greater if the 
initial load (1.5ml at 220ug/ml in this study) concentration was greater. In addition, the 60 
minutes after the experiment was initiated. This suggested nanoparticle penetration as
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Figure 3.4 Size distribution of BSA nanoparticles
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Figure 3.4 represents the size distribution of the fabricated BSA nanoparticles measured by 
photon correlation spectroscopy. The average particle size was determined as 154nm based 
on the Einstein-Diffusion Equation (see Section 3.1.2). In addition the nanoparticles were 
shown to be spherical in nature by electron microscopy (inset), and the size of the 
nanoparticle was also confirmed by this analysis.
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Figure 3.5 Adsorption of BSA nanoparticles to the selected adsorbent solid phases
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Figure 3.5 represents the binding ofBSAp (150nm in diameter) to
adsorbents derivatised with onion exchange chemistry. Before use the adsorbents
were washed in Buffer A to equilibrate the system followed by the addition ofO. I ml
of adsorbent to 1.5ml ofBSAp (220ug/ml). The adsorbent samples
were mixed at room temperature for 2 hours with samples taken at regular time
intervals. The samples were analysed using the Bradford assay (refer to Section 3.2.6).
C/Co represents the protein concentration with respect to the initial load
(Buffer A = 1 OmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide).
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results suggested that PVA DEAE and Celbead Amino were not macroporous adsorbents. 
The Type IV adsorbent included in the study (2% ZsA), reached an adsorption equilibrium 
indicated for Type II adsorbents, which was attributed to the less than 0.4um pore 
dimensions of the 2% agarose layer of the pellicular adsorbent. The commercial benchmark 
STREAMLINE DEAE (Type I, see Figure 2.1) also appeared to allow BSAp to penetrate the 
agarose structure. It was concluded that the penetration might be due to smaller BSAp 
penetrating the 0.2um pores that were assumed to characterise agarose (see Section 2.1.2.1).
Table 3.3 represents the summary of the calculation of BSAp capacities for the 
selected adsorbent solid phases as estimated particle numbers and Table 3.4 summarises the 
protein and particle capacities for the adsorbent solid phases. It was observed that POROS 
SOD (Type II macroporous adsorbent) exhibited the highest binding capacity that was 
attributed to the large surface area available as a consequence of the pore structure (see 
Sections 2.1.3 and 3.3.1; and Figure 2.3). In contrast Celbead Amino (Type II, see Figure 
2.1) had the poorest BSAp capacity which, in addition to the rapid adsorption profile 
suggested that the adsorbent structure was not macroporous. It was interesting to note that the 
estimated BSAp numbers per milliliter of settled adsorbent for all the adsorbent solid phases 
were similar and of the same order of magnitude as the reported values for virus purification 
protocols (Hughye et al, 1995; O'Neil and Balkovic, 1993).
3.3.5 Batch Recovery of BSA Nanoparticles
BSAp were included in the present study as representative nanoparticulate products. 
Consequently, the recovery efficiency of BSAp from the adsorbent solid phases was a critical 
parameter to be considered in the design of adsorbent solid phases for the recovery of 
economically desirable nanoparticulate products.
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Table 3.3 Calculation for the estimation of BSAp numbers as a function of the 
measured protein concentration
PARAMETER
Diameter of one nanoparticle
Volume of a sphere
Volume of one nanoparticle
Number of particles per ml of supernatant
Number of particles per g of protein 
(based upon density assumptions)
Number of particles per mg of protein
VALUE
0.000015cm
7id3/6
1.77xlO' 15 cmj
5.65 xlO14
5.65 x 10 14
5.65x10"
The number of 15 Onm particles bound to the adsorbent solid phases -was estimated from the 
protein concentrations measured by the Bradford assay (see Section 3.2.6). The estimated 
particle number was based upon the assumption that the BSAp were spherical (refer to 
Figure 3.4) and had a density of l.Og/ml (the BSAp did not sediment in solution, data not 
shown). To estimate particle numbers from protein concentrations the number of BSAp per 
ml was determined by dividing 1ml by the volume of one nanoparticle (see above) to 
calculate that 5.65 x 1014 particles would be present in 1ml ofBSA solution. Assuming that 
particle density was l.Og/ml, there are 5.65 x 1014 particles per gram of protein that can be 
expressed as 5.65 x 10" particles per milligram of protein.
95
Table 3.4 Summary of BSA nanoparticle capacities and recoveries from preliminary 
batch binding experiments
ADSORBENT 
TYPE
I
II
III
IV
ADSORBENT
STREAMLINE 
DEAE
Celbead (II) 
DEAE
Celbead Amino
POROS SOD
PVA DEAE
PVA Mo DEAE
PVA TiO2 
DEAE
PVA Zr DEAE
Perfluorocarbon 
emulsion DEAE
Toyopearl 
DEAE
2% ZsA
SMALL 
ION 
CAPACITY 
(jimol Cl- 
/ml 
adsorbent)
170
41
300*
100
1.6
2.78
3.3
54.4
20
490
89
BSAp 
CAPACITY
(mg/nil 
adsorbent)
1.95
0.63
0.15
3.3
0.6
1.13
1.8
1.67
0.83
1.95
1.95
BSAp 
CAPACITY 
(particles/ml 
adsorbent)
1.1x10"
0.36x10"
0.08x10"
1.86x10"
0.34 xlO12
0.64 xlO12
1.0x10"
0.94x10"
0.47x10"
1.1x10"
1.1x10"
% 
RECOVERY
53.8
64.3
57.5
34.1
85.9
92.9
34.7
71.9
38.2
47.7
73.0
* For Celbead Amino the small ion capacity equivalent is ^imol amine groups/ml adsorbent 
as determined at Mumbai University, India.
Table 3.4 summarises the adsorptive capacities and recoveries of BSAp calculated from 
batch adsorption and desorption studies (see Sections 3.3.4 and 3.3.5 respectively; Figures 
3.5; 3.6). The adsorption studies were completed using O.lml of settled volume adsorbent 
added to 1.5ml of BSAp at a concentration of220ug/ml and desorption was achieved in IM 
Nad. The estimated particle numbers were calculated as noted in Table 3.3. The capacity 
was determined by difference analysis of the initial load and the concentration after 120 
minutes, whilst the recovery is the protein recovered as percentage of the protein adsorbed. 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Following binding under standardised conditions to adsorbent solid phases having 
different configurations (see Section 3.2.5; Types I-IV, see Figure 2.1), BSAp were 
effectively desorbed by 1M NaCl (refer to Figure 3.6). The commercial benchmark, 
STREAMLINE DEAE (Type I) reached an apparent equilibrium concentration of desorbed 
product within the shortest time, at 20 minutes which was attributed to a limited degree of 
nanoparticle binding or entrapment (i.e. limited penetration at adsorption). In contrast, the 
adsorbents characterised by large pores (Type II, see Figure 2.1) reached a constant recovery 
after 60 minutes contact time, suggesting that BSAp were characterised by diffusion limited 
desorption. This observation confirmed the classification of the adsorbents (POROS SOD, 
PVA DEAE, PVA TiO2 DEAE, PVA Mo DEAE, PVA Zr DEAE and Celbead (II) DEAE) as 
Type II adsorbent solid phases. The desorption behaviour of BSAp from the Type III 
adsorbents was unexpected, as Toyopearl DEAE reached a desorption equilibrium later than 
the microporous benchmark STREAMLINE DEAE, despite being classified as a virtual solid 
adsorbent expected to adsorb BSAp exclusively at the external particle surface. However, it 
was subsequently assumed that the slow release was attributable to the high small ion 
capacity as concluded for BSAs and not due to significant nanoparticulate penetration (see 
Section 3.3.2). BSAp also desorbed slowly from perfluorocarbon emulsion DEAE (Type III) 
which initially suggested that the BSAp had penetrated the internal volume of the solid 
adsorbent. However, the rapid desorption of BSAs indicated that the Type III classification 
for perfluorocarbon emulsion DEAE was correct (see Section 3.3.2). It was concluded that as 
with Toyopearl DEAE, the number of anion exchange groups available for binding strongly 
influenced the desorption efficiency of BSAp from the adsorbent solid phase (refer to Section 
3.3.6). The slow desorptive behaviour of 2% ZsA (Type IV, see Figure 2.1) confirmed that
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Figure 3.6 Recovery of BSA nanoparticles from the selected adsorbent solid phases
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Figure 3.6 represents the recovery ofBSAp (150nm in diameter) from
adsorbents derivatised with anion exchange chemistry. After the adsorbent was loaded
with BSAp and washed (5 x 1ml) 0.1ml of adsorbent was added to 1.5ml of I. OMNaCl
(in Buffer A). The adsorbent was mixed for 2 hours at room temperature using a rotary
mixer. Samples were taken at regular time intervals and analysed using the Bradford
assay (refer to Section 3.2.6).
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide).
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there was a degree of nanoparticle penetration that was suggested by the adsorptive capture 
profiles (see Section 3.3.1).
Table 3.4 is a summary of the recovery of BSAp from the selected adsorbent solid 
phases expressed as a percentage of the experimentally determined adsorption capacities. In 
comparison to the commercial benchmark, STREAMLINE DEAE (Type I, see Figure 2.1) 
the Type II adsorbents showed good recoveries, with the exception of POROS SOD and PVA 
TiO2 which might be a consequence of the internal structure of the adsorbents. POROS SOD 
was characterised by two discrete pore sizes (see Section 2.1.3, see Figure 2.2) that could 
promote particle entrapment resulting in a low recovery. In addition, the poor recovery of 
BSAp from PVA TiO2 DEAE could also be attributed to particle entrapment. However, both 
the method of manufacture and the internal structure of this adsorbent was unknown and thus 
conclusions regarding the adsorbent performance could not be made. The Type III adsorbents 
(Toyopearl DEAE and perfluorocarbon emulsion DEAE) both exhibited poor performances 
which again indicated that the number of anion exchange groups available at the adsorbent 
surface was too high (refer to Section 3.3.6).
3.3.6 Effect of Small Ion Capacity on the Recovery of BSA Nanoparticles
The adsorption/desorption batch binding experiments exploited in the present study 
indicated that the accessible anion exchange ligand concentration (related to the small ion 
capacity; SIC) influenced the recovery of BSAp (see Section 3.3.2 and 3.3.5). It was thought 
that a higher number of anion exchange groups available for each individual BSAp assembly 
promoted a stronger interaction that was more difficult to chemically disrupt than weaker 
interactions to allow for product release (refer to Figure 3.7). To investigate this theory the 
adsorption/desorption performance of BSAp with custom fabricated perfluorocarbon
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Figure 3.7 Effect of small ion capacity on BSA nanoparticle recovery
DEAE groups
Figure 3.7a represents the binding ofnanoparticles to DEAE upon an adsorbent surface. 
Many DEAE groups are attached per nanoparticle resulting in a tighter binding of the 
product to the adsorbent solid phase.
DEAE groups
Adsorbent surface
Figure 3.7b represents the binding of nanoparticles to DEAE immobilised onto an 
adsorbent solid phase. In comparison to Figure 3.7a the number of DEAE groups per 
nanoparticle is much lower, hence the recovery should be easier as the nanoparticles are 
less tightly bound to the adsorbent.
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emulsion DEAE having different SIC was compared in batch adsorption and desorption 
experiments (see Section 3.2.5).
Perfluorocarbon emulsion adsorbent particles were designated as a Type III solid 
adsorbent (see Figure 2.1), and thus identified as suited to the investigation of the effect of 
small ion capacity on the recovery of BSAp (see Section 3.2.8). The adsorptive capture of 
BSAp is summarised in Figure 3.8 which indicates that all the perfluorocarbon emulsion 
adsorbents reached equilibrium within 10 minutes of common contacting. In addition the 
adsorptive capacity decreased with decreasing small ion capacity that was attributed to fewer 
anion exchange groups being available for BSAp adsorption. The desorption experiments 
performed in 1M NaCl indicated that the recovery of bound BSAp was also influenced by the 
small ion capacity. Perfluorocarbon 1 and 2 were characterised by poor recoveries in 
comparison to the commercial benchmark STREAMLINE DEAE (see Table 3.4), however 
when the small ion capacity was reduced to below 6umol Cl-/ml adsorbent, good BSAp 
recoveries were achieved. As noted previously (see Section 3.3.5) the desorption profile of 
BSAp from perfluorocarbon 1 (20umol Cl-/ml adsorbent; see Figure 3.9) is characterised by 
no apparent release of BSAp until 30 minutes after the desorption was initiated. This was 
attributed to the high concentration of ion exchange groups available at the surface of the 
solid, Type III adsorbents. This brief study highlighted that the concentration of ligand 
involved in the adsorption process is a critical factor to be considered when designing 
adsorbent solid phases for a specific purification procedure.
3.3.7 Maximum Binding Capacity Determination
The selected adsorbent solid phases were characterised using batch binding studies with
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Figure 3.8 Effect of small ion capacity on the binding of BSA nanoparticles
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Figure 3.8 represents the binding ofBSAp to perfluorocarbon emulsion
with different small ion capacities. Before use the adsorbents were washed in Buffer A
to equilibrate the system. Adsorbent (O.lml) was added to 1.5ml ofBSAp
at 220ug/ml (suspended in Buffer A). The adsorbents were mixed for 2 hours at room
temperature using a rotary mixer. Samples (0.1ml) were taken at regular time intervals
and analysed using the Bradford assay (refer to Section 3.2.6).
C/Co represents the protein concentration with respect to the initial load 
(Buffer A = lOmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Figure 3.9 Effect of small ion capacity on the recovery of BSA nanoparticles
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Figure 3.9 represents the recovery ofBSApfromperfluorocarbon emulsion
adsorbents with different small ion capacities. Subsequent to the BSAp binding
the adsorbent was -washed in Buffer A to remove unbound BSAp (5 x 1ml). Adsorbent
(O.lml) was added to 1.5ml ofl.OMNaCl (in Buffer A). The adsorbents were mixed for 2 hours
at room temperature using a rotary mixer. Samples (0.1ml) were taken at regular time intervals
and analysed using the Bradford assay (refer to Section 3.2.6).
The percentage recovery is the protein recovered expressed as apercentage of the protein adsorbed
(Buffer A = lOmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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BSAp to estimate the maximum binding capacities using Langmuir assumptions (Chase, 
1984). The preliminary batch binding studies (see Section 3.2.5) were conducted as one-off 
binding experiments that could only indicate whether the adsorbents worked, as the 
capacities calculated only indicated the amount of BSAp bound under the specified 
conditions (see Section 3.2.5). As noted in Section 3.1.4, the Langmuir isotherm can be used 
to estimate how much product the adsorbent is capable of adsorbing (qm) in addition to the 
affinity of the product for the immobilised anion exchange ligand (kd). This data is important 
when considering design of the scale up of a chromatographic separation and the information 
also allows clear comparisons to be made between the adsorbent solid phases included in the 
study.
As a consequence of the adopted experimental methods (see Section 3.2.7) significant 
quantities of BSAp and adsorbent were required for the study. As a consequence adsorbent 
solid phases that demonstrated a poor performance in the physical characterisation studies 
and the adsorption/desorption studies were eliminated from further study at this stage. The 
adsorbents carried forward for further investigation were:
(i) STREAMLINE DEAE (Type I, see Figure 2.1),
(ii) Celbead (II) DEAE (Type II),
(iii) Celbead Amino (Type II),
(iv) PVA Mo DEAE (Type II),
(v) PVA TiO2 DEAE (Type II),
(vi) PVA Zr DEAE (Type II),
(vii) 2% ZsA DEAE (Type IV).
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Figure 3.10 represents a comparison of the experimental data with the Langmuir 
isotherm. Firm conclusions cannot be drawn from the isotherms due to the limited maximum 
concentration of BSAp (220ug/ml) available for this study as an equilibrium level 
representative of saturation binding was not reached. Consequently linear isotherms were 
constructed to determine values for qm and kd (see Section 3.2.7; refer to Figure 3.11). Table 
3.5 summarizes the values for qm and kd for each of the adsorbent solid phases remaining in 
the study. The predicted qm data suggests that the adsorptive capacities calculated by batch 
binding experiments (see Table 3.4) are close to the experimentally estimated qm values, and 
thus the assumption made about the adsorbent classifications (Types I to IV) based upon the 
adsorption data are valid. In addition, the close comparison of the experimental data to the 
linear isotherm (a reciprocal plot of the Langmuir isotherm) suggested that the binding of 
BSAp to the adsorbents followed Langmuir assumptions (see Section 3.1.4). Kd is the ratio of 
the desorption rate constant to the adsorption rate constant and all of the adsorbent solid 
phases were characterised by a low kd (refer to Table 3.5), that indicated that the desorption is 
slow compared to the adsorption. The low kd values suggest that there is a strong interaction 
between the BSAp and the anion exchange ligand, which will have process implications 
when scaling up the desorption process for effective, efficient recovery.
3.3.8 General Conclusions
The aim of this chapter was to critically evaluate commercial and custom designed adsorbent 
solid phases (designated Types I to IV) in adsorptive studies with nanoparticulate and protein 
products in batch binding experimentation. To circumvent problems associated with 
achieving representative binding studies with commercially realistic products such as viruses, 
plasmid DNA or drug delivery vehicles, BSAp and BSAs were included as
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Figure 3.10 Langmuir isotherms for BSA nanoparticle binding to the selected 
adsorbent solid phases
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Figure 3.10 represents the linear isotherms for BSAp adsorbing to adsorbents
derivatised with anion exchange chemistry. Before use the adsorbent was washed
in Buffer A to equilibrate the system. Adsorbent (50 ul) was added to 1.5ml of BSAp
at increasing concentrations (0-220 ug/ml). The samples were mixed for 5 hours
at room temperature using a rotary mixer. The protein concentration after binding
was determined using the Bradford assay (refer to Section 3.2.6).
The regression lines were generated using non-linear regression using the SigmaPlot
graphics package.
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide
106
Figure 3.11 Linear isotherm for BSA nanoparticles binding to the selected adsorbent 
solid phases
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Figure 3.11 represents the linear isotherms for BSAp adsorbing to adsorbents 
derivatised with anion exchange chemistry. Before use the adsorbent was washed in Buffer 
A to equilibrate the system. Adsorbent (50ftl) was added to 1.5ml of BSAp 
at increasing concentrations (0-220ug/ml). The samples were mixed for 5 hours at room 
temperature using a rotary mixer. The protein concentration after binding was determined
using the Bradford assay (refer to Section 3.2.6)
(Buffer A = WmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Table 3.5 Maximum binding capacity and dissociation constant predictions
ADSORBENT 
TYPE
I
II
IV
ADSORBENT
STREAMLINE 
DEAE
Celbead (II) DEAE
Celbead Amino
PVA Mo DEAE
PVA TiO2 DEAE
PVA Zr DEAE
2% ZsA
MAXIMUM 
CAPACITY (qm, mg/ml 
adsorbent)
1.67
0.63
0.24
0.33
0.71
2.5
2.5
DISSOCIATION 
CONSTANT (Kd, 
M)
1.7 xlO' 11
8.2xlO' lu
1.73 x 10'"
2.19 xlO' 11
4.3 x 10' 10
5.97xlO'9
1.04X10' 11
Table 3.5 represents the maximum binding capacities (q^ and dissociation constants 
estimated from linear isotherm analysis (see Section 3.2.7). Batch binding experiments over a 
broad range ofBSAp concentrations were conducted to construct the linear isotherm. Qm is a 
measure of the maximum concentration ofBSAp that adsorbs to each adsorbent solid phase, 
and kd is a measure of the affinity ofBSAp to the anion exchange groups.
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representative nanoparticulate products and molecular impurities. It is noteworthy that the 
experimental program reported here was entirely achieved with a single batch of BSAp 
prepared from a stock protein concentration of 220(Xg/ml. For the purpose of this study the 
commercial benchmark adsorbent was STREAMLINE DEAE designated as a Type I, 
microporous adsorbent. The remaining adsorbents included in the present study, designated 
Types II to IV were characterised by a wide range of BSAs capacities and in general the 
batch desorption analyses recorded good recoveries. In addition, the adsorbent solid phases 
were further investigated with BSAp that indicated that the number of BSAp bound per 
milliliter of adsorbent was similar for each adsorbent configuration and again in general the 
recoveries were good. Subsequent to the completion of the physical characterisation studies 
and the batch adsorption/desorption studies POROS SOD, PVA DEAE, perfluorocarbon 
emulsion DEAE and Toyopearl DEAE were eliminated from the study due to their judged 
poor performance under a number of categories. The adsorption/desorption studies for the 
selected adsorbent solid phases suggested that the internal and external structure of the 
adsorbents influences the adsorption and desorption of both soluble and particulate products. 
In addition, the ligand concentration appears to be a critical factor to be considered for 
efficient recovery of the desired product.
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CHAPTER 4
LASER SCANNING CONFOCAL MICROSCOPY AS A TOOL FOR 
INVESTIGATING ABSORPTIVE CAPTURE OF SOLUBLE AND
PARTICULATE PROTEIN
4.1 General Introduction
The adsorption of both soluble and particulate protein has been studied for a variety 
of adsorbents having different internal and external geometries designated Types I to IV (see 
Figure 2.1). Batch binding and finite batch experiments have been used to measure the 
adsorption of BSAs and BSAp in addition to measuring protein uptake kinetics to investigate 
the suitability of the adsorbents for nanoparticulate recovery. These methods are indirect 
measurements that only yield information regarding the rates of adsorption and not the 
manner of protein adsorption or the location of the protein product within the adsorbent solid 
phase. Therefore to obtain a realistic picture of adsorptive separations, laser scanning 
confocal microscopy (LSCM) was employed as a technique to directly visualise fluorescent 
derivatives of the protein (both soluble and particulate) within the adsorbent structure. 
Overall in the present study, selected adsorbent solid phases were investigated for their 
suitability as fluidised bed adsorbents for the recovery of nanoparticulate products such as 
viruses, plasmid DNA and drug delivery vehicles. In this chapter LSCM was employed to 
investigate the adsorptive behaviour of BSAp (representative of nanoparticulate products) 
and BSAs (representative of molecular component impurities), to adsorbent solid phases 
having different internal and external geometries. The adsorbents retained in the study are 
represented in Table 4.1. Adsorbent solid phases that demonstrated a poor performance in
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Table 4.1 Summary of the adsorbent solid phases remaining in the study
ADSORBENT 
TYPE
I
II
IV
ADSORBENT
STREAMLINE
(6%)
Celbead (II)
Celbead Amino
PVAMo
PVA TiO2
PVAZr
2% ZsA
PORE SIZE
<0.2um
Sum
3um
lum
lum
l^m
>0.4um
ADSORBENT 
GEOMETRY
Microporous
Macroporous
Macroporous
Macroporous
Macroporous
Macroporous
Pellicular 
Macroporous
MANUFACTURER
Amersham 
Biosciences
Indian Construct
Indian Construct
Swedish Construct
Swedish Construct
Swedish Construct
Birmingham 
Construct
Table 4.1 represents the commercial and custom fabricated adsorbent solid phases that were 
remaining in the study subsequent to the physical and biochemical characterisation studies 
described in Chapters 2 and 3. STREAMLINE DEAE was a commercial adsorbent supplied 
by Amersham Biosciences (see Section 2.1.2), the PVA adsorbents were supplied by Igor 
Galaev (Lund University, Sweden; see Section 2.1.5), the Celbead adsorbents were supplied 
by ArvindLali (Mumbai University, India; see Section 2.1.4) and the 2% ZsA was fabricated 
at Birmingham University by Yan Sun (see Section 2.2.1). The pore size data was supplied by 
the respective manufacturers.
Ill
terms of the recovery of BSAs and BSAp (see Chapter 3) were eliminated from the study as 
unsuitable candidate solid phases for fluidised bed recovery of particulate products.
4.1.1 Laser Scanning Confocal Microscopy
Laser Scanning Confocal Microscopy (LSCM) has recently been identified as a useful 
tool for studying the adsorption of proteins to chromatographic matrices, and has been 
established as a valuable instrument for obtaining high resolution images and three 
dimensional reconstruction of a variety of biological materials. LSCM offers several 
advantages over conventional light microscopy since the depth discriminating property of 
LSCM is harnessed to produce virtual optical sections of the specimen. Optical sectioning is 
a scientifically accepted description of acquiring images using a confocal microscope 
(Ljunglof and Hjorth, 1996), as an alternative method to microtome sectioning which is both 
destructive and time consuming (Subramanian et al, 1994). Figure 4.1 represents the 
simplified optics of a LSCM. The argon-krypton laser beam is emitted from the light source 
and the beam is deflected onto an objective lens via a dichroic mirror (a colour selective 
mirror that reflects a particular band of spectral energy). The objective lens focuses the laser 
beam onto a focal plane within the fluorescent specimen being imaged, which is termed a 
scanning beam that scans the image in an X-Y plane (refer to Figure 4.2). The mixture of 
reflected and fluorescent light from the imaged specimen is captured by the same objective 
lens which focuses the beam back through the dichroic mirror, which deflects the reflected 
light but allows the fluorescent light to pass through to a photodetector via a pinhole aperture 
(Pawley, 1995). In addition the fluorescent light not within the focal plane is deflected by the 
pinhole aperture that results in the out of focus information both above and below the focal 
plane being greatly reduced (Pawley, 1985). A two dimensional optical section is generated 
by performing a laser sweep across a specimen centered on the focal plane. As the laser
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Figure 4.1 Simplified diagrammatic representation of the optics of a laser scanning 
confocal microscope
Photodetector
Laser Source
Focal Plane
In focus laser beam
Out of focus laser beams
Pinhole aperture
Dichroic Mirror
Specimen
Objective Lens
Focus
Figure 4.1 represents a simplification of the critical optics of a laser scanning confocal 
microscope in addition to the track of the fluorescent and transmitted light from the specimen 
to the photodetector. The focal plane of the image can be altered by moving the platform to 
image the adsorbent samples at varying depths (see Section 4.1.1).
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Figure 4.2 Diagrammatic representation of the focal planes used in laser scanning 
confocal microscopy
X
Figure 4.2 represents the focal planes used in laser scanning confocal microscopy, X, Y and 
Z. An image scanned in the XY plane produces a 2 dimensional representation of the sample. 
If X-Y scans are generated at equal increments through the Z plane a three-dimensional 
image is generated by stacking the 2 dimensional images.
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scans across the specimen, the analogue light signal detected by the photodetector is 
converted into a digital signal contributing to a pixel-based image displayed on the computer 
attached to the LSCM. The relative intensity of the fluorescent light emitted from the 
specimen corresponds to the resulting pixel image. The plane of focus (termed the Z plane; 
refer to Figure 4.2) is selected by a computer controlled fine stepping motor that moves the 
microscope stage up and down to facilitate specimen imaging at varying depths. Stacks of 
optical sections taken at successive focal planes (known as a Z stack) can be reconstructed to 
generate a three dimensional view of the specimen.
As previously stated LSCM has become a valuable tool for analysing protein 
adsorption within chromatographic adsorbents e.g. (i) direct imaging of protein after binding 
procedures (Ahmed and Pyle, 1999; Linden et al, 1999), (ii) visualisation of protein transport 
in porous adsorbents (Ljunglof and Thommes, 1998) (iii) visualisation of ligand distribution 
within the adsorbents (Ljunglof et al, 2000) and (iv) investigation of the binding of plasmid 
DNA to individual chromatographic adsorbent particles (Ljunglof et al, 1999; Thwaites et al, 
2002). LSCM was included in the present study to further investigate the influence of the 
adsorbent configuration (designated Types I to IV, see Figure 2.1) on the 
adsorptive/desorptive performance of BSAs and BSAp. The soluble and particulate proteins 
were fluorescently labelled and visualised after contacting with the adsorbent solid phases.
4.1.2 Fluorescent Probes used in Laser Scanning Confocal Microscopy
Biological specimens to be imaged by LSCM must necessarily be labelled with a 
fluorescent probe. The essential requirements for a such probe used in LSCM are that they (i) 
conjugate easily and irreversibly with the protein, (ii) do not affect the biological 
characteristics of the protein, (iii) have a high fluorescence emission, (iv) be stable and (v) 
display a strong contrast to the background fluorescence of the material (Shepperd and
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Shotton, 1997). Commonly used fluorescent probes for LSCM are represented in Table 4.2. 
Several factors must be considered when selecting LSCM probes including the 
excitation/emission wavelength of the probe to be used, the lasers and the filters available 
and the decay of the fluorescent signal due to photobleaching, induced by exposure to UV 
light.
4.1.2.1 Fluorescein Isothiocyanate
Fluorescein isothiocyanate (FITC) is one of the most commonly used fluorescent 
probes for protein conjugation. In addition to an excellent fluorescence yield and good water 
solubility, FITC has an excitation maximum that closely matches the 488nm spectral line of 
the argon-krypton laser used in LSCM (Pawley, 1995; refer to Section 4.1.1). FITC was 
introduced by Riggs et al (1958) and is characterised by a molecular weight of 389 Daltons 
and exhibits a characteristic wavelength of maximum absorption and emission of 495nm and 
525nm respectively (refer to Figure 4.3). However, fluorescein based probes and their 
conjugates have several practical disadvantages including (i) a relatively high rate of 
photobleaching (Song et al, 1995), (ii) pH sensitive fluorescence (Sjoback et al, 1995) where 
FITC has a pKa of approximately pH 6.4 thus reducing the signal below pH 7.0, and (iii) 
natural quenching by 50% upon analyte conjugation.
4.2 Materials and Methods
4.2.1 Chemicals
Fluorescein isothiocyanate was supplied by Sigma-Aldrich, (Poole, Dorset, UK). All other 
chemicals were reagent grade, unless otherwise stated and supplied by Sigma-Aldrich (Poole, 
Dorset, UK) or BDH (Poole, Dorset, UK).
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Table 4.2 Commonly used fluorescent probes used in laser scanning confocal 
microscopy
FLUORESCENT
PROBE
BODIPY
Picogreen
Propidium Iodide
Rhodamine 123
Snarf 1
Texas Red
EXCITATION
(nm)
503
490
536
511
563
596
EMISSION
(nm)
512
525
617
534
639
615
APPLICATION
Labelling of
living neurons
DNA staining
Quantitation of
apoptosis
Protein labeling
Intracellular pH
monitoring
Cell nuclei
labeling
REFERENCE
Durand et al
(2000)
Thwaites et al
(2002)
Zhang et al
(1999)
Ahmed and Pyle
(1999)
Ondarza and
Hootman(1997)
Lundell and
Hirsh(1994)
Table 4.2 represents a summary of the commonly used fluorescent probes used in laser 
scanning confocal microscopy including the excitation and emission wavelengths.
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Figure 4.3 Absorption and emission spectra for fluorescein isothiocyanate
absorption 
amtasion
300
495
&2b
400 500 
Wavelengthlnrnf
Figure 4.3 represents the absorption and emission spectra for fluorescein isothiocyanate 
(FITC) showing the maximum absorption wavelength to be 490nm and the emission 
wavelength to be 525nm. FITC is a commonly used fluorescent probe for laser scanning 
confocal microscopy that was used in this study to visualise the penetration of soluble and 
paniculate BSA within the internal structure of selected adsorbent solid phases. (Reproduced 
from Pawley, 1985).
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4.2.2 Equipment
• Leiss 510 Laser Scanning Confocal Microscope, Zeiss Ltd, Stockport, UK
• Rotary blood mixer, Stuart Scientific, UK
• Pharmacia LKB Ultrospec III spectrophotometer, Amersham Biosciences, Uppsala, 
Sweden
• pH meter, Hanna Instruments, H19321, Microprocessor Bench pH meter
• General laboratory glassware
4.2.3 Conjugation of Fluorescein Isothiocyanate to Soluble and Particulate BSA
Fluorescein isothiocyanate was selected as a suitable covalent probe for the 
visualisation of protein adsorption exploiting LSCM. The conjugation method employed was 
proposed by Kawamura (1977) and adapted by Zhanren Zhang (personal communication). 
BSAp were initially suspended in Buffer A (lOmM Tris-HCl, pH 7.5 with 0.01% Tween 20 
and 0.02% sodium azide) subsequent to the diafiltration operational step of the 
manufacturing process. For the probe to be successfully conjugated the protein nanoparticles 
were buffer exchanged into conjugation buffer (0.1M NaHCOs, pH 8.3 with 0.5M NaCl; 
Buffer B). Due to the sample volumes being processed, PD-10 desalting columns (Amersham 
Biosciences, Uppsala, Sweden) were selected as a suitable method for buffer exchange. 
These columns contained 9.1ml of Sephadex G-25 medium gel filtration media consisting of 
beaded dextran particles (50-150um in diameter) crosslinked using epichlorohydrin with a 
molecular weight exclusion of 5 x 103 Daltons (for globular proteins). The PD-10 column, 
having a void volume of 2.5ml, was initially equilibrated with 25ml of Buffer B followed by 
the addition of 2.5ml of BSAp suspended in Buffer A. The initial bed effluent was discarded, 
3.5ml of Buffer B was added and the void volume of effluent containing BSAp suspended in 
Buffer B was collected. FITC was added to 2.5ml of BSAp (in Buffer B) in a volume of
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0.16ul of a stock solution of FITC (Img/ml), per microgram of protein (either soluble or 
particulate). The nanoparticle/FITC mixture was rigorously mixed at room temperature for 1 
hour using a rotary mixer and subsequently added to a fresh PD-10 column pre-equilibrated 
with Buffer A to separate the FITC conjugated BSAp from the unbound fluorescent dye. 
After 2.5ml of FITC conjugated BSAp were added the effluent was discarded and 3.5ml of 
Buffer A was added and the effluent containing the FITC conjugated BSAp was collected. 
BSAp-FITC were stored at 4°C in the absence of ultraviolet light to ensure that there was no 
degradation of the FITC due to photobleaching. The procedure used for conjugating FITC to 
BSAs was the same as the proposed method for BSAp, except the initial BSA was mixed in 
Buffer B circumventing the initial buffer exchange step.
4.2.4 Adsorption of Fluorescently Labelled Soluble and Particulate BSA for 
Visualisation in LSCM
All of the adsorbent solid phases imaged using LSCM were loaded with fluorescently 
labelled BSAs and BSAp exploiting batch binding experimentation. Adsorbed BSAs and 
BSAp were imaged at regular time intervals during a 30 minute experiment and after 24 
hours. The equilibrium experiments were completed by adding O.lml of adsorbent 
(extensively washed in Buffer A to equilibrate the system) to 1.5ml of fluorescently labelled 
BSA (either soluble or particulate) and mixed for 24 hours at room temperature using a rotary 
mixer. After 24 hours the remaining protein solution was removed and the adsorbent 
extensively washed in Buffer A to remove unbound or loosely bound labelled protein. The 
adsorbent samples were then immediately imaged by LSCM. In addition the adsorption of 
BSAs and BSAp to the selected adsorbent solid phases was investigated over 30 minutes. 
Before use the adsorbent was extensively washed in Buffer A to equilibrate the system, after 
which O.lml was added to 1.5ml of fluorescently labelled protein (either soluble or
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participate) and mixed at room temperature. Samples of the supernatant (O.lml) and the 
adsorbent (10ul) were taken at 1,10,20 and 30 minutes. The adsorbent was washed in Buffer 
A (5 x 1ml) to remove unbound or loosely bound protein and imaged by LSCM (refer to 
Section 4.2.5), whilst the protein concentration of the supernatant was determined using the 
Bradford assay (see Section 3.2.6). Both experiments were conducted with BSAs at a 
concentration of 5mg/ml and BSAp at 220ug/ml as in previous batch binding studies (see 
Section 3.2.5).
4.2.5 Laser Scanning Confocal Microscopy Analysis
The Laser Scanning Confocal Microscope (Leiss 510 supplied by Zeiss Ltd) was 
made available by D.Hardie (Department of Immunology, University of Birmingham). 
Subsequent to the protein binding procedure (see Section 4.2.4), the adsorbents were all 
washed in Buffer A to remove unbound protein from the system. A sample of the washed 
adsorbent was then suspended in a drop of distilled water on a petri dish and the adsorbent 
was imaged through a xlO magnification lens (in addition to a xlO eyepiece lens) using water 
immersion. The samples were analysed using a 488nm and 534nm laser to detect the FITC 
fluorescence and the transmission image respectively. The initial image was captured at 128 
pixels/mm to ascertain the settings of the confocal microscope for a blank image to minimise 
background fluorescence. The size of the pinhole aperture (see Section 4.1.1) was minimised 
to reduce the amount of out of focus light included in the final image. Once the settings had 
been adopted for a single adsorbent the same settings were used for the fluorescently labelled 
adsorbent samples. To produce a clear, sharp picture the image was captured at 512 
pixels/mm. A complete scan of each adsorbent sample was made using the Z stack function, 
which enabled a series of X-Y scans to be generated throughout the entire depth of the 
adsorbent particles.
121
4.3 Results and Discussion
The adsorption and desorption behaviour of BSAs and BSAp to the selected 
adsorbent solid phases (designated Type I, II and IV; see Figure 2.1) was investigated further 
by laser scanning confocal microscopy (LSCM), to assess the product distribution within the 
adsorbent structure and to determine a method for direct measurement of protein and 
particulate adsorption.
4.3.1 Visualising Intraparticle Soluble and Particulate Protein Transport in the Selected 
Adsorbent Solid Phases by Laser Scanning Confocal Microscopy
Subsequent to the adsorption/desorption studies summarised in Chapter 3, several 
conclusions about the performance of the selected adsorbent solid phases were made (Types I 
to IV; see Figure 2.1) that were attributed to known characteristics of the internal and 
external design of the adsorbents. This chapter describes the use of LSCM to visualise the 
distribution of the protein products (BSAs and BSAp) within the adsorbent solid phases in an 
attempt to validate the conclusions made in Chapter 3. The scanning technique employed by 
the laser scanning confocal microscope imaged the fluorescent protein molecules or particles 
in an X-Y plane (see Figure 4.2) and detected the fluorescence response of the FITC- 
conjugated proteins by a simultaneous excitation and emission of the probe.
After the adsorbent was challenged with fluorescently labelled BSAs or BSAp the 
adsorbent particles were scanned for a fluorescence response. Figure 4.4A represents the 
adsorption of fluorescently labelled BSAs to STREAMLINE DEAE after a 24 hour contact 
time (Type I; see Figure 2.1). The profile indicates that BSAs has adsorbed in a thin 33um 
outer layer upon the adsorbent (equivalent to 31.6% of the adsorbent radius) whilst the inner 
volume of the adsorbent appeared to be unused. This behaviour was also noted in Figure
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Figure 4.4 Confocal microscopy images of STREAMLINE DEAE (Type I adsorbent) 
contacted with soluble and particulate BSA imaged after 24 hours
B
Figure 4.4 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of 24 hours with both (A) fluorescently labelled BSAs and (B) BSAp. The 
proteins were adsorbed to STREAMLINE DEAE (Type I adsorbent, see Figure 2.1) using 
batch binding methods where 0.1ml of adsorbent was added to 1.5ml of fluorescently labelled 
BSA (either soluble or particulate) and mixed for 24 hours at room temperature using a 
rotary mixer. After adsorption the unbound protein was removed from the system and the 
adsorbent excessively washed using Buffer A. The adsorbent was then imaged using a laser 
scanning confocal microscope, from which the central optical slice of the adsorbent was 
selected and the fluorescence profiles were generated, 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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4.4B that illustrates the fluorescence profile of BSAp after a contact time of 24 hours, where 
BSAp penetrated to a depth of 22.5um (21.5%) of the adsorbent particle radius. This limited 
penetration observation was expected for BSAp due to the estimated diameter of the 
nanoparticles (150nm; see Section 3.3.3). It was expected that penetration into the 6% (w/v) 
agarose material of STREAMLINE DEAE would be limited and that the adsorption would 
predominate at the external surface of the adsorbent. In reality, BSAp appeared to penetrate 
the adsorbent structure to a degree as suggested by the adsorption/desorption profiles in 
Section 3.3.4. This was attributed to the size distribution of BSAp where nanoparticles 
smaller than 150nm are present (see Figure 3.4). In contrast, the limited penetration of BSAs 
into the STREAMLINE DEAE structure was unexpected as it was assumed that at apparent 
equilibrium in the batch binding experiment the protein would be evenly distributed 
throughout the adsorbent. The reasons for this observation were unknown but might be 
attributed to:
(i) the optical properties of the dense crystalline quartz particles within the 
STREAMLINE structure masking the fluorescence signal from FITC labelled 
BSAs adsorbed within the inner volume of the adsorbent 
(ii) or, a complete BSAs adsorption equilibrium had not been attained within the
24 hour contact period.
To investigate this observation further, binding studies were completed as illustrated 
in Figure 4.5. STREAMLINE DEAE was incubated with fluorescently labelled BSAs for 48 
hours after which the fluorescence image was scanned. The resulting profile demonstrated 
that the penetration of BSAs into the adsorbent particle increased with increase in contact 
time. The profile in Figure 4.5B indicated that BSAs had penetrated 48um into the adsorbent 
radius after 48 hours (equivalent to 45.9%) in comparison to 33um (31.6%) after a 24 hour 
contact time (see Figure 4.5A). This implied that significant fluorescence masking was not
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Figure 4.5 The adsorption of soluble BSA to STREAMLINE DEAE after contact times 
of 24 and 48 hours
A B
Figure 4.5 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of (A) 24 hours and (B) 48 hours for fluorescently labelled BSAs. The protein 
was adsorbed to STREAMLINE DEAE (Type I adsorbent, see Figure 2.1) using batch 
binding methods where 0.1ml of adsorbent was added to 1.5ml offluoresceiitly labelled BSAs 
and mixed for 24 hours or 48 hours at room temperature using a rotary mixer. After 
adsorption the unbound protein was removed from the system and the adsorbent excessively 
washed using Buffer A. The adsorbent was then imaged using a laser scanning confocal 
microscope, from which the central optical slice was selected and the fluorescence profiles 
were generated. 
(Buffer A = lOmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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occurring, but that the adsorbent had not reached equilibrium. Several binding experiments 
were completed using STREAMLINE DEAE and the same binding pattern was observed in 
each, therefore it was concluded that to achieve equilibrium with soluble protein an extended 
contact time was required
In addition to the equilibrium binding studies, the adsorption of BSAs and BSAp to 
STREAMLINE DEAE was investigated over a shorter period of 30 minutes to measure the 
progression of adsorption with time. Figures 4.6 and 4.7 represent the adsorption of 
fluorescently labelled BSAs and BSAp to STREAMLINE DEAE respectively at time 
intervals of 1, 10, 20 and 30 minutes (see Section 4.2.4). The fluorescence profiles indicated 
that with elapsed time BSAs and BSAp penetrated into the adsorbent structure and Figure 4.8 
represents the degree of penetration expressed as percentage of the radius of the adsorbent 
particle in which fluorescence was detected. The degree of penetration of both BSAs and 
BSAp agree with the results generated from the adsorption studies completed in Chapter 3. 
BSAs adsorption progressed slowly suggesting diffusion limited adsorption as was indicated 
in Figure 3.2. Additionally, BSAp also appeared to penetrate the adsorbent as time elapsed as 
implied in Figure 3.5.
The results indicated that the degree of penetration of BSAs after a 30 minute contact 
time (25.1 (am or 23.9%) was very similar to that after a 24 hour contacting period (2.5um or 
21.5%; see Figure 4.4 and Figure 4.8). This suggested that once penetration had reached a 
depth of approximately 30um (28.7%) the rate of adsorption appeared to decrease but within 
48 hours it was observed that the penetration had reached 47.8% (50um). The protein 
adsorption was also measured indirectly using the Bradford protein assay. The data obtained 
demonstrated that the concentration of adsorbed protein was greater at 24 hours than at 30 
minutes (data not shown). The transmission photomicrograph of STREAMLINE DEAE, 
illustrated in Figure 2.8 suggests that the quartz particles contained within the adsorbent are
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Figure 4.6 Confocal microscopy images of STREAMLINE DEAE contacted with 
fluorescently labelled soluble BSA
B
D
Figure 4.6 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of 30 minutes with fluorescently labelled BSAs. The nanoparticles were 
adsorbed to STREAMLINE DEAE using batch binding methods where 0. Iml of adsorbent 
was added to 1.5ml offluorescently labelled BSAs. At regular time intervals of 1, 10, 20 and 
30 minutes (A-D) lOul of adsorbent was removed and washed in Buffer A to remove unbound 
protein, and imaged using confocal microscopy. For each time interval adsorbent sample the 
central optical slice was selected and the fluorescence profile generated. 
(Buffer A = lOmMTris-HCl, pH 7.4 with 0.01% Tween 20 and0.02%sodium azide).
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Figure 4.7 Confocal microscopy images of STREAMLINE DEAE contacted with 
fluorescently labelled BSA nanoparticles
A B
D
Figure 4.7 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of 30 minutes with fluorescently labelled BSAp. The nanoparticles were 
adsorbed to STREAMLINE DEAE using batch binding methods where 0.1ml of adsorbent 
was added to 1.5ml of fluorescently labelled nanoparticles. At regular time intervals of 1, 10, 
20 and 30 minutes (A-D) lOfil of adsorbent was removed and washed in Buffer A (lOmM 
Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide) to remove unbound 
nanoparticles, and imaged using confocal microscopy. For each time interval adsorbent 
sample the central optical slice was selected and the fluorescence profile generated.
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Figure 4.8 Bar chart representing the percentage of the radius of a STREAMLINE DEAE 
adsorbent particle utilised for soluble and particulate BSA adsorption
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Time (min)
•M STREAMLINE DEAE (Type I) BSAs 
STREAMLINE DEAE (Type I) BSAp
Figure 4.8 represents the penetration ofbothfluorescently labelled BSAs and BSAp into 
the adsorbent particles of STREAMLINE DEAE expressed as a percentage of the adsobent 
radius in which adsorption was observed. The penetration was calculated from fluorescence 
profiles generated by confocal microscopy (see Figure 4.6). A sample of adsorbent (0.1ml) 
added to 1.5ml offluorescently labelled BSAs and BSAp and mixed at room temperature using 
a rotary mixer. Samples were taken at regular time intervals and analysed using confocal 
microscopy and the Bradford assay. 
(Buffer A = WmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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not distributed within the outer 30um of the adsorbent radius. Consequently it may be 
surmised that the degree of penetration of BSAs is increasing with time, but within the 
particle structure the distribution of the fluorescently labelled protein could be too disperse to 
be detected using LSCM. Alternatively the presence of the inert quartz particles could have 
inhibited the efficient diffusion on BSAs within the structure or the quartz could have a 
quenching effect of the fluorescence. This would result is less fluorescence being detected by 
the confocal microscope.
Equilibrium binding studies (24 hours) and short time course experiments (30 
minutes) were completed for each adsorbent solid phase remaining in the study (see Section 
3.3.6). The Type II adsorbents included in the study (refer to Table 4.1) were characterised 
by the manufacturing process to possess large pores (greater than 0.6um in diameter; see 
Figure 2.1; Table 2.1) and the adsorption/desorption profiles produced in Chapter 3 suggested 
that these pores would facilitate the transport of nanoparticles into the adsorbent structure. 
The results from time-based batch binding experiments indicated that the adsorption of BSAs 
was rapid suggesting that it was not diffusion limited (see Figure 3.2) whereas the adsorption 
of BSAp (150nm in diameter; see Figure 3.4) was less rapid. This suggested that the 
nanoparticles penetrated the adsorbent structure, but that the transport was diffusion limited.
Figure 4.9 illustrates the equilibrium fluorescence profiles of PVA TiC«2 DEAE and 
PVA Mo DEAE (both Type II) with both BSAs and BSAp in experiments completed in an 
equivalent manner to tests with STREAMLINE DEAE. The adsorption behaviour of BSAs 
and BSAp within both PVA TiO2 and PVA Mo appears to predominate in an outer layer of 
the adsorbent structure. Figure 4.9A and 4.9B represent PVA TiO2 contacted with 
fluorescently labelled BSAs and BSAp respectively and both appeared to exhibit the same 
degree of penetration at 23.4% and 26.7% of the radius of randomly selected adsorbent
130
Figure 4.9 Confocal microscopy images of PVA TiO2 DEAE and PVA Mo DEAE (Type 
n adsorbents) contacted with soluble and particle BSA after 24 hours
A B
D
Figure 4.9 represents the fluorescence profiles of PVA TiO2 DEAE and PVA Mo DEAE 
generated from confocal microscopy after a contact time of 24 hours with both fluorescently 
labelled (A) and (C) BSAs and (B) and (D) BSAp. Adsorbent (O.lml) was added to 1.5ml of 
protein (soluble or paniculate) and mixed at room temperature for 24 hours using a rotary 
mixer. After adsorption the adsorbents were washed excessively in Buffer A (lOmM Tris-HCl, 
pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide) to remove unbound protein, the 
adsorbenst were then imaged using confocal microscopy. The central optical slice of the 
adsorbents was selected and the fluorescence profiles generated.
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particles. It is interesting to note that this similarity is also observed for PVA Mo where the 
penetration of BSAs and BSAp are 11.2% and 13.9% of the radius respectively. It was 
assumed that there would be a greater degree of penetration into these Type II macroporous 
adsorbents in comparison to STREAMLINE DEAE a Type I microporous adsorbent (see 
Figure 2.1) due to the large pore diameter (claimed to be lum; see Table 2.1). However the 
penetration appears to be limited, but both BSAs and BSAp penetrate approximately to the 
same degree into the radius of the adsorbent that suggests that there is unrestricted diffusion 
of BSAp and BSAs into the adsorbent structure up to a point.
A higher degree of penetration may not have been observed due to the operation of 
the experiments in batch mode, as the penetration was solely diffusion mediated. Large 
macropores are expected to encourage convective flow through the adsorbent structure, but a 
pressure drop is required to induce this type of flow (i.e. POROS; Afeyan and Fulton, 1991). 
It would be interesting to investigate the adsorption of BSAp to these adsorbents in a fixed 
bed operation. Figures 4.10 and 4.11 represent the adsorption of BSAs and BSAp to PVA 
TiOi and PVA Mo respectively expressed as the percentage radius in which fluorescence was 
detected over time for randomly selected particles. The results validate the conclusions made 
in Chapter 3 based upon the adsorption/desorption studies. Figure 4.10 indicates that there 
was a decline in the penetration of BSAp from 10 minutes to 30 minutes that may be 
attributed to further penetration of the FITC conjugated nanoparticles into the adsorbent 
structure. This would have resulted in lower concentrations of FITC BSAp that could not be 
detected by laser scanning confocal microscopy.
The final PVA adsorbent included in this study, PVA Zr DEAE (Type II; see Figure 
2.1 and Table 2.1), was incubated with BSAs and BSAp in an equivalent manner to the 
previous experiments but an unusual effect was observed as indicated in Figure 4.12. All of
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Figure 4.10 Bar chart representing the percentage of the radius of a PVA TiO2 DEAE 
adsorbent particle utilised for soluble and participate BSA adsorption
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Figure 4.10 represents the penetration ofbothfluorescently labelled BSAs and BSAp into 
the adsorbent particles of PVA TiO2 DEAE expressed as the percentage of the radius in 
which adsorption occurred The radius was calculated from fluorescence profiles 
generated by confocal microscopy (see Figure 4.6). A sample of adsorbent (0.1ml) was 
added to 1.5ml offluorescently labelled BSAs and BSAp and mixed at room temperature using 
a rotary mixer. Samples were taken at regular time intervals and analysed using confocal 
microscopy and the Bradford assay.
Buffer A = 1 OmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide)
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Figure 4.11 Bar chart representing the percentage of the radius of a PVA Mo DEAE adsorbent 
particle utilised for soluble and particulate BSA adsorption
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PVA Mo DEAE (Type II) BSAs 
PVA Mo DEAE (Type II) BSAp
Figure 4.11 represents the penetration ofbothfluorescently labelled BSAs and BSAp into 
the adsorbent particles of PVA Mo DEAE expressed as a percentage of the radius 
in which adsorption occurred. The radius was calculated from fluorescence profiles 
generated by confocal microscopy (see Figure 4.6). A sample of adsorbent was 
added to 1.5ml offluorescently labelled BSAs and BSAp and mixed at room temperature 
using a rotary mixer. Samples were taken at regular time intervals and analysed using 
confocal microscopy and the Bradford assay.
(Buffer A = 1 OmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide).
134
Figure 4.12 Confocal microscopy images of PVA Zr DEAE (Type II adsorbent) 
contacted with soluble and particulate BSA and imaged after 24 hours
B
Figure 4.12 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of 24 hours with both (A) fluorescently labelled BSAs and (B) BSAp. The 
proteins were adsorbed to PVA Zr DEAE (Type II adsorbent) using batch binding methods 
where O.lml of adsorbent was added to 1.5ml of fluorescently labelled BSA (either soluble or 
particulate) and mixed for 24 hours at room temperature using a rotary mixer. After 
adsorption the adsorbent was excessively washed in Buffer A to remove any unbound protein. 
The adsorbent was then imaged using confocal microscopy, from which the central optical 
slice was selected and the fluorescence profile generated. 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
135
the protein (both BSAs and BSAp) appeared to adsorb to the surface of the zirconium silicate 
core and not the PVA coating. As noted previously (see Section 2.1.5) the method of 
production for the PVA adsorbent (supplied by Igor Galaev) was unknown and therefore 
critical information concerning the preparation of the zirconium silicate prior to being added 
to the PVA as a high density filler was not available. The zirconium silicate encapsulated in 
this adsorbent was sourced from the same batch used in the fabrication of the pellicular 
adsorbent 2% ZsA (see Section 2.2.4) which did not exhibit the same effect for either BSAs 
or BSAp (refer forward to Figure 4.14). During the manufacturing process for 2% ZsA, the 
zirconium silicate was extensively washed in water (see Section 2.2.4). It is possible that in 
the fabrication procedure for PVA Zr, the silicate was either not exhaustively washed or 
chemically treated in a manner sufficient to reduce protein adsorption to the filler. 
Additionally it can be concluded that the adsorbent contains large 1 um pores as claimed (see 
Section 2.1.5) that enabled both BSAs and BSAp to fully penetrate the PVA base material of 
the adsorbent.
Figure 4.13 represents a similar analysis of the Celbead adsorbents, the final Type II 
macroporous adsorbents included in the study (see Section 2.1.4) and the images indicate that 
Celbead (II) DEAE and Celbead Amino are structurally different. Celbead (II) DEAE 
allowed BSAs and BSAp to penetrate into the adsorbent structure in a manner that suggested 
the presence of large pores. However, the fluorescence profiles also demonstrated that a large 
percentage of the internal adsorbent area was unavailable for adsorption which accounted for 
the low adsorption capacities measured and expressed in Tables 3.2 and 3.3. In contrast 
Celbead Amino exhibited exclusive surface binding and no BSAs or BSAp penetration (see 
Figure 4.13C; Section 3.3.4). The confocal microscopy images confirm the Celbead Amino 
adsorbent to be non-porous and thus the original assumption of classification of the adsorbent
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Figure 4.13 Confocal microscopy images of Celbead (II) DEAE and Celbead Amino 
(Type n adsorbents) contacted with soluble and particulate BSA imaged after 24 hours
c D
Figure 4.13 represents the fluorescent profiles generated by confocal microscopy after a 
contact time of 24 hours with both (A) and (C) fluorescently labelled BSAs and (B) and (D) 
BSAp. The proteins were adsorbed to Celbead (II) DEAE and Celbead Amino using batch 
binding methods where 0.1ml of adsorbent was added to 1.5ml of fluorescently labelled BSA 
(either soluble or particulate) and mixed at room temperature for 24 hours using a rotary 
mixer. After adsorption the adsorbents were excessively washed with Buffer A to remove 
unbound protein. The adsorbents were then imaged using confocal microscopy from which 
the central optical slice was selected and the fluorescence profiles were generated. 
(Buffer A = lOmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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as a Type II macroporous adsorbent (see Figure 2.1) appears to be incorrect. In addition, due 
to the nature of the adsorption profiles and the irregular shape of the Celbead adsorbents (see 
Figures 2.17 and 2.18) it was not possible to calculate the percentage radius of individual 
adsorbent particles.
The final adsorbent included in the study was a Type IV pellicular adsorbent 
designated as 2% ZsA (see Figure 2.1 and Table 2.1) and confocal microscopy images 
illustrating the adsorption of BSAs and BSAp are represented in Figure 4.14. The initial 
observation from the fluorescence images is that BSAs completely penetrated the agarose 
layer of the pellicular adsorbent up to the zirconium silicate core (Figure 4.14A). In contrast, 
BSAp adsorbed exclusively to the adsorbent surface with approximately 10% of the 
adsorbent radius being used for adsorption that is equal to 10.5um penetration (see Figure 
4.15). This suggested that there was a degree of penetration into the 2% agarose layer. 
However it has been demonstrated by Thwaites et al (2002) that apparent penetration of 
plasmid DNA into 6% agarose structures was attributed to surface roughness as opposed to 
actual penetration. Consequently, the small degree of BSAp penetration observed in 2% ZsA 
could be attributed to such surface characteristics.
It is noteworthy that a significant BSAp penetration was observed for 6% 
STREAMLINE DEAE of 22.5um after a 24 hour contact time, whereas for 2% ZsA there is 
virtually no apparent penetration. This observation was unexpected as a 6% agarose gel 
would be expected to allow the penetration of globular proteins having a molecular weight of 
10,000 to 5,000,000 Daltons and a 2% agarose gel allows the penetration of proteins having 
molecular weights of 250,000 to 450,000,000 Daltons (BioRad Product Information). It was 
therefore expected that BSAp would penetrate further into 2% ZsA adsorbent particles in 
comparison to 6% STREAMLINE particles.
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Figure 4.14 Confocal microscopy images of 2% ZsA (Type IV adsorbent) contacted 
with soluble and participate BSA and imaged after 24 hours
B
Figure 4.14 represents the fluorescence profiles generated by confocal microscopy after a 
contact time of 24 hours with both (A) fluorescently labelled BSAs and (B) BSAp. The 
proteins were adsorbed to 2% ZsA (Type IV adsorbent) using batch binding methods where 
O.lml of adsorbent was added to 1.5ml of fluorescently labelled BSA (either soluble or 
paniculate) and mixed at room temperature for 24 hours using a rotary mixer. After 
adsorption the adsorbent was excessively washed in Buffer A to remove unbound protein. The 
adsorbent was the imaged using confocal microscopy from which the central optical slice of 
the adsorbent was selected and the fluorescence profiles were generated. 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Figure 4.15 Bar chart representing the percentage of the radius of a 2% ZsA DEAE adsorbent 
particle utilised for soluble and particulate BSA adsorption
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Figure 4.15 represents the penetration ofbothfluorescently labelled BSAs and BSAp into 
the adsorbent particles of 2% ZsA expressed as a percentage of the particle radius in 
which adsorption occurred. The radius was calculated from fluorescence profiles generated 
by confocal microscopy (see Figure 4.6). 
(Buffer A = WmM Tris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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4.3.2 Direct Evaluation of the Fluorescence Profiles
The relative intensity of the fluorescent light emitted from the adsorbent sample 
corresponds to the resulting pixel image generated by the computer. Therefore from the 
individual profile for each adsorbent sample loaded with fluorescently labelled BSAs or 
BSAp a calculation of the relative concentration of the adsorbate within the adsorbent 
particles is possible. Linden et al (1999) described a simple calculation for determining the 
relative capacity of the adsorbents that has been modified and applied to the work described 
herein. The integral fluorescence (I) within the volume of the adsorbent particle where 
adsorption has occurred is calculated using Equation 4.1, which takes into consideration the 
volume of the adsorbent particle used for adsorption. By relating this value to the adsorbent 
particle volume (Equation 4.2) the relative capacity (Qrei) is obtained in arbitrary units per 
cm3 of adsorbent.
/= area under the curve [(ra —T\) IT, n] Equation 4.1
For equation 4.1 the area under the curve was calculated using a Sigma Plot graphics package 
transformation that integrates the area under curves using the trapezoidal rule.
Qrei = 11 volume of 1 particle Equation 4.2
The data calculated using these equations allows the confocal microscope images to be 
quantified in terms of the fractional approach to equilibrium (F = Qrei/ QK\= verses time) from 
direct measurements within the adsorbent particles, in addition to the observation of the 
product transport within the adsorbent solid phases.
Figures 4.16 and 4.17 represent the batch uptake curves for all the adsorbents 
constructed after the integration and normalisation of the fluorescence profiles for both BSAs
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Figure 4.16 Batch uptake curves representing the normalised and integrated fluorescence 
from the laser scanning confocal microscopy images for BSAs
1.50
1.25 -
1.00 -
0.75
0.50 -
0.25 -
0.00
10 15 20 
Time (min)
25 30 35
STREAMLINE DEAE (Type I) 
PVAMoDEAE(Typell) 
PVA TiO2 DEAE (Type II)
Celbead(II)DEAE
2% ZsA DEAE (Type IV)
Figure 4.16 represents the fractional approach to equilibrium after the integration and 
normalisation of the fluorescence profiles within a 30 minute adsorption experiment 
(see Figure 4.6). A sample of adsorbent (O.lml) was added to 1.5ml offluorescently 
labelled BSAs and mixed at room temperature using a rotary mixer. Samples of both 
the adsorbent and supernatant were taken at regular time intervals and the adsorbent 
samples imaged by confocal microscopy. The resulting fluorescence profiles were used 
to calculate the relative fluorescence (F; see Equations 4.1 and 4.2). The relative 
fluorescence for CelbeadAmino and PVA Zr DEAE could not be calculated as neither 
were characterised by a spherical adsorption profile. 
(Buffer A = 1 OmM Tris-HCl, pH 7.4 with 0.01 % Tween 20 and 0.02% sodium azide).
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Figure 4.17 Batch uptake curves representing the normalised and integrated fluorescence 
from the laser scanning confocal microscopy images for BSAp
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Figure 4.17 represents the fractional approach to equilibrium after the integration 
and normalisation of the fluorescence profiles -within a 30 minute adsorption experiment 
(see Figure 4.6). A sample of adsorbent (0.1ml) was added to 1.5ml offluorescently 
labelled BSAp and mixed at room temperature using a rotary mixer. Samples of both 
the adsorbent and supernatant were taken at regular time intervals and the adsorbent 
samples imaged by confocal microscopy. The resulting fluorescence profiles were used 
to calculate the relative fluorescence (F; see Equations 4.1 and 4.2). The relative 
fluorescence of Celbead Amino and PVA Zr DEAE could not be calculated as neither 
were characterised by a spherical adsorption profile.
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and BSAp respectively. The curves illustrate that as the experiment progressed the 
fluorescence generally increased in line with the concentration of adsorbed protein. The 
exception was the pellicular Type IV adsorbent, 2% ZsA where the recorded fluorescence 
actually decreased as the experiment progressed. This was attributed in part to the zirconium 
silicate particles contained within the agarose material of the adsorbent whose dense nature 
could potentially compromise the optical properties and mask the full fluorescence of the 
labelled BSAs and BSAp (see Figure 4.15).
It was important to validate the quantitative interpretation of the confocal images with 
an independent method (for example the Bradford protein assay) to indirectly measure the 
decrease in the fluid phase protein concentration overtime (see Section 4.2.4). Figures 4.18 
and 4.19 represent a comparison of the direct measurement of adsorption using LSCM and 
the indirect measurement using the Bradford assay for the commercial benchmark 
STREAMLINE DEAE. The fractional approach to equilibrium for fluorescence (F) is 
expressed as the relative capacity (Qrei) divided by the relative capacity at equilibrium (Qrei=; 
see Equation 4.2). In addition, the fractional approach to equilibrium for the protein 
concentration is expressed as the concentration of adsorbed protein (C) divided by the 
equilibrium adsorption capacity (C0).
It was observed that the adsorption profiles did not correlate for either BSAs (see 
Figure 4.18) or BSAp (see Figure 4.19). This indicated that the measured maximum 
fluorescence capacity was much lower than the equivalent protein capacity suggesting that 
the maximum fluorescence determined was much lower than would have been expected. This 
observation could be attributed to the presence of composite materials in the adsorbent 
structure affecting the optical properties of the adsorbent. This adsorption pattern was 
observed for the other adsorbents included in the study. Similar experiments have been
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Figure 4.18 The fractional approach to equilibrium for the adsorption of BSAs to 
STREAMLINE DEAE comparing both fluorescence analysis and protein analysis
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Figure 4.18 represents the comparison of the adsorption profiles for STREAMLINE DEAE 
calculated from confocal microscopy and protein analysis using the Bradford assay. A sample 
of adsorbent (0. Iml) was added to 1.5ml offluorescently labelled BSAs and mixed at room 
temperature using a rotary mixer. Samples of both the adsorbent and supernatant were taken 
at regular time intervals and the adsorbent analysed using confocal microscopy (see Equations 
4.1 and 4.2) and the supernatant was analysed using the Bradford assay and expressed 
as a fractional approach to equilbrium over time (F; see Section 4.3.2)..
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Figure 4.19 The fractional approach to equilibrium for the adsorption of BSAp to 
STREAMLINE DEAE comparing both fluorescence analysis and protein analysis
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Figure 4.19 represents the comparison of the adsorption profiles for STREAMLINE DEAE 
calculated from confocal microscopy and protein analysis using the Bradford assay. A sample 
of adsorbent (0.1ml) was added to 1.5ml offluorescently labelled BSAs and mixed at room 
temperature using a rotary mixer. Samples of both the adsorbent and supernatant were taken 
at regular time intervals and the adsorbent analysed using confocal microscopy (F, see Equations 
4.1 and 4.2) and the supernatant was analysed using the Bradford assay and expressed 
as a fractional approach to equilibrium over time.
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reported in the literature (Ljunglof and Hjorth, 1996; Ljunglof and Thommes, 1998; Linden 
et al, 1999) where this method has been successfully employed as a technique for directly 
measuring protein uptake. It was concluded from this study that the success of the method is 
dependent upon the adsorbent solid phases in which the fluorescently labelled protein is 
imaged. In the literature the adsorbent solid phases employed were Sepharose adsorbents that 
consist solely of agarose (see Section 2.1.2.1). Therefore there are no density enhancing 
materials that will interfere with the detection of the fluorescence from the probe. Each 
adsorbent used in the present study contained a high-density filler, either quartz, 
molybdenum, titanium oxide or zirconium silicate, all of which have different optical 
properties to the base material of the adsorbent solid phases.
4.3.4 General Conclusions
The technique of LSCM was employed in the present study to directly visualise the 
protein (both soluble and particulate) within the structure of the adsorbent solid phases, to 
validate the conclusions made about the adsorbents subsequent to the adsorption/desorption 
studies (see Sections 3.3.1 and 3.3.4). In addition, the technique was investigated as a method 
for the direct measurement of the adsorption of BSAs and BSAp. The results suggested that 
quantitative interpretation of the technique was not reliable for adsorbents that contained 
materials having poor optical qualities (see Section 4.3.3). However, the technique was seen 
to be a useful tool to qualitatively visualise the distribution of the protein products within the 
adsorbent solid phases. As with any technique, there are associated limitations where the 
adsorption is observed at the single particle level however for the purpose of this study 
particles were randomly selected from the adsorbent sample. The fluorescence profiles were 
analysed in triplicate, to ensure that the data generated represented an average adsorption 
distribution. This technique can also be used to predict the performance of adsorbent solid
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phases used for chromatographic separations, and to determine experimental conditions such 
as the concentration of protein and the contact time required for an adsorbent to reach 
equilibrium and also assess the efficiency of a chromatographic adsorbent for capture of a 
specific product.
The study indicated that Celbead (II) DEAE and Celbead Amino adsorbents had a 
limited surface area available for adsorption and were considered to be unsuitable for the 
fluidised bed recovery of nanoparticulate products. The adsorptive and desorptive 
performance of the PVA TiO2 DEAE adsorbent was generally good, but no better than other 
Type II adsorbents. The disappointing bed expansion performance (see Figure 2.20), was the 
criterion exploited to reject PVA TiO2 DEAE from the study.
The remaining adsorbents, PVA Zr DEAE, PVA Mo DEAE, STREAMLINE DEAE 
and 2% ZsA, were considered to be the most suitable adsorbents for the fluidised bed 
recovery of nanoparticulate products from the range of the adsorbent initially selected for 
study. The initial scouting experiments exploited 'clean' systems containing only soluble or 
particulate BSA in buffer. Further experiments exploiting complex feedstocks such as cell 
culture supernatants and yeast homogenates were required to investigate the performance of 
the adsorbent solid phases in realistic systems from which nanoparticulates could be sourced 
and recovered.
It is noteworthy that FITC conjugated proteins and protein nanoparticles are expected 
to behave differently in comparison to native products (refer Forward to Section 5.2.6). FITC 
binds primarily to the positively charged lysine residues of BSA (see Table 3.1) therefore this 
interaction would not be likely to interfere with the adsorption of BSAs and BSAp to the 
anion exchange adsorbents. The negatively charged aspartate and glutamate residues are 
assumed to be the amino acids involved in the adsorption of the protein to the positively 
charged anion exchange adsorbents. However, the presence of FITC bound to the protein
148
may interfere with this interaction and so it is important to be aware that the images produced 
of protein adsorption using LSCM may not be identical with the adsorption of native proteins 
to the same adsorbent solid phases.
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CHAPTERS
THE AFFINITY CAPTURE OF NANOPARTICULATE PRODUCTS 
FROM CELL CONTAINING INSECT CELL CULTURE LYSATE
5.1 General Introduction
Preliminary studies described in Chapters 2 to 4 have critically evaluated adsorbent 
solid phases characterised by different internal and external geometries for their suitability as 
adsorbents for the fluidised bed recovery of nanoparticulate products. Table 5.1 summarises 
the qualities of the adsorbents that demonstrated a promising performance for such an 
application. The important criteria for an ideal adsorbent are (i) adequate fluidisable 
characteristics, (ii) effective nanoparticulate recovery and (iii) limited adsorption and 
efficient desorption of undesired molecular impurities from within the adsorbent structure. 
Scouting experiments were completed using clean systems containing either pure BSAs or 
pure BSAp (see Chapter 3) but further adsorption experiments were indicated using a 
realistic complex feedstock to mimic the recovery of nanoparticle products from systems 
representative of industrial practices.
The adsorbents used in this study were selected as a consequence of their 
performance in the anion exchange recovery of soluble and particulate BSA. Ion exchange 
chromatography (IEC) is one of the most commonly used separation techniques (Bonnerjea 
et al, 1986) based upon the reversible adsorption of charged molecules to oppositely charged 
immobilised ligands (see Section 2.1.9). However, realistic complex feedstocks such as cell 
culture fluid and fermentation broths contain cells, cell debris and molecular impurities such 
as endotoxins , DNA and proteins, whose common indigenous negative charge means that a
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Table 5.1 Summary of the selected adsorbent solid phases
ADSORBENT 
TYPE
I
II
IV
ADSORBENT
STREAMLINE 
(6% Agarose)
PVAMo
PVAZr
2% ZsA
PORE SIZE
<0.2um
\\irn
lum
<0.4|am
MANUFACTURER
Amersham Biosciences
Swedish Construct
Swedish Construct
Birmingham Construct
Table 5.1 represents the adsorbent solid phases included in the present study selected from 
the initial candidate adsorbent solid phases subsequent to physical and biochemical 
characterisation studies (Chapters 2 and 3). Remaining in the study was the Type I 
commercial adsorbent STREAMLINE alongside the macroporous Type II adsorbents 
manufactured by Igor Galaev (Lund University, Sweden) and the Birmingham pellicular 
construct (Type IV) manufactured by Yan Sun (Tianjin University, PR of China).
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good separation of the desired product from the fluid or broth is difficult to achieve solely on 
charge differences. It was concluded that IEC would not generally be a suitable separation 
technique for the recovery of nanoparticulate products from such feedstocks and thus affinity 
capture of nanoparticles was considered as a suitable alternative.
Cibacron Blue 3GA is a monochlorotriazine textile dye (refer to Section 5.1.1) that 
has a reported affinity for human serum albumin (Leatherbarrow and Dean, 1980). Thus, this 
was selected as a readily available affinity model specifically employing HSA nanoparticles 
instead of BSA as previously studied (see Chapter 3).
The objective of the present study has been to investigate the recovery of 
nanoparticulate proteins that were included in the study as mimics for viruses and plasmid 
DNA. Much emphasis has also been placed on the requirement to separate such products 
from complex feedstocks and product components. Therefore to investigate this affinity 
model insect cell culture lysate was introduced as a test feedstock from which viral products 
would commonly be recovered such as baculovirus (refer forward to Section 5.1.3).
5.1.1 Cibacron Blue 3GA Pseudo Affinity Dye
In the present study Cibacron Blue 3GA, a monochlorotriazine textile dye (see Figure 
5.1), was selected as a candidate affinity ligand recognised to exhibit general affinity 
interactions with a number of protein and enzyme groups (Table 5.2; Clonis and Lowe, 
1980). The affinity of the dye for serum albumins, particularly human serum albumin (HSA) 
was exploited herein to investigate the performance of the selected adsorbent solid phases 
with both soluble and paniculate forms of that protein (refer to Section 5.1.2). The binding 
interaction of HSA with Cibacron Blue 3GA has been considered in great depth. Studies by 
Leatherbarrow and Dean (1980) suggested that there are two types of dye-protein interactions
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Figure 5.1 The principle structural elements of Cibacron Blue 3GA
O NH2
so3-
NH
so3-
Figure 5.1 represents the structure of the triazine dye, Cibacron Blue 3GA where segment A 
represents the sulphonated anthraquinone and B represents the bridging diaminobenzene 
sulphonate. In addition, segment C is the reactive chlorotriazine functional group -where 
nucleophilic substitution occurs with the hydroxide groups of a hydrophilic polysaccharide 
material. Finally, segment D represents the O-aminobenzene sulphonate ring.
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Table 5.2 A selection of proteins and enzymes purified using Cibacron Blue 3GA
PROTEIN
Alcohol dehydrogenase
Pyruvate kinase
Albumin
Interferon
SOURCE
Horse liver
Yeast
Yeast
Chicken egg
Human serum
Bovine serum
Mammalian
Mouse
REFERENCE
Easterday and Easterday (1974)
Adinolfi and Hopkinson (1978)
Kopperschlager et al (1968)
Dean and Watson (1979)
•
Young and Webb( 1978)
Ticha etal (1978)
Bollin etal (1978)
Boyer and Hsu( 1993)
Table 5.2 represents a summary of proteins and enzymes that have been successfully purified 
using the triazine dye, Cibacron Blue 3GA. The dye is a pseudo affinity ligand that mimics 
the structure of enzyme substrates and can interact with the binding sites of structurally 
similar biomolecules.
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that are related to the physiological function of HSA. The first interaction is via the 
hydrophobic fatty acid binding sites present on all albumins whilst the second is a more 
specific interaction with the commonly available billirubin binding site (see Section 3.2.3). 
Pannell et al (1974) and Beissner and Rudolph (1978) demonstrated further evidence of the 
specific binding mechanism of HSA. They discovered that the anthraquinone group of the 
Cibacron Blue 3GA dye is fundamental for the binding of HSA (refer to Figure 5.1). In 
addition, Leatherbarrow and Dean (1980) noted that Cibacron Blue 3GA and billirubin are 
structurally similar, since both molecules consist of planar aromatic ring systems and the 
position of the negatively charged groups can be superimposed. As a consequence of this 
specificity of HSA for Cibacron Blue 3GA this absolute-ligand interaction system was 
selected for the work presented herein.
5.1.2 Human Serum Albumin
Human serum albumin (HSA) is structurally similar to bovine serum albumin (see 
Section 3.1.3). The amino acid sequence is different (see Table 3.1), but both proteins contain 
the same number of lysine residues indicating that the behaviour of the proteins when 
conjugated to FITC or Rhodamine B isothiocyanate should be similar. HSA was selected for 
this study as a consequence of the affinity of the Cibacron Blue 3GA ligand for serum 
albumin and particularly human serum albumin.
5.1.3 IPL 41 Insect Cell Culture Medium
Subsequent to the selection of the affinity ligand and the protein of interest for this 
study, a feedstock system representative of insect cell culture was chosen. Like mammalian 
cell media, insect cell culture medium consists of numerous amino acids and sugars such as 
mono and disaccharides (see Appendix III) in addition to vitamins and sterols that cannot be
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synthesised by insect cells. The representative feedstock, IPL-41 insect cell medium supplied 
by R. Jarman-Smith, (Animal Cell Technology Group, University of Birmingham), is a 
serum free medium supplemented with pluronic F-68, yeastolate and lipids (refer to the 
Appendix III). This resulted in fewer protein impurities within the system in comparison to 
serum containing media making it more suitable for Cibacron Blue affinity chromatography. 
This medium is used for the culture of a Lepidopteran cell line sf-9 derived from the primary 
cell line sf-21 isolated from Spodoptera frugiperda pupal ovaries (Vaughn et al, 1977).
Trschirley (1975) recognised that baculovirus infected Lepidoptera, and could be 
manipulated to infect insect cell cultures. Consequently, recombinant baculovirus infected 
cells are now commonly used for the high level expression of foreign genes for use in the 
biopharmaceutical industry (Kioukai et al, 1995). Consequently, the IPL-41 cell culture 
medium was thus selected as a representative complex feedstock for the recovery of 
nanoparticulate products
5.1.4 Rhodamine B Isothiocyanate
Laser scanning confocal microscopy (LSCM) was employed in this study to 
investigate the adsorption of fluorescently labelled HSAp. As a consequence of the 
spectrophotometric absorbance of Cibacron Blue 3GA dye, FITC (see Section 4.1.2.1) could 
not be employed because of interference. Thus, a probe that exploited the laser wavelength of 
534nm was adopted in the form of Rhodamine B isothiocyanate, a commonly used 
fluorescent probe for protein and antibody conjugation. Rhodamine B isothiocyanate is 
characterised by a molecular weight of 536.1 and exhibits a characteristic wavelength of 
maximum absorption and emission of 510nm and 595nm respectively.
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5.2 Materials and Methods
5.2.1 Chemicals
Cibacron Blue 3GA, Human Serum Albumin (Fraction V powder, 96% purity) and 
Rhodamine B Isothiocyanate were supplied by Sigma-Aldrich (Poole, Dorset, UK). All other 
chemicals and reagents were supplied at reagent grade unless otherwise stated by Sigma- 
Aldrich (Poole, Dorset, UK) or BDH (Poole, Dorset, UK).
5.2.2 Equipment
• Malvern Zetasizer 1OOOHS/IHPL, Malvern Instruments Ltd, Malvern, UK.
• Rotary blood mixer, Stuart Scientific Company Ltd, UK.
• Pharmacia LKB Ultrospec HI spectrophotometer, Amersham Biosciences, Uppsala, 
Sweden.
• pH meter, Hanna Instruments, HI9321, Microprocessor Bench pH meter.
• Millipore ultrafiltration unit, Millipore, Bedford, MA, USA.
• Pharmacia 1cm (id) chromatography column, Amersham Biosciences, Uppsala, Sweden.
• Peristaltic pump, model 101U (maximum output 15W). Watson-Marlow Company Ltd, 
Cornwall, UK.
• Water bath, Stuart Scientific Company Ltd, UK.
• Rotary mixing unit, Stuart Scientific Company Ltd, UK.
• Luminescence spectrometer LS50B, PERKIN-ELMER, High Wycombe, UK.
• Leiss 510 Laser Scanning Confocal Microscope, Zeiss Ltd, Stockport, UK.
• General laboratory glassware
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5.2.3 Methods
The majority of methods employed in this chapter have been described in detail in the 
preceding Chapters 2, 3 and 4, and are crossreferenced accordingly. New methods are 
depicted below.
5.2.3.1 Preparation of Immobilised Cibacron Blue 3GA
Selected adsorbent solid phases were derivatised to impart pseudo-affinity 
functionality to the candidate ideal adsorbents. Cibacron Blue 3GA, a triazine dye, was 
immobilised onto the adsorbents using an adapted method first published by Dean and 
Watson (1979). Vacuum filtered adsorbent (25g) was suspended in 50ml of deionised water 
and 0.75g of Cibacron Blue 3GA was added and the mixture agitated for 15 minutes. 
Subsequent to the addition of the dye, 7.5g of NaCl was added and the mixture agitated for a 
further 30 minutes followed by the addition of 30ml of 1M NaCOs. The mixture was 
transferred to a round-bottomed flask, attached to a rotary mixing unit and the flask was 
incubated in a water bath at 65°C for 24 hours under gentle agitation and semi-submersion. 
After incubation the solid phase was removed from the liquid phase and washed with 
alternate washes of hot and cold water to remove the unreacted dye. The remaining weakly 
bound dye was removed by specific displacement in a protein wash followed by a chaotropic 
elution step in a fixed bed contactor (Gibson, 1992). The adsorbent was suspended in Buffer 
A (lOmM Tris-HCl, pH 7.5 with 0.01% Tween 20 and 0.02% sodium azide) and packed into 
a chromatography column. The column was loaded with 100ml of Img/ml bovine serum 
albumin at a flow rate of Iml/min, and eluted with 100ml of 3M KSCN (in Buffer A) at 
Iml/min. A final wash of Buffer A concluded the procedure and the adsorbents were stored at 
4°C.
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5.2.3.2 Estimation of the Immobilised Dye Concentration
The dye content of the adsorbent solid phases was estimated following a method 
proposed by Chambers (1977). The adsorbent particles were hydrolysed in the presence of a 
strong acid resulting in the release of the immobilised dye. The dye concentration was 
quantified spectrophotometrically against a previously prepared standard curve (see 
Appendix IV). Vacuum filtered adsorbent (0.5ml) was dispersed in 25ml of 6M HC1 and 
agitated in a temperature controlled water bath at 95°C for 30 minutes. After hydrolysis the 
remaining solids were removed by centrifugation and 1ml of the supernatant was diluted to 
200ml with deionised water. The absorbance of the supernatant at 595nm was recorded 
against a blank generated from a non-immobilised adsorbent sample treated in an equivalent 
manner. The dye concentration was estimated from the standard curve (see Appendix IV).
5.2.3.3 Total Protein Determination - Fluorescence Spectroscopy
The total protein concentration in adsorption/desorption experiments was 
determined using either the Bradford assay (see Section 3.2.6 and Appendix V) or a 
fluorescence assay exploiting the excitation and emission of fluorescein isothiocyanate 
(FITC) described in Section 4.2.3. The fluorescence from the probe was detected and the 
protein concentration determined using a luminescence spectrometer (LS50B, PERKIN- 
ELMER, UK). Fluorescence is a short-lived emission that usually occurs within 10"9 and 10"7 
seconds of the samples being excited, and when the luminescence spectrometer is operating 
in the fluorescence mode two gating periods occur. In the first gating period (the point at 
which the device measures the fluorescence) the instrument integrates the excitation and 
emission signals. The second gating period occurs shortly before the next flash of 
fluorescence emission and integrates the signal detected by the device when no light is falling
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on the detector. The second value obtained by the device is then subtracted as a blank from 
the first so that the corrected fluorescence is free from other signals detected by the device.
FITC was conjugated to HSAp primarily via the lysine residues on the protein surface 
using the method described in Section 4.2.3 to achieve a maximum load per mole of protein 
and enable nanoparticle detection at low concentrations (refer to Section 5.2.6.1; refer to 
Figure 5.2). It was expected that HSAp conjugated to FITC would behave differently to 
native HSAp. Lysine 220 is one of the amino acids present within the billirubin binding site. 
It is reported that the affinity interaction between Cibacron Blue 3GA, the affinity ligand 
employed in this study, and human serum albumin occurs at the billirubin binding site 
(Leatherbarrow and Dean, 1980). This is due to the structural similarities of billirubin and 
Cibacron Blue 3GA (Leatherbarrow and Dean, 1980). Consequently, a reduction in 
adsorption capacity of FITC conjugated HSAp in comparison to native HSAp was expected. 
It is also noteworthy that the pi of the protein may also change as the charge of the protein 
will alter as the lysine residues become utilised. To construct the fluorescence calibration 
curve (refer to Appendix VI) used in this study the protein concentration of the FITC 
conjugated nanoparticles was estimated using the Bradford assay (see Section 3.2.6). The 
HSAp samples were diluted by an appropriate amount and the fluorescence determined by 
excitation and emission of FITC at 488nm and 525nm respectively. The protein 
concentration was determined from the fluorescence calibration curve (refer to Appendix VI) 
and all the samples were analysed in duplicate.
160
Figure 5.2 Graph representing the fluorescence of FITC labelled HSAp at increasing 
concentrations of conjugated FITC
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Figure 5.2 represents the fluorescence of FITC labelled HSAp with increasing concentrations of 
conjugated FITC. The molarity was determined following a method described in Section 3.2.6.1. 
FITC was loaded onto the HSAp at increasing concentrations and the fluorescence determined 
using afluorimeter (PERKIN-ELMER, luminescence spectrometer). The measurement represents 
the fluorescence of the FITC (at a particular molar concentration) on Jug/ml of HSAp measured 
using the Bradford assay (see Section 3.2.6; refer to Appendix V).
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5.2.3.4 Determination of the Maximum Fluorescein Isothiocyanate Concentration 
Loaded onto HSA Nanoparticles
FITC was conjugated to HSAp using the method described in Section 4.2.3, but 
varying the initial concentration of the FITC stock solution added to the HSAp during the 
conjugation step. FITC primarily conjugates to the lysine residues of protein molecules (see 
Table 3.1), and since HSA contains 59 lysine residues in total, this accounts for 
approximately 10% of the total protein molecule (see Table 3.1). Therefore it is assumed that 
once all the available lysine residues are exploited no further conjugation associated 
fluorescence will be detected.
The molar ratios of conjugated fluorescent probe to protein were determined using a 
method described by Kawamura (1977) exploiting the optical density of the FITC conjugated 
protein at 280nm and at 495nm using the following equation.
(3.14 x OD495) / OD28o - (0.30 x OD495) Equation 5.1
It is noteworthy that this method is only an approximation of the relative molar ratios 
as the optical density of HSAs at 280nm is different to the same concentration of HSAp. 
Amino acid analysis of HSAp (see Appendix VII) completed by Dr J. Fox, Alta Biosciences, 
University of Birmingham, indicated that at 220ug/ml measured at 280nm, the equivalent 
protein concentration estimated from amino acid analysis was 198ug/ml (see Appendix VII). 
Consequently the absorbance of HSAp at 280nm overestimates the protein concentration by 
approximately 10%.
For the purpose of HSAp detection and adsorption interference (refer forward to 
Table 5.5) the maximum fluorescence per mole of FITC was determined using Equation 5.1 
to estimate the number of moles of FITC added at the conjugation step (see Section 4.2.3).
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Figure 5.2 represents the determination of the maximum conjugated FITC loaded per mole of 
HSAp, where the amount of fluorescence detected reached a plateau. It is possible that 
further conjugation had occurred, but was not detected. In addition, at this plateau all the 
available lysine residues may have been exploited resulting in no further detectable FITC 
conjugation.
5.2.3.5 Preparation of the Insect Cell Culture Lysate
IPL-41 insect cell culture fluid, supplied by R. Jarman-Smith (Animal Cell 
Technology Group, University of Birmingham), was taken during the exponential growth 
phase of sf-9 insect cells. Cells were seeded at a cell density of 0.2-0.4 x 106 cells/ml into a 
Techne flask containing IPL-41 medium supplemented with Pluronic 68, yeastolates and 
lipids. The cells were incubated at 27°C with agitation at 60rpm at pH 6.0-6.4. Once the cells 
had achieved a density of approximately 2 x 106 cells/ml the culture fluid was used as the 
representative complex feedstock in the study. The total protein concentration was estimated 
to be Img/ml using the Bradford assay attributed to the presence of growth factors and 
enzymes produced from the cells during the growth phase (see Section 3.2.6). Freeze- 
thawing the cell culture fluid three times lysed the cells within the medium to create a 
representative experimental feedstock for which the pH and conductivity was subsequently 
determined.
5.2.3.6 The Adsorptive Capture and Recovery of HAS Nanoparticles for the Selected 
Adsorbent Solid Phases
Preliminary batch binding studies employing BSAs and BSAp as representative 
contaminants, product components and nanoparticulate products respectively, were 
completed and described in Chapter 3. However these experiments exploited anion exchange
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chromatography that has been considered to be unsuitable for the recovery of nanoparticulate 
products from complex feedstocks such as the insect cell lysate selected and included in the 
study (see Section 5.1). As a consequence, a pseudo-affinity dye ligand, Cibacron Blue 3GA 
was introduced into the study (see Section 5.1.1) and HSAp were fabricated as the test 
particulate adsorbate (see Section 5.1.2; Section 3.2.3).
Four different batch binding experiments were completed exploiting Cibacron Blue 
3GA and HSAp. The initial experiment was a benchmark study performed as a comparison to 
the adsorption/desorption studies for BSAp to adsorbents derivatised with anion exchange 
chemistry (see Section 3.3.4). The studies in the previous chapters have been concerned with 
the performance of the solid phases for the efficient recovery of nanoparticulate products 
from clean systems. However, it is important to investigate the performance of the selected 
adsorbent solid phases in industrially realistic conditions and hence, experiments were 
completed exploiting particle numbers representing an average particle number from typical 
retrovirus or adenovirus litre (Hughes, 2001). Experiments were also completed with 
different nanoparticle concentrations in the presence or absence of cell culture lysate.
After the adsorbent was equilibrated in Buffer C the HSAp solution was added to 
O.lml of adsorbent and the system mixed rigorously for 2 hours at room temperature using a 
rotary mixer. Samples were taken at regular time intervals and the protein concentration was 
determined either by Bradford or fluorescence assays (see Section 3.2.6; 5.2.6). After the 
adsorption was completed at 120 minutes the adsorbents were washed in Buffer C (lllmM 
sodium phosphate buffer, pH 6.4) to remove any unbound protein or cell debris from the 
system. The HSAp and intracellular proteins from the cell lysate were desorbed by 
suspending O.lml of protein loaded adsorbent in 1.5ml of 3M KSCN (in Buffer C). The 
system was mixed for 2 hours at room temperature using a rotary mixer and samples taken at
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regular time intervals and assayed to determine the protein concentration using the Bradford 
and fluorescence assays.
It is well documented that Cibacron Blue 3GA has a tendency to leach from the 
adsorbent solid phases into the supernatant during the adsorption and desorption procedures 
(Stewart et al, 1990). Therefore when each binding experiment was completed blank samples 
containing equivalent volumes of adsorbent and buffer, (both Buffer C and 3M KSCN) were 
included to monitor dye leakage from the adsorbent solid phases.
5.3 Results and Discussion
5.3.1 Photon Correlation Spectroscopy Sizing of Human Serum Albumin Nanoparticles
Figure 5.3 represents the photon correlation spectroscopy sizing of human serum 
albumin nanoparticles showing an average particle size of 66nm with 89% of the particles 
within the size range of 50-80nm in diameter.
5.3.2 Determination of the Immobilised Dye Concentration
The concentration of Cibacron Blue 3GA dye immobilised to the adsorbent solid 
phases was determined using acid hydrolysis to cleave the dye from the adsorbent and a dye 
calibration curve (refer to Appendix IV). Table 5.3 represents the dye concentrations 
determined for each of the adsorbent solid phases, with STREAMLINE Blue exhibiting the 
highest dye content in contrast to much lower figures for PVA Mo Blue, PVA Zr Blue and 
2% ZsA Blue. This was attributed to the increased internal surface area available for reaction 
for the STREAMLINE adsorbent particles in comparison to the other adsorbent solid phases 
included in the study. The Type II and Type IV adsorbent solid phases had limited internal 
surface area available for both ligand derivatisation and subsequent albumin adsorption due 
to the macroporous and pellicular structures respectively. Type II adsorbents were
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characterised as assumed as having pore sizes greater than 0.6|Lim (refer to Figure 2.1). 
Therefore it can be concluded that the pore volume to adsorbent volume is greater for Type II 
adsorbents than for the Type I microporous adsorbent (see Figure 2.1). In addition, Type IV 
pellicular adsorbents are characterised by a solid core surrounded by a thin pellicle of porous 
material. It was demonstrated that the solid core comprised approximately 50% of the Type 
IV adsorbent used in this study (2% ZsA; see Section 4.3.1; Figure 4.14). Consequently it can 
be concluded that the surface are available for adsorption is much less than for 
STREAMLINE (Type I; see Figure 2.1). It could also be surmised that the PVA composite 
adsorbents contained less reactive hydroxyls that agarose resulting in lower concentrations of 
dye immobilised.
5.3.3 Preliminary Studies for the Affinity Capture and Recovery of HSA Nanoparticles
Preliminary studies for the affinity capture and recovery of 66nm HSA nanoparticles 
(see Section 5.3.1; Figure 5.3) exploiting the pseudo-affinity dye Cibacron Blue 3GA were 
completed. Figure 5.4 represents the adsorption profiles of the four selected adsorbent solid 
phases remaining in the study (STREAMLINE Blue, Type I; PVA Mo Blue and PVA Zr 
Blue, Type II; 2% ZsA Blue, Type IV). All of the adsorbents were characterised by an 
apparent slow adsorption rate suggesting nanoparticle penetration as was expected from the 
results presented in Chapter 4. Laser scanning confocal microscopy images (LSCM; see 
Figures 4.4, 4.9, and 4.12-4.14) suggested that 150nm BSAp (see Section 3.3.3) penetrated 
into the structure of each of these adsorbents and so it was therefore expected that 66nm 
HSAp would also penetrate into the adsorbent structures.
2% ZsA Blue was highlighted as having a superior adsorption capacity in comparison 
to the other adsorbents included in the study (see Table 5.4). This performance was
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Figure 5.3 Size distribution of HSA nanoparticles
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Figure 5.3 represents the size distribution of the fabricated HSA nanoparticles measured by 
photon correlation spectroscopy. The average particle size was determined as 66nm based 
on the Einstein-Diffusion Equation (see Section 3.1.2). In addition the nanoparticles were 
shown to be approximately spherical in nature by electron microscopy, and the size of the 
nanoparticle was also confirmed by this analysis. 
Electron microscopy image (inset) represents a single HSA nanoparticle.
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Table 5.3 Concentration of the Cibacron Blue 3GA dye immobilised to the adsorbent 
solid phases
ADSORBENT TYPE
I
II
IV
ADSORBENT
STREAMLINE Blue
PVA Mo Blue
PVA Zr Blue
2% ZsA Blue
DYE
CONCENTRATION
(punol/ml settled
adsorbent)
3.9
0.068
0.079
0.01
Figure 5.3 represents the immobilised dye concentration of the adsorbent solid phases 
determined after acid hydrolysis to remove the dye from the adsorbent base (see Section 
5.2.4; 5.2.5). The dye concentration was determined spectrophotometrically and calculated 
from the calibration curve (refer to Appendix IV) and converted into moles of dye 
immobilised per ml of settled adsorbent. The small ion capacities determined for the anion 
exchange derivatives of these base adsorbents are illustrated in Table 3.4.
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Figure 5.4 Adsorption of HSA nanoparticles to the selected adsorbent 
solid phases
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Figure 5.4 represents the binding ofHSAp to adsorbents derivatised with 
Cibacron Blue 3GA dye. The adsorbents were washed before use in Buffer C then 0.1ml 
of adsorbent was added to 1.5ml ofHSAp at a concentration of220ug/ml 
suspended in Buffer C. The system was mixed at room temperature for 2 hours using a 
rotary mixer and samples were taken at regular time intervals and analysed in duplicate 
using the Bradford assay (see Section 3.2.6).
(Buffer C = 111mM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and
0.01%Tween20).
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Table 5.4 Summary of the adsorptive capacities and recoveries of HSAp for the selected 
adsorbent solid phases derivatised with Cibacron Blue 3GA
1?
ADSORBENT
TYPE
I
II
IV
ADSORBENT
STREAMLINE
Blue (6%)
PVA Mo Blue
PVA Zr Blue
2% ZsA Blue
DYE
CONCENTRATION
(fimol/ml settled
adsorbent)
3.9
0.068
0.079
0.01
HSAp
CAPACITY
(mg/ml
adsorbent)
1.42
0.79
0.83
2.21
HSAp
CAPACITY
(particles/ml
adsorbent)
1.26x10"
0.7 xlO13
0.73 x 10 13
1.96x10"
%
RECOVERY
99.3
93.1
70.8
76.6
Table 5.4 represents a summary of the adsorption capacities and recoveries of HSAp for 
Cibacron Blue 3GA immobilised adsorbent solid phases. The adsorption capacities -were 
calculated using difference analysis between the initial load and the end point of the 
experiment at 120 minutes. Adsorbent (O.lml) was added to 1.5ml solution of HSAp at a 
concentration of220ug/ml and the system mixed at room temperature for 120 minutes using 
a rotary mixing unit. After 120 minutes the adsorbents were washed in Buffer C to remove 
any unbound or loosely bound protein (5 x 1ml). The HSAp were eluted using 1.5ml of 3M 
KSCN added to O.lml of HSAp loaded adsorbent and mixed for 120 minutes at room 
temperature using a rotary mixer. The protein concentrations were determined using the 
Bradford assay and the recovery was expressed as a percentage of the total protein bound. 
The particle numbers were determined following the method described in Table 3.4 
exploiting a particle diameter of66nm.
(Buffer C = lllmMsodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 0.01% 
Tween 20).
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contradictory to what was expected based upon the dye content of the adsorbents (see Table 
5.3) since 2% ZsA Blue exhibited the lowest dye concentration (O.Olumol dye/ml settled 
adsorbent). This data in addition to the LSCM images suggested that the ligand concentration 
could influence the adsorption of HSAp to the selected adsorbent solid phases. Figure 5.5 
represents the LSCM profile of HSAp bound to 2% ZsA Blue at equilibrium (after 24 hours). 
The image demonstrates that 60% of the adsorbent radius (3 5 urn) was exploited for 
adsorption with HSAp penetrating into the entire agarose layer available within the adsorbent 
structure. However, Figure 4.14 represents the LSCM image of BSAp bound to 2% ZsA 
DEAE at equilibrium (after 24 hours contact time). This image indicated that BSAp 
penetrated only into the initial 10.5um of the adsorbent radius. This could be attributed to the 
different sizes of the nanoparticles as HSAp are significantly smaller than BSAp at 66nm in 
comparison to 150nm. However, the LSCM images of STREAMLINE and PVA Mo were 
similar for both the affinity (see Figures 5.6; 5.7) and anion exchange (see Figures 4.8; 4.12) 
form of the adsorbents suggesting that the size of nanoparticles does not influence the 
adsorption of HSAp into a 6% agarose material. It could therefore be surmised that the 2% 
agarose structure would enable easier penetration than a 6% agarose structure. Hence the 
results suggest that the high DEAE concentration of the anion exchange adsorbent (see Table 
2.4) resulted in the pores becoming blocked near the surface preventing further penetration. 
With the 2% ZsA Blue adsorbent, the dye concentration is low that could enable the HSAp to 
travel further into the adsorbent structure unhindered.
A critical parameter to be considered is the recovery of nanoparticulate products once 
they have adsorbed to the adsorbent particles. HSAp bound under standardised conditions 
were recovered from the adsorbent solid phases using 3M KSCN in Buffer C, a chaotropic 
solution that is often used to strip residual material from an adsorbent as a prelude to the re- 
equilibration and re-use of the adsorbent solid phase (Bierau, 2001). Consequently, all of the
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Figure 5.5 Laser scanning confocal microscopy image representing the adsorption of 
fluorescently labelled HSAp to 2% ZsA Blue
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Figure 5.5 represents the laser scanning confocal microscopy image offluorescently labelled 
HSAp after adsorption to 2% ZsA Blue. This image was the central optical slice produced 
using Rhodamine B isothiocyanate as the fluorescent label. This probe was conjugated to 
HSAp following the method described in Section 4.2.3 to enable the adsorption of HSAp to be 
imaged in the presence of the Cibacron Blue 3GA dye affinity ligand. HSAp (1.5ml) at a 
concentration of220ug/ml were added to 0.1ml of adsorbent and mixed for 24 hours at room 
temperature. After the adsorption was stopped, the remaining Rhodamine-conjugated HSAp 
were removed from the system using washes of Buffer C (5 x 1ml washes). The adsorbent 
particles were imaged immediately using the laser scanning confocal microscopy. The profile 
represents the fluorescence detected along the length of the arrow on the image. (Buffer C = 
11 ImM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 0.01% Tween 20).
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Figure 5.6 Laser scanning confocal microscopy image representing the adsorption of 
fluorescently labelled HSAp fo STREAMLINE Blue
Figure 5.6 represents the laser scanning confocal microscopy image of Rhodamine B 
isothiocyanate labelled HSAp after adsorption to STREAMLINE Blue. HSAp (1.5ml) at a 
concentration of 220ug/ml were added to 0.1ml of equilibrated adsorbent and the samples 
mixed for 24 hours at room temperature, after which the excess unbound or loosely bound 
HSAp were removed using washes of Buffer C (5 x 1ml). The adsorbent particles were then 
imaged immediately using the laser scanning confocal microscope with the central optical 
slice shown. The profile is represented as the fluorescence detected along the length of the 
arrow depicted in the image. (Buffer C = lllmM sodium phosphate buffer, pH 6.4 with 
0.02% sodium azide and 0.01% Tween 20).
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Figure 5.7 Laser scanning confocal microscopy images representing the adsorption of 
fluoi escently labelled HSAp to PVA Mo Blue and PVA Zr Blue
B
A
Figure 5.7 represents the laser scanning confocal microscopy images of Rhodamine B 
isothiocyanate labelled HSAp after adsorption to A) PVA Mo Blue and B) PVA Zr Blue. 
HSAp (1.5ml) at a concentration of 220[*g/ml were added to 0.1ml of equilibrated adsorbent 
and the samples mixed for 24 hours at room temperature, after which the excess unbound or 
loosely bound HSAp were removed using washes of Buffer C (5 x 1ml). The adsorbent 
particles were then imaged immediately using the laser scanning confocal microscope with 
the central optical slice shown. (Buffer C = lllmM sodium phosphate buffer, pH 6.4 with 
0.02% sodium azide and 0.01% Tween 20).
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adsorbents included in the present study demonstrated an efficient recovery of HSAp (refer to 
Figure 5.8) where STREAMLINE Blue (Type I; Figure 2.1), PVA Mo Blue (Type II) and 
PVA Zr Blue (Type II) exhibited recoveries of greater than 90% (refer to Table 5.4). The 
poorest recovery of HSAp was demonstrated by 2% ZsA Blue (Type IV; see Figure 2.1) at 
76.6% (see Table 5.4). This was attributed to the apparent depth of penetration of the 
nanoparticles to approximately 3Sum as demonstrated by the laser scanning confocal 
microscopy image (see Figure 5.5). It was assumed that the depth of penetration resulted in a 
degree of nanoparticle entrapment within the adsorbent structure. In addition to the 
adsorption/desorption studies the leakage of Cibacron Blue 3GA dye from the adsorbent solid 
phases was also investigated. It was determined that if the adsorbents were extensively 
washed prior to use (i.e. 10 x adsorbent volume washes in the appropriate buffer) no dye 
leakage was detectable during the adsorption, washing or elution procedures.
5.3.4 The Affinity Capture and Recovery of Human Serum Albumin Nanoparticles 
Employing Industrially Realistic Particle Numbers
The aim of this chapter was to investigate the capture and recovery of nanoparticulate 
products from an industrially realistic system and hence it was important to investigate the 
recovery of nanoparticulate products from feedstocks characterised by suitable product 
concentrations. Therefore the adsorption of HSAp at a concentration of 1 x 108 particles/ml 
was investigated as a representative harvested virus feedstock (Hughes, 2001). The 
equivalent protein concentration of 84ng/ml was determined from the HSAp stock 
(220ug/ml) by Bradford assay prior to the required dilution of the supernatant. The Bradford 
assay cannot be used to detect protein concentrations of less than lug/ml (see Section 3.2.6) 
and hence a fluorescence assay exploiting FITC conjugated HSAp was employed to 
determine the nanoparticle concentration (see Section 5.2.6).
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Figure 5.8 The recovery of HSA nanoparticles from the selected adsorbent solid phases
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Figure 5.8 represents the recovery of HSA nanoparticles from adsorbents derivatised with 
Cibacron Blue 3GA. After adsorption the adsorbents were washed in Buffer C to remove all 
unbound HSA nanoparticles. Adsorbent (O.lml) loaded with HSA nanoparticles was added to 
1.5ml O/3MKSCN. This was mixed at room temperature on a rotary mixer for 2 hours and 
samples were taken at regular time intervals and analysed in duplicate using the Bradford assay.
(Buffer C = 111 mM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 
0.01%Tween20).
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The influence of the degree of FITC conjugation upon the adsorption of HSAp to 
Cibacron Blue 3GA solid phases was investigated with batch binding experiments completed 
for STREAMLINE Blue (the commercial benchmark adsorbent) and HSAp having different 
concentrations of conjugated FITC. The results from this study are expressed in Table 5.5 
and it was concluded that as the concentration of FITC conjugated to the HSAp increased the 
adsorption capacity decreased and the recovery was maintained at approximately 100%. This 
observation could be attributed to several factors. FITC conjugates primarily to lysine 
residues (Pawley, 1995) and so it can be surmised that FITC will conjugate to lysine 220, an 
amino acid residue present in the billirubin binding site of HSA (Leatherbarrow and Dean, 
1980; see Section 5.1.2). The affinity interaction between HSA and Cibacron Blue 3GA is 
thought to be due to the structural similarities of billirubin and the dye (see Section 5.1.1). 
Consequently any interruption of this interaction could result in lower adsorption capacities. 
In addition, there are negatively charged sulphate groups present on Cibacron Blue 3GA (see 
Figure 5.1) that could interact with positively charged amino acids present in HSA (see Table 
3.1) including arginine, histidine and lysine (Leatherbarrow and Dean, 1980). Ideally an 
FITC concentration of less than 1 mole of FITC per mole of HSA would have been desirable 
for the study as the adsorptive capacity of STREAMLINE Blue was only reduced by 
approximately 7% at this concentration (see Table 5.5). However, due to the low 
concentration range of nanoparticles employed in these studies (see Section 5.2.8) the 
maximum FITC load of 12.7 moles of FITC per mole of protein was required for the 
adequate detection of the nanoparticles.
Figure 5.9 represents the adsorptive capture of FITC-HSAp at a concentration of 10 
particles per milliliter of supernatant. All of the adsorbents remaining in the study 
(STREAMLINE Blue, Type I; PVA Mo Blue, Type II; PVA Zr Blue, Type II and 2% ZsA 
Figure 2.1) reached an adsorption equilibrium within 30 minutes and all Blue, Type IV; see
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Table 5.5 Impact of the degree of FITC conjugation upon the adsorption of HSAp to 
STREAMLINE
MOLES OF FITC PER 
MOLE OF HSA
0.0
1.89
3.06
4.45
7.08
12.49
12.7
ADSORPTION 
CAPACITY (mg/ml 
adsorbent)
1.45
1.32
1.30
1.02
0.92
0.67
0.66
% RECOVERY IN 3M 
KSCN
100
100
102.3
108.7
101.7
102.9
102.2
Table 5.5 represents the effect of FITC on the adsorption of HSAp to STREAMLINE 
derivatised with Cibacron Blue 3GA. Subsequent to the conjugation of FITC to the HSAp the 
adsorption capacities were measured employing equivalent binding experiments as used in 
the previous batch binding studies (see Chapter 3). Pre-equilibrated adsorbent (0.1ml) was 
added to 1.5ml of FITC conjugated HSAp at a concentration of220ug/ml. The samples were 
mixed at room temperature for 120 minutes using a rotary mixer. Samples were taken at 
regular time intervals and analysed in duplicate using the Bradford assay. The adsorbent 
was washed (5 x 1ml) in Buffer C (pH 6.4) then added to 1.5ml of KSCN (in Buffer C) and 
mixed at room temperature for!20 minutes. Percentage recovery is expressed as a 
percentage of the bound protein recovered within 2 hours. (Buffer C = 111 mM sodium 
phosphate buffer, pH6.4 with 0.02% sodium azide and0.01% Tween 20).
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Figure 5.9 Adsorption of HSAp at a low initial nanoparticle concentration
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Figure 5.9 represents the binding of nanopartides to adsorbents derivatised with
Cibacron Blue 3GA. Nanopartides were used at a low concentration (84ng/ml)
to mimic a realistic viral titre of Iff particles/ml. To analyse the concentration of HSAp
at this low concentration a fluorophore was attached to allow the concentration to be
determined using fluorescence spectroscopy. The fluorophore used was fluoroscein isothiocyanate
(FITC) and was immobilised via the lysine residues on the HSA protein. The
fluorophore was added to a maximum fluorophore load of approximately 12.7moles of FITC
per mole of protein (see Section 5.2.6.1) Adsorbent (0.4ml) was added to 6. Oml of HSA nanopartides
in Buffer Cat a concentration of84ng/ml. This was mixed at room temperature for 2 hours on a
rotary mixer with samples taken at regular time intervals. The samples were analysed using a
fluorescence assay.
(Buffer C = lllmM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and
0.01%Tween20).
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exhibited similar adsorption capacities (see Table 5.6). The rapid adsorption profiles were 
attributed to there being surface limited adsorption, due to the low nanoparticle 
concentration.
HSAp bound under standardised conditions were desorbed using 3M KSCN in Buffer 
C. The desorption profiles were unexpected as it was observed that there was no desorption 
of HSAp detected until 20 minutes after the initiation of the experiment (refer to Figure 5.10) 
This might be attributed to the nanoparticle concentration being too low to be detected by 
fluorescence microscopy (see Appendix VI). In addition, the recoveries were surprisingly 
low with 2% ZsA Blue exhibiting the highest recovery at 56.7% (see Table 5.6). These 
results suggested that the dye concentration on the adsorbent particles could influence the 
recovery of HSAp in 3M KSCN as 2% ZsA Blue had the lowest dye concentration of each of 
the adsorbents in the study (see Table 5.3). If there are fewer ligands available for binding 
then theoretically there should be fewer points of attachment. Hence, it should be easier to 
desorb the product as suggested for anion exchange groups (see Figure 3.7).
5.3.5 The Affinity Capture and Recovery of Human Serum Albumin Nanoparticles in 
the Presence of Insect Cell Culture Lysate
The preliminary affinity capture and recovery of HSAp exploiting the pseudo-affinity 
dye Cibacron Blue 3GA (see Section 5.3.3; 5.3.4) indicated that the affinity system could 
potentially be used to recover nanoparticulate products. One of the important factors 
associated with the recovery of nanoparticulate products such as retrovirus or adenovirus, is 
the recovery from complex feedstocks. Consequently, it was proposed that exploiting an 
affinity system for the fluidised bed adsorption of these products is a potentially suitable 
method for the downstream processing of nanoparticulate products. Fluidised Bed 
Adsorption Chromatography can be employed to circumvent problems associated with the
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Table 5.6 Summary of the adsorptive capacities and recoveries of HSAp at a low initial 
concentration
ADSORBENT
TYPE
I
II
IV
ADSORBENT
STREAMLINE
Blue
PVA Mo Blue
PVA Zr Blue
2% ZsA Blue
HSAp
CAPACITY
(jig/ml adsorbent)
0.89
0.77
0.99
0.93
HSAp
CAPACITY
(particles/ml
adsorbent)
7.88 xlO9
6.80 x!0y
8.76 x!0y
8.23 x!0y
%
RECOVERY
37.2
36.1
42.9
56.7
Table 5.6 represents the capacities and recoveries of HSAp of adsorbents derivatised with 
Cibacron Blue 3GA -with a low initial nanoparticle concentration of 1 xl(f particles/ml of 
supernatant having an equivalent protein concentration of 84ng/ml. Before use the 
adsorbents were washed in Buffer C to equilibrate the system, then 0.4ml of adsorbent was 
added to 6ml of HSAp containing supernatant (Buffer C = 111 mM sodium phosphate buffer, 
pH 6.4 with 0.02% sodium azide and 0.01% Tween 20). The system was mixed for 120 
minutes at room temperature using a rotary mixer with samples taken at regular time 
intervals and analysed using a fluorescence assay (see Section 5.2.6). The adsorptive 
capacities were determined by difference analysis and the recovery was expressed as a 
percentage of the HSAp bound during the adsorption procedure. The HSAp were recovered 
in 6ml of 3M KSCN added to 0.4ml of protein loaded adsorbent after 5 x 1ml washes with 
Buffer C, and mixed for 120 minutes at room temperature using a rotary mixer. Samples 
were taken at regular time intervals and assayed using a fluorescence assay (see Section 
5.2.6).
181
Figure 5.10 Recovery of HSA nanoparticles
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Figure 5.10 represents the recovery ofFITC HSApfrom adsorbents derivatised with
Cibacron blue 3GA dye. After the adsorbents were loaded with HSAp they were washed in Buffer C
(5 x 1ml) to remove unbound nanoparticles. Adsorbent (0.4ml) was added to 6.0ml ofSMKSCN
and mixed at room temperature for 2 hours on a rotary mixer. Samples were taken at regular time
intervals and analysed in duplicate using a fluorescence assay (see Section 5.2.6).
The percentage recovery represents the concentration of protein expressed as a percentage of the
protein bound.
(Buffer C = lllmM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 0.01%
Tween 20).
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chromatography of complex feedstocks (see Section 1.3; 1.4), whilst affinity chromatography 
can be exploited to attempt to separate the product from the feedstock components.
Proof of principle experiments were completed employing insect cell culture lysate 
(supplied by R. Jarman-Smith) as a representative feedstock (see Section 5.2.7) from which 
HSAp were recovered. HSAp were added to insect cell culture lysate to a final concentration 
of 108 particles/ml of supernatant. Figures 5.11 and 5.12 represent the adsorption profiles for 
FITC HSAp (measured employing fluorescence spectroscopy; see Section 5.2.6) and cell 
culture lysate components (measured employing the Bradford assay; see Section 3.2.6). The 
FITC HSAp load was exhausted (see Figure 5.11) which was attributed to the presence of 
feedstock components with which HSAp could associate including enzymes and growth 
factors produced by the cells during cell growth.
The profiles of cell lysate component adsorption were as expected subsequent to the 
studies completed for the adsorption of BSAs to the anion exchange derivatives of the 
adsorbents (see Chapter 3). The Type I microporous adsorbent, STREAMLINE Blue, 
exhibited a slow adsorption that did not reach completion within the experimental time (120 
minutes; see Section 5.2.8). The adsorption onto the Type II macroporous adsorbents (PVA 
Mo Blue and PVA Zr Blue) and the Type IV pellicular adsorbent (2% ZsA Blue) was rapid 
which was attributed to the respective adsorbent structures.
2% ZsA Blue exhibited the lowest adsorption capacity of each of the adsorbents 
included in this study (see Table 5.7) that was attributed to either the low dye content of the 
adsorbent solid phase (see Table 5.3) or the limited surface area available for adsorption due 
to the pellicular structure of the adsorbent solid phase (see Section 1.5).
It is noteworthy that all of the adsorbents in the study demonstrated significant 
adsorption capacities for the insect cell culture lysate components. This suggests that this 
model affinity system (Cibacron Blue 3GA and human serum albumin) is not an ideal system
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Figure 5.11 HSA nanoparticle adsorption at a low nanoparticle concentration
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Figure 5.11 represents the adsorption ofHSApfrom cell lysate at a concentration of Iff 
particles/ml. Before use the adsorbents were washed in Buffer C to equilibrate the system. Adsorbent 
(0.4ml) was added to 6. Oml of cell lysate containing FITC conjugated nanopartides. The system was 
mixed for 2 hours at room temperature using a rotary mixer. Samples (0.4ml) were taken at regular 
time intervals and analysed using a fluorescence assay.
The HSAp used in this study were estimated to contain 12.7 moles FITC per mole of protein. 
(Buffer C = lllmM sodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 
0.01%Tween20).
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Figure 5.12 The adsorption of insect cell culture lysate components to the selected 
adsorbent solid phases
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Figure 5.12 represents the adsorptive capture of insect cell culture lysate to the 
selected adsorbent solid phases immobilised with Cibacron Blue 3GA dye. The 
adsorbent (O.lml) was washed in Buffer Cprior to use to equilibrate the system, then 1.5ml 
of cell culture medium (containing lysedsf-9 cells) was added and mixed for 2 hours at room 
temperature using a rotary mixer. Samples were taken at regular time intervals and analysed
in duplicate using the Bradford assay (see Section 3.2.6).
The initial Co concentration for the cell culture medium was measured at 1.05mg/ml
using the Bradford assay (refer to Section 3.2.6). C/Co is measure of the protein 
concentration as a fraction of the initial protein concentration.
(Buffer C = 111mMsodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 
0.01%Tween20).
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Table 5.7 Summary of the adsorptive capacities of total protein and recoveries of insect 
cell culture lysate from the selected adsorbent solid phases
ADSORBENT
TYPE
I
II
IV
ADSORBENT
STREAMLINE
Blue
PVA Mo Blue
PVA Zr Blue
2% ZsA Blue
DYE
CONCENTRATION
(fimol dye/settled ml
adsorbent)
3.9
0.068
0.079
0.01
TOTAL
PROTEIN
CAPACITY
(mg/ml
adsorbent)
6.32
4.59
4.46
3.53
%
RECOVERY
49.6
83.1
77.9
82.2
Table 5.7 represents the total protein capacities and recovery of the cell lysate components to 
adsorbents derivatised with Cibacron Blue 3GA dye (see Figure 5.13 and 5.15). Before use 
the adsorbent was extensively washed in Buffer C to equilibrate the system and 0.4ml of 
adsorbent was added to 6ml of cell lysate. The system was mixed for 120 minutes at room 
temperature using a rotary mixer with samples taken at regular time intervals and analysed 
using the Bradford assay and the capacities were determined by difference analysis. The 
recovery ofHSAp in 6ml ofSMKSCN that was added to 0.4ml of protein loaded adsorbent is 
represented as the protein recovered expressed as a percentage of the protein adsorbed. 
(Buffer C = 111mMsodium phosphate buffer, pH 6.4 with 0.02% sodium azide and 0.01% 
Tween 20).
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for the separation of nanoparticulate products from complex feedstocks. Ideally SDS PAGE 
analysis should have been completed to assess the adsorption and desorption and to 
determine product purity. However time constraints within the project did not allow for this.
Figures 5.13 and 5.14 represent the desorption profiles of HSAp and cell lysate 
components respectively. It is immediately apparent that the desorption of HSAp (measured 
by fluorescence spectroscopy; see Section 5.2.6) in the presence of cell culture lysate is very 
different to the desorption from a clean system (see Figure 5.10) as HSAp appeared to desorb 
within 10 minutes after the addition of 3M KSCN (see Figure 5.13). This could be attributed 
to the presence of the cell culture lysate components as the HSAp could have been bound less 
strongly to the Cibacron Blue 3GA ligand due to an increased number of interactions of the 
ligand with the cell culture lysate components (see Figure 5.11). In addition, the recovery of 
HSAp was greater in the presence of lysate components (see Figure 5.13; Table 5.8) than in 
clean systems (see Figure 5.10; Table 5.6). This may be attributed to both the presence of the 
lysate components and the dye concentration of the adsorbent solid phases. It was proposed 
that the recovery of HSAp from a clean system was low due to the increased number of 
potential ligand attachments per HSAp. Therefore, if the cell culture lysate components are 
interacting with the Cibacron Blue 3GA dye (as suggested in Figure 5.12) then fewer ligands 
will be available per HSAp. Thus reducing the affinity of the adsorbent for HSAp and 
increasing the recovery (see Figure 3.7).
The profiles for the recovery of cell culture lysate components (see Figure 5.14) were 
as expected based upon assumptions made about the adsorbents from previous studies (see 
Chapter 3). STREAMLINE Blue exhibited the poorest recovery at 49.6% that was attributed 
to the internal and external geometry of the adsorbent solid phase categorised as a 
microporous adsorbent (Type I) for the present study. It was expected that the small 
molecular weight components within the feedstock would diffuse into the microporous
187
Figure 5.13 Recovery of HSA nanoparticles
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Figure 5.13 represents the recovery ofFITC HSApfrom adsorbents derivatised with 
Cibacron blue 3GA dye. After the adsorbents were loaded with nanoparticles 
recovered from cell culture lysate the adsorbents were washed in Buffer C to 
remove unbound protein from the system. Adsorbent (O.lml) was added to 1.5ml 
ofSMKSCNand mixed for 2 hours at room temperature using a rotary mixer. 
Samples were taken at regular time intervals and analysed in duplicate using a 
fluorescence assay (see section 5.2.6).
(Buffer C = lllmMsodiumphophate buffer, pH 6.4 with 0.02% sodium azide and 
0.01%Tween20).
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Figure 5.14 The recovery of insect cell culture lysate components from the selected adsorbent 
solid phases
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Figure 5.14 represents the recovery of insect cell culture lysate using 3MKSCN 
from the selected adsorbent solid phases immobilised with Cibacron Blue 3GA. The protein 
loaded adsorbent was washed in Buffer C (5 x 1ml) to remove any unbound cell culture lysate. 
The adsorbent (0.1ml) was added to 1.5ml ofBMKSCNand mixed for 2 hours at room 
temperature using a rotary mixer. Samples (0.1ml) were taken at regular time intervals and 
analysed in duplicate using the Bradford assay (see Section 3.2.6).
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Table 5.8 Summary of the adsorptive capacities and recoveries of insect cell culture 
lysate containing HSAp from the selected adsorbent solid phases
ADSORBENT
TYPE
I
II
IV
ADSORBENT
STREAMLINE
Blue
PVA Mo Blue
PVA Zr Blue
2% ZsA Blue
DYE
CONTENT
(fimol/ml
settled
adsorbent)
3.9
0.068
0.079
0.01
HSAp
CAPACITY
(fig/ml
adsorbent)
1.26
1.26
1.26
1.26
HSAp
CAPACITY
(particles/ml
adsorbent)
1.1x10"
1.1x10"
1.1x10"
1.1x10"
%
RECOVERY
80.2
63.4
91.3
82.7
Table 5.8 represents the protein capacities and recoveries of the HSAp suspended in cell 
culture lysate to adsorbents derivatised with Cibacron Blue 3GA. Before use the adsorbents 
-were extensively washed in Buffer C to equilibrate the system and 0.4ml was added to 6ml of 
cell culture lysate. The system was mixed for 2 hours at room temperature using a rotary 
mixer with samples taken at regular time intervals and analysed in duplicate using the 
fluorescence assay (see Section 5.2.6). HSAp were recovered in 6ml of KSCN added to 0.4ml 
of HSAp loaded adsorbent and mixed for 2 hours at room temperature. Samples were taken 
at regular time intervals and assayed in duplicate using the fluorescence assay. The % 
recovery was determined as a percentage of the total capacity. (Buffer C = lllmM sodium 
phophate buffer, pH6.4 with 0.02% sodium azide and 0.01% Tween 20).
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structure of the adsorbent as was indicated in Figure 5.12. It was therefore likely that poor 
recovery was due to the impurities being trapped within the adsorbent structure. For the 
remaining adsorbents the recoveries were greater than 77% that was again attributed to the 
respective adsorbent structures (see Table 5.7). The Type II macroporous adsorbents (PVA 
Mo Blue and PVA Zr Blue) were assumed to be characterised by large macropores (see 
Section 2.1.5) that would facilitate the diffusion of the impurities out of the adsorbent 
structure during the elution process. In addition, 2% ZsA Blue was a Type IV, pellicular 
adsorbent that had shorter diffusion distances over which the impurities were required to 
diffuse (see Figure 2.1).
5.3.6 General Conclusions
The aim of this chapter was to investigate the adsorption of HSAp exploiting 
industrially realistic particle numbers in a realistic complex feedstock (insect cell culture 
lysate) employing affinity chromatography. Initial experiments were completed with HSAp 
concentrations comparable to that for the BSAp batch binding experiments completed in 
Chapter 3. The results indicated HSAp capacities for Cibacron Blue 3GA derivatised 
adsorbents were similar to those achieved exploiting anion exchange chemistries for the 
adsorption of BSAp (see Table 3.4). In addition, the recovery of HSAp using 3M KSCN was 
adequate particularly for STREAMLINE Blue (Type I) and PVA Mo Blue (Type II) that 
exhibited recoveries greater than 90% (see Table 5.4). As a consequence of these results 
batch binding experiments were completed to assess the adsorption of HSAp at a 
concentration of 108 particles/ml to the Cibacron Blue 3GA derivatised adsorbents. All of the 
adsorbents included in the present study exhibited similar capacities due to the limited 
product available (see Table 5.6). However, the recovery of HSAp in 3M KSCN was poor at 
less than 50% for STREAMLINE Blue (Type I), PVA Mo Blue (Type II) and PVA Zr Blue
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(Type II). 2% ZsA Blue demonstrated that highest recovery at 56% that was attributed to the 
low dye content of the adsorbent solid phase (see Table 5.3).
The recovery of HSAp was then further investigated exploiting an insect cell culture 
lysate as a representative complex feedstock. It was noted that the HSAp load was exhausted 
within 10 minutes and the recovery (in 3M KSCN) was better than that for HSAp desorbed in 
a clean system (compare Table 5.6 and Table 5.8). This was attributed to the presence of cell 
culture lysate components. The components of the lyaste are likely to include proteins such 
as enzymes and cell growth factors with which the FITC conjugated nanoparticles could 
electrostatically interact. Figures 5.13 and 5.15 indicate that there is a significant degree of 
adsorption of the cell lysate components, hence if the nanoparticles are interacting with these 
products then they could be removed from the sampling supernatant. Overall the results 
produced were similar to those for anion exchange chromatography. Therefore it was 
concluded that this particular affinity system would not be suitable for the recovery of 
nanoparticulate products from complex feedstocks. It is noteworthy that the FITC or 
Rhodamine B Isothiocyante conjugated HSAp are expected to behave differently to native 
HSAp due to the conjugation of the fluorescent probes to the lysine residues of human serum 
albumin. It was expected that the adsorption of HSAp would be influenced in addition to the 
likely occurence that the charge of the protein was altered as a consequence of the surface 
lysine residues (negatively charged residues) being the point of conjugation to the probe.
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CHAPTER 6
CONCLUSIONS AND FURTHER WORK 
6.1 Final Conclusions
The study presented here was concerned with investigating the effect of adsorbent 
design upon the separation of nanoparticulate products such as protein nanoparticles as 
representative viruses, plasmid DNA and drug delivery vehicles. Candidate adsorbent solid 
phases having discrete internal and external geometries were selected and characterised both 
physically and biochemically (see Table 2.1).
The current chromatographic processes for the purification of viruses and plasmid 
DNA employ materials and techniques primarily designed for the purification of smaller 
protein products. Product rich cell culture supernatants and cell lysates are currently clarified 
and concentrated by ultrafiltration/diafiltration and density gradient centrifugation techniques 
(Prazeres et al, 1999). The product is commonly recovered in a fixed bed chromatography 
step with adsorbent solid phases designed principally for the purification of proteins (Huyghe 
et al, 1995; Blanche et al, 2000). There are problems associated with such techniques for the 
recovery of these products, as due to process inefficiencies there is loss of product integrity, 
particularly with viruses and inherent handling losses. In addition, the adsorbent solid phases 
employed for the fixed bed recovery of the product are not optimally designed for such 
operations with nanoparticulate products resulting in product losses due to an inefficient 
system where product entrapment and co-purification of contaminants is likely.
A revised process method was proposed integrating the clarification, concentration 
and primary capture steps (see Figure 1.3). By employing fluidised bed adsorption 
chromatography the downstream processing steps are simplified. To increase the efficiency 
of this primary capture step both the adsorbent design and suitable ligands for nanoparticulate 
capture were considered.
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6.1.1 Candidate Adsorbent Solid Phases
The experiments presented in Chapter 2 investigated the physical characteristics of 
adsorbent solid phases having different internal and external geometries designated Types I 
to IV (see Table 2.1 and Figure 2.1). Microporous adsorbents were designated as Type I 
adsorbent solid phases and were characterised by pore diameters of less than 0.2um. 
Therefore the commercial benchmark adsorbent, STREAMLINE was designated as a Type I 
adsorbent. Type II adsorbent solid phases were classified as macroporous adsorbents having 
pore sizes greater than 0.6um in diameter (see Figure 2.1). Type II adsorbents included in the 
present study were, POROS SOD, PVA, PVA TiO2, PVA Mo, PVA Zr, Celbead (II) and 
Celbead Amino. These included both commercial and custom designed adsorbents (Swedish 
and Indian constructs). Two solid adsorbents were also included in the study and designated 
as Type III adsorbent solid phases, Toyopearl-HW40 and the Birmingham construct 
perfluorocarbon emulsion particles. The remaining adsorbent in the study, 2% ZsA 
(Birmingham construct) was designated as a Type IV pellicular adsorbent that comprised a 
dense solid zirconium silicate core surrounded by a 20um porous skin of agarose having an 
assumed pore size of less than 0.4um. The adsorbent solid phases were characterised in terms 
of size, shape, density and bed expansion characteristics to assess the suitability of these 
adsorbents for fluidised bed adsorption operations.
The physical characterisation studies (see Chapter 2) indicated that the candidate 
adsorbents were generally spherical in shape with the exception of the custom fabricated 
adsorbents Celbead (II) and Celbead Amino (Type II; see Figure 2.1; see Figures 2.8-2.18). 
The sizes of the adsorbent solid phases, determined using a Malvem Mastersizer (see Section 
2.2.7.2; Malvern Instruments, UK) were varied (see Table 2.3). Perfluorocarbon emulsion 
particles were shown to have a particle size of lOum whilst PVA Zr particles were 525um in 
diameter (see Table 2.3). The measured densities of the adsorbents also varied with
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perfluorocarbon emulsion particles having a density of 2.1g/ml in comparison to PVA at 
1.12g/ml (see Table 2.4). Bed expansion characterisation studies indicated that all the 
fluidisable candidate adsorbent solid phases, with the exception of the perfluorocarbon 
emulsion, exhibited superior expansion characteristics in comparison to the commercial 
benchmark STREAMLINE (see Figure 2.20). POROS SOD and Toyopearl HW-40 were not 
included in the bed expansion studies due to their limited densities (see Table 2.4). The non- 
derivatised candidate adsorbents were immobilised with the anion exchange chemistry, 
diethylaminoethyl (DEAE), and the relative small ion capacities (SIC) were determined. SIC 
of the adsorbent solid phases varied depending upon the reactivity of the hydroxyls on the 
base material (agarose, cellulose or polyvinyl alcohol) and the surface area available for 
immobilisation (see Table 2.5).
Celbead Amino demonstrated a superior performance in comparison to the other 
adsorbent solid phases included in the study in terms of bed expansion characteristics (see 
Figure 2.20). All of the adsorbents included in the physical characterisation studies were 
further investigated by batch adsorption/desorption studies as described in Chapter 3.
6.1.2 Selection of Candidate Adsorbents Exploiting Synthetic Nanoparticles
Experiments summarised in Chapter 3 investigated the biochemical performance of 
the candidate adsorbent solid phases by investigating the adsorption/desorption 
characteristics of BSAs and BSAp exploiting anion exchange chromatography. BSAs was 
included in the present study to represent small molecular weight contaminants commonly 
found in cell culture lysates such as cells, cell debris and DNA and also as a model for the 
recovery of product from product components. A major problem associated with 
commercially realistic studies of virus or plasmid DNA recovery is the quantity of 
nanoparticulates required for representative studies. This problem was circumvented by
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exploiting synthetic nanoparticles comprised of coacervated and crosslinked bovine or human 
serum albumin (see Section 3.1.1). The fabricated nanoparticles were sized using photon 
correlation spectroscopy (see Section 3.1.2). BSAp had an average particle size of 150nm in 
diameter (see Figure 3.4) whilst HSAp had an average particle size of 66nm in diameter (see 
Figure 5.3).
For the purpose of this study, STREAMLINE DEAE was selected as the benchmark 
adsorbent solid phase and the batch adsorption/desorption characteristics of each adsorbent 
BSAs and BSAp was investigated. The results indicated that the adsorbent design influenced 
the adsorption and recovery of both BSAs and BSAp. Rapid adsorption and desorption of 
BSAs was characteristic of the adsorbents perceived to have reduced diffusional limitations 
in comparison to STREAMLINE DEAE (see Figure 3.2). This included the macroporous 
(Type II) adsorbents where the convective pores were thought to facilitate the transport of 
large nanoparticulate products through the adsorbent particles to smaller diffusive pores 
contained within the adsorbent structure. The solid adsorbents had exclusive surface 
adsorption and so there were no diffusional limitations for BSAs adsorption. The surface area 
over which adsorption occurred was also thought to be reduced in the pellicular adsorbent 
(see Figure 3.2).
The relatively solid adsorbent Toyopearl HW-40 (Type III, see Figure 2.1) exhibited 
an unexpected desorption behaviour (see Figure 3.3). BSAs desorbed slowly suggesting that 
there were diffusional limitations due to BSAs penetration into the adsorbent structure. This 
was determined to be unlikely due to the limited pore size of Toyopearl HW-40 (see Table 
2.1). Therefore it was assumed that the high small ion capacity (see Table 2.5) had a negative 
effect upon the desorption of BSAs. The effect of SIC on the adsorption and desorption of 
BSAs has not been fully investigated in this study. POROS SOD (Type II, see Figure 2.1) 
exhibited the highest BSAs capacity whilst the Type II, III and IV adsorbents all exhibited
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adequate recoveries in comparison to STREAMLINE (see Table 3.4) attributed to the 
internal and external structures of the adsorbents. In contrast the Type II adsorbents Celbead 
(II) and Celbead Amino performed poorly in the adsorption and desorption studies 
respectively.
The adsorption and recovery of BSAp also appeared to be influenced by the design of 
the adsorbent solid phase. The results indicated two distinct adsorption profiles (see Figure 
3.5) attributed to the pore structures of the adsorbents included in the study. The adsorbents 
with pore dimensions expected to exclude nanoparticles (Type III solid adsorbents) reached 
an equilibrium within 20 minutes attributed to exclusive surface binding. In contrast the 
adsorbent solid phases believed to possess larger pores (i.e. Type II macroporous adsorbents) 
reached equilibrium after an experimental time of 60 minutes indicating that BSAp had 
penetrated into the macroporous structure. Celbead Amino exhibited rapid BSAp adsorption 
that suggested that the adsorbent was not macroporous. The Type II adsorbents (with the 
exception of Celbead Amino) all exhibited diffusion limited adsorption that suggested that 
the macroporous classification was correct (see Figure 3.5). Desorption studies also 
confirmed that the small ion capacity (SIC) appeared to affect the recovery of BSAp. Both 
Type III adsorbents (Toyopearl HW-40 DEAE and perfluorocarbon emulsion DEAE) were 
characterised by slow desorption profiles (see Figure 3.6), which could only be attributed to 
the concentration of anion exchange groups available for adsorption since no penetration 
could have occurred.
Subsequent to the batch adsorption studies, the impact of small ion capacity on the 
recovery of BSAp was investigated exploiting the perfluorocarbon emulsion particles. This 
adsorbent was selected on the assumption of being solid in nature. Hence all the anion 
exchange groups immobilised onto the adsorbent would be present at the adsorbent surface 
and available for adsorption. Five perfluorocarbon emulsions were manufactured having
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different SIC (see Section 3.2.8) and the adsorption and desorption of BSAp was studied. The 
results indicated that as the SIC decreased the binding capacities decreased and the recovery 
increased. It was therefore concluded that SIC influences the recovery of BSAp, but to 
optimise anion exchange adsorbents suitable for the recovery of nanoparticulate products 
requires further investigation.
The maximum binding capacities of BSAp to the selected adsorbent solid phases were 
determined using Langmuir assumptions. The results generated compared well with the 
theoretical linear isotherm (a reciprocal plot of the Langmuir isotherm) and thus it was 
concluded that the adsorption of BSAp to the selected adsorbent solid phases followed 
Langmuir assumptions (see Section 3.2.1). Subsequent to the studies presented in Chapter 3 
POROS SOD, PVA DEAE, perfluorocarbon emulsion DEAE and Toyopearl DEAE were 
eliminated from further study, based upon conclusions about the physical and biochemical 
performance of the adsorbent solid phases.
6.1.3 Laser Scanning Confocal Microscopy as a Tool for Visualising Nanoparticulate 
and Soluble Protein Adsorption
Chapter 4 summarises experiments designed to visualise the adsorption of both BSAs 
and BSAp to the selected adsorbent solid phases. In Chapter 3 conclusions were made about 
the selected adsorbent solid phases based upon batch binding experimentation. This is an 
indirect method of assessing the performance of the adsorbent solid phases as the results only 
indicate how much protein (soluble or particulate) bound to the adsorbents and not how or 
where the protein was adsorbing. Therefore to obtain a realistic picture of the adsorptive 
capture laser scanning confocal microscopy (LSCM) was employed. Fluorescently labelled 
BSAs and BSAp were adsorbed to the selected adsorbents in an equivalent manner to the 
batch binding studies. The adsorbent particles were then visualised at equilibrium by LSCM.
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All of the adsorbents included in the study (PVA TiO2 DEAE, PVA Mo DEAE, PVA Zr 
DEAE, Celbead (II) DEAE, Celbead Amino, 2% ZsA DEAE and STREAMLINE DEAE) 
were characterised by adsorption in an outer layer of the adsorbent structure, whilst the inner 
part of the adsorbent remained unused. Celbead (II) DEAE was an exception to this 
observation where the pore structure can clearly be seen (see Figure 4.13).
The work completed in Chapters 3 and 4 indicated that anion exchange 
chromatography is not a suitable technique for the separation of nanoparticulate products 
from product components or complex feedstocks. All of the adsorbent solid phases included 
in the study exhibited high adsorption capacities for BSAs as well as BSAp. The anion 
exchange ligand, DEAE, attracts negatively charged biomolecules that complex biological 
feedstocks are likely to comprise.
6.1.4 The Recovery of Representative Nanoparticulates from a Representative 
Feedstock
Chapter 5 summarises experiments exploiting the model affinity system of Cibacron 
Blue 3GA and serum albumin. Nanoparticles fabricated from human serum albumin were 
recovered using the four remaining adsorbents (STREAMLINE, PVA Mo, PVA Zr and 2% 
ZsA) immobilized with the Cibacron Blue 3GA dye. HSAp were also recovered exploiting 
low nanoparticulate numbers representative of retroviral litres (Hughes, 2001) and in the 
presence or absence of cell culture lysate. The initial adsorption/desorption studies completed 
with HSAp indicated that this affinity model could be exploited for the recovery of 
nanoparticulate products. Therefore further studies were completed using an industrially 
realistic particle number of 108 particles/ml of supernatant. The results indicated that all of 
the adsorbents performed poorly under these conditions. However, to complete the study 
HSAp at low concentrations were recovered from an insect cell culture lysate, a
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representative feedstock. In the presence of cell culture lysate the adsorption and recovery of 
HSAp with the Cibacron Blue 3GA ligand was improved with higher adsorption capacities 
and greater recoveries (see Table 5.6 and 5.7). This was attributed to the presence of the cell 
lysate components influencing the adsorption and desorption processes.
Based upon these results Cibacron Blue 3GA could be exploited for the recovery of 
nanoparticulate products. However, the adsorption/desorption of the cell culture lysate 
components was also investigated. The results indicated that there was a significant 
adsorption of the components on all of the adsorbent solid phases included in the present 
study. This was attributed to the negatively charged sulphate groups present within the 
structure of Cibacron Blue 3GA (see Figure 5.1) interacting with positively charged 
biomolecules. It was therefore concluded that Cibacron Blue 3GA would not be suitable for 
the capture and recovery of nanoparticulate products from complex biological feedstocks.
6.1.5 Concluding Remarks
Throughout the study the adsorbents demonstrating a poor performance either 
physically or biochemically, were removed from the study. The four adsorbents carried 
forward to the final study were considered to exhibit a superior performance for the recovery 
of nanoparticulate products. However, the study indicated that both the PVA Mo and PVA Zr 
(Swedish constructs) and 2% ZsA (Birmingham construct) could potentially be used for the 
recovery of nanoparticulate products demonstrating a better overall performance than the 
benchmark, STREAMLINE. In addition, it was also concluded in the study that anion 
exchange chromatography and dye affinity chromatography were not suitable methods for 
the recovery of such products due to the interactions of the ligands with the cell culture lysate 
components. It is also important to note that using such chemistries would not enable the 
particulate product to be separated from product components.
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6.2 Further Work
Fluidised Bed Recovery of Nanoparticulate Products
The work completed in this study has highlighted that 2% ZsA, PVA Mo and PVA Zr 
demonstrated adequate recoveries of nanoparticulate mimics in comparison to the bench 
mark adsorbent STREAMLINE, based upon batch adsorption studies (see Chapters 3-5). 
Batch adsorption studies were adopted as scouting experiments to identify adsorbents that 
would be suitable for fluidised bed adsorption of nanoparticulates. Therefore the next 
obvious stage to this work would be to complete laboratory scale fluidised bed adsorption 
studies to assess the adsorbents further. This work would provide information concerning the 
dynamic binding capacities of the adsorbents as a function of the flow rate applied to the bed 
and hence indicate more accurately the potential performance of these adsorbents in a large 
scale fluidised bed process for the recovery of industrially relevant nanoparticulate products.
Recovery of Industrially Realistic Nanoparticulate Products
The work completed in this study has been concerned with the capture and recovery of 
nanoparticulate proteins exploited as naive mimics for products such as retrovirus, 
adenovirus and plasmid DNA. Therefore proof of principle experiments are required 
employing such nanoparticulate products to investigate the effect of industrially relevant 
feedstocks on the recovery of nanoparticulates in relation to the adsorbent design.
Alternative Modes of Adsorption
The introduction of realistic products such as viruses will mean that alternative modes 
of capture should be considered. It was concluded that both anion exchange and dye affinity 
chromatography would not be suitable systems due to the significant degree of adsorption of 
soluble protein and cell culture lysate components. Other ligands that could be successfully
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exploited for such applications include immobilised metal affinity chromatography (Porath et 
al, 1975). The principle of this technique is that amino acid residues such as histidine and 
also lysine and tryptophan to a degree can specifically interact through nonbonding lone-pair 
electron coordination with metal ions such as Cu (II), Ni (II) and Zn (II). In addition, for viral 
purification a histidine tag could be attached to the surface of the virus enabling purification 
of the product. Affinity systems could also be exploited, such as antigen-antibody 
interactions or interactions between molecules such as streptavidin and biotin.
Alternative Methods for the Recovery of Nanoparticulate Products
It is noteworthy that these ligands would be unlikely to separate the desired product 
from product components and therefore affinity chromatography techniques may not be 
suitable for the recovery of pure nanoparticulate products. Therefore other techniques should 
be considered for downstream processing of viruses and plasmid DNA. Gel filtration 
chromatography could potentially be used for the primary purification of large products from 
complex feedstock on the basis of size, however the viscosity of such feedstocks could be a 
limiting factor. Membrane separation techniques could also be considered as a suitable 
method for the purification of nanoparticulate products from complex feedstocks such that 
large pores within the membrane structures should enable the use of viscous, complex 
feedstocks, whilst the ligands attached to the membrane surface will capture the product. This 
is a technique that will be dependent on suitable ligands for separation and separating the 
product from product components may also be difficult.
Modification of Adsorbent Design to Improve Nanoparticulate Recovery
The results presented in this study highlighted that both pellicular (2% ZsA) and 
macroporous adsorbents (PVA Mo and PVA Zr) exhibited a superior performance to
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conventional adsorbent solid phases. All of these adsorbents were prototypes hence there is 
much scope for the improvement of these adsorbents by altering the manufacturing process. 
Work has been completed on modifying the pellicular adsorbent 2% ZsA (Jahanshahi et al, 
manuscript submitted) to produce a robust adsorbent for direct product sequestration from 
cell disruptates. The results from this study and the work presented here indicated that the 
pellicular structure of the adsorbent resulted in potentially faster processing times and hence 
further work investigating the optimum pellicle depth for adequate recoveries of 
nanoparticulates whilst limiting processing times could be completed.
Recent work completed within the Biochemical Recovery Group, (Zhanren Zhang, 
personal communication) has been concerned with the production of adsorbents comprising a 
laminate coating of underivatised material. This work has potential applications for the 
recovery of nanoparticulate products as this laminate layer should enable the penetration of 
small products within the system, such as proteins and DNA whilst the larger desirable 
products will remain within the supernatant.
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Appendix I Polyvinyl alcohol calibration curve
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Appendix I represents a PVA calibration curve for determining the concentration of samples 
containing unknown quantities of PVA utilising the iodometric assay (see Section 2.2.3.1). 
PVA samples were prepared having different concentrations and were added to an iodine 
solution (see Section 2.2.3.1) in a 1:2 ratio. The samples were mixed and a green colour 
complex was formed which was measured spectrophotometrically at 670nm against a buffer 
blankoflOmMTris-HCl buffer, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Appendix II Bradford calibration curve for soluble BSA
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Appendix II represents the Bradford calibration curve for soluble BSA. Samples of the 
protein are prepared at concentrations between 5 and 50jug/mlfrom a 2mg/ml stock solution 
supplied by the manufacturer (PERBIO), in lOmM Tris-HCl, pH 7.4 with 0.02% Tween 20 
and 0.01% sodium azide. An equal volume of Bradford assay reagent (see Section 3.2.6) is 
added to the sample, mixed and stored at room temperature for 5 minutes. The absorbance of 
the sample at 595nm is measured and plotted against the protein concentration to ascertain a 
calibration curve to determine unknown protein concentrations against a buffer blank.
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Appendix III IPL-41 Insect cell culture medium components
COMPONENT
Inorganic Salts
CaCl2 . H2O (anhydrous)
CoCl2 . 6H2O
CuCl2 (anhydrous)
FeSO4 . 7H2O
MgSO4 (anhydrous)
MgCl2 . 4H2O
(NH4)6Mo7O25 . 4H2O
KC1
NaHCO3
NaH2PO4
ZnCl2
Amino Acids
p-Alanine
L-Arginine.HCl
L-Aspartic Acid
L-Asparagine (anhydrous)
L-Cystine.2HCl
L-Glutamic Acid
L-Glutamine
Glycine
L-Histidine
Hydroxy-L-Proline
L-Isoleucine
L-Leucine
L-Lysine.HCl
L-Methionine
L-Phenylalanine
L-Proline
DL-Serine
L-Threonine
L-Tryptophan
L-Tyrosine.2Na
L-Valine
g/L
0.5
0.00005
0.000158
0.00055
0.918
0.00002
0.00004
1.2
0.35
1.009
0.00004
0.3
0.8
1.3
1.3
0.13
1.5
1.0
0.2
0.2
0.8
0.75
0.25
0.7
1.0
1.0
0.5
0.4
0.2
0.1
0.36
0.5
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Appendix IV Cibacron Blue 3GA calibration curve
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Appendix IV represents a Cibacron Blue 3GA calibration curve constructed by measuring the 
absorbance of the dye at 595nm at varying concentrations. By plotting the absorbance 
against dye concentration enabled a calibration curve to be constructed. Subsequent to the 
immobilisation of the dye to the adsorbent solid phases (see Section 5.2.4) the dye 
concentration was estimated after removal by acid hydrolysis using this calibration curve 
(see Section 5.2.5).
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Appendix V Bradford calibration curve for soluble HSA
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Appendix V represents the Bradford calibration curve for soluble HSA. Samples of the 
protein are prepared at concentrations between 5 and 25ug/mlfrom a 2mg/ml stock solution 
in Buffer C. An equal volume of Bradford assay reagent (see Section 3.2.6) is added to the 
sample, mixed and stored at room temperature for 5 minutes. The absorbance of the sample 
at 595nm is measured and plotted against the protein concentration to ascertain a 
calibration curve to determine unknown protein concentrations against a buffer blank of 
lOmMTris-HCl, pH 7.4 with 0.01% Tween 20 and 0.02% sodium azide).
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Appendix VI Fluorescence calibration curve
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Appendix VI represents an example fluorescence calibration curve (see Section 5.2.6) 
determined from the fluorescence of samples, measured with a PERKIN-ELMER fluorimeter 
plotted against the protein concentration determined by the Bradford assay (see Section 
3.2.6). The protein concentration of unknown samples was determined by relating the 
fluorescence detected to the protein concentration.
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Appendix VII Amino acid analysis data
AMINO ACID NMOLE/ML fiG/ML MG/ML G/100G
Cysteic acid
Aspartic acid
Threonine
Serine
Glutamic acid
Proline
Glycine
Alanine
Cystine
Valine
Methionine
Isoleucine
Leucine
Tyrosine
Phenylalanine
Histidine
Tryptophan
Lysine
Arginine
-
166.50
108.53
97.60
182.54
78.00
44.42
180.30
37.11
127.51
14.48
29.74
204.23
54.80
91.63
74.33
150.42
77.25
-
19
11
9
24
8
3
13
8
13
2
3
23
9
14
10
-
19
12
-
0.02
0.01
0.01
0.02
0.01
0.00
0.01
0.01
0.01
0.00
0.00
0.02
0.01
0.01
0.01
0.02
0.01
0.00
1.92
1.10
0.85
2.36
0.76
0.25
1.28
0.82
1.26
0.34
0.34
2.31
1.35
1.35
1.02
0.00
1.93
1.21
Totals 1,719.39 198 0.20 19.84
Dr J Fox, Alta Biosciences, University of Birmingham, completed the amino acid analysis 
after acid hydrolysis for 24 hours at ll(fC. Asn and Gin are completely converted to Asp 
and Glu during the acid hydrolysis of the protein. The values for Thr and Ser have been 
corrected for hydrolysis losses of 5% and 10% respectively. Trp usually suffers complete loss 
during acid hydrolysis and is not normally quantified. In proteins Cys is usually observed as 
cystine. The recovery of Cys is variable 'when using standard hydrolysis conditions. The 
values have been rounded off.
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